|
US6630328B2
(en)
|
1909-07-15 |
2003-10-07 |
Genencor International, Inc. |
Increasing production of proteins in gram-positive microorganisms
|
|
US4046636A
(en)
*
|
1974-06-20 |
1977-09-06 |
Syva Company |
Diazepam enzyme conjugates
|
|
US4191613A
(en)
*
|
1971-05-14 |
1980-03-04 |
Syva Company |
Malate dehydrogenase conjugates for enzyme immunoassays
|
|
US4203802A
(en)
*
|
1971-05-14 |
1980-05-20 |
Syva Company |
Inhibitable enzyme amplification assay
|
|
US3905871A
(en)
*
|
1971-05-14 |
1975-09-16 |
Syva Co |
Lactam conjugates to enzymes
|
|
US4282325A
(en)
*
|
1971-05-14 |
1981-08-04 |
Syva Company |
Enzyme bound corticosteroids
|
|
US4039385A
(en)
*
|
1972-05-08 |
1977-08-02 |
Syva Company |
Cardiac glycoside enzyme conjugates
|
|
NL171930C
(nl)
*
|
1972-05-11 |
1983-06-01 |
Akzo Nv |
Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
|
|
US3790447A
(en)
*
|
1972-07-05 |
1974-02-05 |
Abbott Lab |
Streptococci diagnostic method
|
|
US3975237A
(en)
*
|
1972-11-06 |
1976-08-17 |
Syva Company |
Compounds for enzyme amplification assay - - ecgonine analogs
|
|
US3966556A
(en)
*
|
1972-11-06 |
1976-06-29 |
Syva Company |
Compounds for enzyme amplification assay methadone analogs
|
|
US4040907A
(en)
*
|
1974-06-20 |
1977-08-09 |
Syva Company |
Iodothyronine enzyme conjugates
|
|
US4061466A
(en)
*
|
1974-10-16 |
1977-12-06 |
Ingvar Gosta Holger Sjoholm |
Biologically active composition and the use thereof
|
|
NL7501215A
(nl)
*
|
1975-02-01 |
1976-08-03 |
Akzo Nv |
Methode voor het aantonen en bepalen van een antigeen of antilichaam.
|
|
US4043872A
(en)
*
|
1975-02-20 |
1977-08-23 |
Syva Company |
Polyiodothyronine immunoassay
|
|
USRE32696E
(en)
*
|
1975-09-04 |
1988-06-14 |
Akzona Incorporated |
Enzymatic immunological method for determination of antigens and antibodies
|
|
US4096138A
(en)
*
|
1975-12-08 |
1978-06-20 |
Scherr George H |
Immunological test procedure
|
|
US4166767A
(en)
*
|
1976-03-25 |
1979-09-04 |
Dainippon Pharmaceutical Co., Ltd. |
Insolubilized antibody
|
|
JPS5341420A
(en)
*
|
1976-09-29 |
1978-04-14 |
Mochida Pharm Co Ltd |
Immunochemically measuring methoa of hapten
|
|
GB1572220A
(en)
*
|
1976-10-07 |
1980-07-30 |
Mochida Pharm Co Ltd |
Immunochemical process of measuring physiologically active substances
|
|
US4098876A
(en)
*
|
1976-10-26 |
1978-07-04 |
Corning Glass Works |
Reverse sandwich immunoassay
|
|
US4134792A
(en)
*
|
1976-12-06 |
1979-01-16 |
Miles Laboratories, Inc. |
Specific binding assay with an enzyme modulator as a labeling substance
|
|
IT1153999B
(it)
*
|
1977-03-15 |
1987-01-21 |
Snam Progetti |
Composizione atta alla determinazione della triiodotironina e metodo diagnostico impiegante la stessa
|
|
IL51667A
(en)
*
|
1977-03-16 |
1979-10-31 |
Miles Yeda Ltd |
Immunoassay for the determination of a hapten
|
|
US4156081A
(en)
*
|
1977-04-15 |
1979-05-22 |
Syva Company |
Theophylline antigens and antibodies
|
|
IT1114861B
(it)
*
|
1977-05-12 |
1986-01-27 |
Sclavo Inst Sieroterapeut |
Metodo per la determinazione del contenuto di costituenti di fluidi biologici e mezzi adatti allo scopo
|
|
US5605800A
(en)
*
|
1978-04-13 |
1997-02-25 |
Institut Pasteur |
Method of detecting and characterizing a nucleic acid or a sequence of the latter, and enzymatic reactant for the application of this method
|
|
FR2422956A1
(fr)
*
|
1978-04-13 |
1979-11-09 |
Pasteur Institut |
Procede de detection et de caracterisation d'un acide nucleique ou d'une sequence de celui-ci, et reactif enzymatique pour la mise en oeuvre de ce procede
|
|
DE2825650C3
(de)
*
|
1978-06-12 |
1981-02-05 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Verfahren zur Bestimmung des Thyroxin-bindungsindex im Serum
|
|
US4269938A
(en)
*
|
1979-03-08 |
1981-05-26 |
Eastman Kodak Company |
Assay of peroxidatively active materials
|
|
US4376825A
(en)
*
|
1979-05-07 |
1983-03-15 |
Syva Company |
Enzyme amplification compounds for assays for androgens
|
|
JPS55152459A
(en)
*
|
1979-05-18 |
1980-11-27 |
Yamasa Shoyu Co Ltd |
Method and reagent for measuring quantity of cyclic nucleotide
|
|
US4289748A
(en)
*
|
1979-05-31 |
1981-09-15 |
United States Of America |
Ultrasensitive enzymatic radioimmunoassay method
|
|
US4299916A
(en)
*
|
1979-12-26 |
1981-11-10 |
Syva Company |
Preferential signal production on a surface in immunoassays
|
|
US4391904A
(en)
*
|
1979-12-26 |
1983-07-05 |
Syva Company |
Test strip kits in immunoassays and compositions therein
|
|
FI61965C
(fi)
|
1980-01-17 |
1982-10-11 |
Suovaniemi Finnpipette |
Foerfarande foer detektering av hemoglobin i avfoering
|
|
US4347312A
(en)
*
|
1980-03-20 |
1982-08-31 |
Research Triangle Institute |
Detection of antibiotics in milk
|
|
JPS5714748A
(en)
*
|
1980-07-01 |
1982-01-26 |
Dainippon Pharmaceut Co Ltd |
Kit for quantitative determination of valproic acid and its method for quantitative determination
|
|
US4323647A
(en)
*
|
1980-10-15 |
1982-04-06 |
University Of Miami |
Steric hindrance enzyme immunoassay
|
|
JPS58500874A
(ja)
*
|
1981-06-02 |
1983-05-26 |
エレクトロ−ヌ− クレオニツクス、インコ−ポレ−テツド |
免疫沈殿分析
|
|
US4604365A
(en)
*
|
1981-06-02 |
1986-08-05 |
Electro-Nucleonics, Inc. |
Immunoprecipitation assay
|
|
US5703206A
(en)
*
|
1981-09-08 |
1997-12-30 |
Univ Rockefeller |
Macrophage inflammatory protein 2 (MIP-2)
|
|
US4419453A
(en)
*
|
1981-09-28 |
1983-12-06 |
The Dow Chemical Company |
Immunological agglutination assays with dyed or colored latex and kits
|
|
US4506009A
(en)
*
|
1982-03-30 |
1985-03-19 |
University Of California |
Heterogeneous immunoassay method
|
|
US4535057A
(en)
*
|
1982-07-26 |
1985-08-13 |
Amf Incorporated |
Immunoassay employing monoclonal herpes simplex antibody and biotin-avidin detection system
|
|
US4530900A
(en)
*
|
1982-09-13 |
1985-07-23 |
Seragen Diagnostics Inc. |
Soluble insoluble polymers in enzymeimmunoassay
|
|
ZA841924B
(en)
*
|
1983-07-25 |
1984-10-31 |
Becton Dickinson Co |
Chromogenic tracers for use in an assay
|
|
EP0154631A4
(fr)
*
|
1983-07-27 |
1985-11-25 |
American Hospital Supply Corp |
Procede de reduction selective de nitrile.
|
|
FR2550799B1
(fr)
*
|
1983-08-17 |
1986-02-21 |
Commissariat Energie Atomique |
Compose marque par une enzyme, son procede de preparation et son utilisation en enzymoimmunologie
|
|
DE3433652A1
(de)
*
|
1984-09-13 |
1986-03-20 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Immunchemisches messverfahren fuer haptene und proteine
|
|
US4713347A
(en)
*
|
1985-01-14 |
1987-12-15 |
Sensor Diagnostics, Inc. |
Measurement of ligand/anti-ligand interactions using bulk conductance
|
|
US4786594A
(en)
*
|
1986-05-14 |
1988-11-22 |
Syntex (U.S.A.) Inc. |
Enzyme immunoassay
|
|
DE68928124T2
(de)
*
|
1988-09-02 |
1997-10-16 |
Chiron Corp., Emeryville, Calif. |
Makrophagenabgeleiteter entzündungsmediator(mip-2)
|
|
ATE133714T1
(de)
|
1988-09-29 |
1996-02-15 |
Chiron Corp |
Polynukleotid-bestimmung mit selektierbaren spaltstellen
|
|
CA2031109C
(fr)
*
|
1990-07-27 |
1992-01-28 |
Susan J. Danielson |
Analogues de ligand pour des immunodosages derives de produits d'oxydation d'un acide dicarboxylique
|
|
CA2029006C
(fr)
*
|
1990-07-27 |
2001-07-17 |
Michael R. Detty |
Produits d'oxydation d'un acide dicarboxylique
|
|
US5614504A
(en)
*
|
1990-08-01 |
1997-03-25 |
The University Of South Florida |
Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
|
|
US5268298A
(en)
*
|
1991-04-26 |
1993-12-07 |
Life Technologies, Inc. |
System for delivering oxygen to a cell culture medium
|
|
CA2113823A1
(fr)
*
|
1991-07-19 |
1993-02-04 |
Cytimmune Sciences, Inc. |
Methode et trousse de dosage des cytokines endogenes
|
|
US5965379A
(en)
*
|
1991-07-19 |
1999-10-12 |
Cytimmune Sciences Inc. |
Method for measuring endogenous cytokines
|
|
US5464749A
(en)
|
1991-07-22 |
1995-11-07 |
Bayer Corporation |
Immunoassay of free substances in biological fluids
|
|
US5939524A
(en)
*
|
1991-12-09 |
1999-08-17 |
The Scripps Research Institute |
Platelet GPIII P1A1 and P1A2 epitopes, their preparation and use
|
|
US5624804A
(en)
*
|
1991-12-20 |
1997-04-29 |
The Rockefeller University |
Immunochemical detection of In vivo advanced glycosylation end products
|
|
US5354692A
(en)
*
|
1992-09-08 |
1994-10-11 |
Pacific Biotech, Inc. |
Analyte detection device including a hydrophobic barrier for improved fluid flow
|
|
US5874423A
(en)
*
|
1992-09-10 |
1999-02-23 |
Yissum Research Development Co. Of The Hebrew University Of Jerusalem |
Digitalis-like compounds
|
|
US7326535B2
(en)
*
|
1993-09-15 |
2008-02-05 |
Ortho Diagnostic Systems Inc. |
Immunoreactive peptides from Epstein-Barr virus
|
|
US7060283B1
(en)
|
1992-09-15 |
2006-06-13 |
Ortho Diagnostic Systems, Inc. |
Immunoreactive peptides from Epstein-Barr virus
|
|
US5637467A
(en)
*
|
1992-10-13 |
1997-06-10 |
Behringwerke Ag |
Heterogeneous assay using a pendulous drop
|
|
US6953573B1
(en)
|
1993-03-17 |
2005-10-11 |
University Of Washington |
Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated
|
|
US5801005A
(en)
*
|
1993-03-17 |
1998-09-01 |
University Of Washington |
Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
|
|
US5869445A
(en)
*
|
1993-03-17 |
1999-02-09 |
University Of Washington |
Methods for eliciting or enhancing reactivity to HER-2/neu protein
|
|
US6562333B1
(en)
|
1993-06-14 |
2003-05-13 |
Schering Corporation |
Purified mammalian CTLA-8 antigens and related reagents
|
|
US6638905B2
(en)
*
|
1993-06-18 |
2003-10-28 |
The Salk Institute For Biological Studies |
Cloning and recombinant production of CFR receptor(s)
|
|
US6495343B1
(en)
|
1993-06-18 |
2002-12-17 |
The Salk Institute For Biological Studies |
Cloning and recombinant production of CRF receptor(s)
|
|
US5516639A
(en)
*
|
1993-07-22 |
1996-05-14 |
Mayo Foundation For Medical Education And Research |
Antibodies specific for human prostate glandular kallkrein
|
|
US20040259113A1
(en)
*
|
1993-07-22 |
2004-12-23 |
Mayo Foundation For Medical Education And Research, Hybritech Incorporated |
Method for detection of metastatic prostate cancer
|
|
US6103237A
(en)
*
|
1993-07-22 |
2000-08-15 |
Hybritech Incorporated |
Stable variant hK2 polypeptide
|
|
US5684144A
(en)
*
|
1993-07-28 |
1997-11-04 |
University Of North Texas |
Escherichia coli csrA gene, protein encoded thereby, and methods of use thereof
|
|
US6884590B1
(en)
|
1994-02-11 |
2005-04-26 |
Cedars-Sinai Medical Center |
Methods of screening for ulcerative colitis and crohn's disease
|
|
US5681699A
(en)
*
|
1994-02-11 |
1997-10-28 |
Cedars-Sinai Medical Center |
Methods of diagnosing ulcerative colitis and Crohn's disease
|
|
US6335160B1
(en)
|
1995-02-17 |
2002-01-01 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
|
US6406855B1
(en)
|
1994-02-17 |
2002-06-18 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
|
WO1995030758A1
(fr)
*
|
1994-05-10 |
1995-11-16 |
Mayo Foundation For Medical Education And Research |
Polypeptide hk2 recombine
|
|
WO1995034640A1
(fr)
*
|
1994-06-13 |
1995-12-21 |
Henry Ford Health System |
Neuronatine, nouveau gene neuronal neonatal
|
|
US5589344A
(en)
*
|
1994-06-15 |
1996-12-31 |
Johnson & Johnson Clinical Diagnostics, Inc. |
Test kit and method for competitive specific binding assay
|
|
ATE198623T1
(de)
|
1994-08-12 |
2001-01-15 |
Myriad Genetics Inc |
Verfahren zum nachweis von prädisposition von ovarial- und brustkrebs
|
|
ATE201445T1
(de)
|
1994-08-12 |
2001-06-15 |
Myriad Genetics Inc |
Mutationen des mit 17q verbundenen ovarial- und brustkrebs empfindlichkeitsgens
|
|
US6048837A
(en)
*
|
1994-08-17 |
2000-04-11 |
The Rockefeller University |
OB polypeptides as modulators of body weight
|
|
US6001968A
(en)
|
1994-08-17 |
1999-12-14 |
The Rockefeller University |
OB polypeptides, modified forms and compositions
|
|
US6124439A
(en)
*
|
1994-08-17 |
2000-09-26 |
The Rockefeller University |
OB polypeptide antibodies and method of making
|
|
US6124448A
(en)
*
|
1994-08-17 |
2000-09-26 |
The Rockfeller University |
Nucleic acid primers and probes for the mammalian OB gene
|
|
US6471956B1
(en)
|
1994-08-17 |
2002-10-29 |
The Rockefeller University |
Ob polypeptides, modified forms and compositions thereto
|
|
US6309853B1
(en)
|
1994-08-17 |
2001-10-30 |
The Rockfeller University |
Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
|
|
US6350730B1
(en)
|
1994-08-17 |
2002-02-26 |
The Rockefeller University |
OB polypeptides and modified forms as modulators of body weight
|
|
US6974666B1
(en)
*
|
1994-10-21 |
2005-12-13 |
Appymetric, Inc. |
Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
|
|
US8236493B2
(en)
|
1994-10-21 |
2012-08-07 |
Affymetrix, Inc. |
Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
|
|
US5843673A
(en)
*
|
1994-10-25 |
1998-12-01 |
Curators Of The University Of Missouri |
Method of screening for endometriosis
|
|
US6531277B2
(en)
|
1994-10-25 |
2003-03-11 |
The Curators Of The University Of Missouri |
Endometriosis-specific secretory protein
|
|
US20030152909A1
(en)
*
|
1994-11-16 |
2003-08-14 |
Mitrani Eduardo N. |
In vitro micro-organs, and uses related thereto
|
|
US5633149A
(en)
*
|
1994-12-07 |
1997-05-27 |
Incyte Pharmaceuticals, Inc. |
Polynucleotide encoding novel chemokine expressed in inflamed adenoid
|
|
US7005509B1
(en)
|
1995-02-17 |
2006-02-28 |
Incyte Corporation |
Chemokine PANEC-1 polynucleotides and compositions and methods related thereto
|
|
US6506553B1
(en)
|
1995-03-30 |
2003-01-14 |
Ortho Diagnostics Systems, Inc. |
Method for diagnosis of Epstein-Barr virus associated disease
|
|
US5728807A
(en)
*
|
1995-05-16 |
1998-03-17 |
Ramot-University Authority For Applied Research And Industrial Development, Ltd. |
Mutated proteins associated with ataxia-telangiectasia
|
|
US5858661A
(en)
|
1995-05-16 |
1999-01-12 |
Ramot-University Authority For Applied Research And Industrial Development |
Ataxia-telangiectasia gene and its genomic organization
|
|
US5777093A
(en)
*
|
1995-05-16 |
1998-07-07 |
Ramot-University Authority For Applied Research & Industrial Development Ltd. |
cDNAs associated with ataxia-telangiectasia
|
|
GB0112226D0
(en)
*
|
2001-05-18 |
2001-07-11 |
Danisco |
Method of improving dough and bread quality
|
|
US5977322A
(en)
|
1995-06-14 |
1999-11-02 |
The Regents Of The University Of California |
High affinity human antibodies to tumor antigens
|
|
DE69625678T3
(de)
|
1995-12-18 |
2006-11-09 |
The University Of Utah Research Foundation, Salt Lake City |
Chromosom 13 verbundene Brustkrebsempfindlichkeitsgen BRCA2
|
|
US5837492A
(en)
|
1995-12-18 |
1998-11-17 |
Myriad Genetics, Inc. |
Chromosome 13-linked breast cancer susceptibility gene
|
|
EP0880598A4
(fr)
|
1996-01-23 |
2005-02-23 |
Affymetrix Inc |
Evaluation rapide de difference d'abondance d'acides nucleiques, avec un systeme d'oligonucleotides haute densite
|
|
US20040210045A1
(en)
*
|
1996-01-23 |
2004-10-21 |
Mcgall Glenn |
Nucleic acid labeling compounds
|
|
US20010018514A1
(en)
*
|
1998-07-31 |
2001-08-30 |
Mcgall Glenn H. |
Nucleic acid labeling compounds
|
|
US6965020B2
(en)
|
1996-01-23 |
2005-11-15 |
Affymetrix, Inc. |
Nucleic acid labeling compounds
|
|
US7282327B2
(en)
*
|
1996-01-23 |
2007-10-16 |
Affymetrix, Inc. |
Nucleic acid labeling compounds
|
|
US7291463B2
(en)
|
1996-01-23 |
2007-11-06 |
Affymetrix, Inc. |
Nucleic acid labeling compounds
|
|
US6864059B2
(en)
*
|
1996-01-23 |
2005-03-08 |
Affymetrix, Inc. |
Biotin containing C-glycoside nucleic acid labeling compounds
|
|
US7423143B2
(en)
*
|
1996-01-23 |
2008-09-09 |
Affymetrix. Inc. |
Nucleic acid labeling compounds
|
|
AU2189397A
(en)
|
1996-02-08 |
1997-08-28 |
Affymetrix, Inc. |
Chip-based speciation and phenotypic characterization of microorganisms
|
|
EP1728875A3
(fr)
|
1996-02-08 |
2007-05-09 |
Affymetrix, Inc. |
Spéciation de micro-organismes à partir de micro plaquettes et caractérisation des phénotypes de ceux-ci
|
|
US6924094B1
(en)
|
1996-02-08 |
2005-08-02 |
Affymetrix, Inc. |
Chip-based species identification and phenotypic characterization of microorganisms
|
|
US5882644A
(en)
*
|
1996-03-22 |
1999-03-16 |
Protein Design Labs, Inc. |
Monoclonal antibodies specific for the platelet derived growth factor β receptor and methods of use thereof
|
|
CA2249994A1
(fr)
*
|
1996-03-22 |
1997-09-25 |
University Of Georgia Research Foundation, Inc. |
Compositions immunogenes comprenant des peptides porphyromonas gingivalis et procedes
|
|
US6942862B2
(en)
*
|
1996-04-01 |
2005-09-13 |
University Of Washington |
Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins
|
|
WO1997044461A2
(fr)
*
|
1996-05-22 |
1997-11-27 |
Novopharm Biotech, Inc. |
Fragments de liaison a l'antigene detectant specifiquement des cellules cancereuses, nucleotides codant lesdits fragments, et leur utilisation pour la prophylaxie et le depistage de cancers
|
|
US6342349B1
(en)
|
1996-07-08 |
2002-01-29 |
Burstein Technologies, Inc. |
Optical disk-based assay devices and methods
|
|
US20050214827A1
(en)
*
|
1996-07-08 |
2005-09-29 |
Burstein Technologies, Inc. |
Assay device and method
|
|
US6331275B1
(en)
|
1996-07-08 |
2001-12-18 |
Burstein Technologies, Inc. |
Spatially addressable, cleavable reflective signal elements, assay device and method
|
|
WO1998001533A1
(fr)
|
1996-07-08 |
1998-01-15 |
Burstein Laboratories, Inc. |
Procede et dispositif a element de signal clivable
|
|
US20050069923A1
(en)
*
|
1996-07-08 |
2005-03-31 |
Mullis Kary Banks |
Dual bead assays using cleavable spacers and/or ligation to improve specificity and sensitivity including related methods and apparatus
|
|
ES2308787T3
(es)
|
1996-08-16 |
2008-12-01 |
Schering Corporation |
Antigenos de superficie de celular de mamiferos; reactivos relacionados.
|
|
US20070299005A1
(en)
*
|
1996-09-24 |
2007-12-27 |
Tanox, Inc. |
Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
|
|
EP0932678B2
(fr)
|
1996-09-24 |
2010-03-10 |
Genentech, Inc. |
Famille de genes codant les peptides lies a l'apoptose, peptides ainsi codes et leurs procedes d'utilisation
|
|
US6093809A
(en)
*
|
1996-10-01 |
2000-07-25 |
University Technology Corporation |
Telomerase
|
|
US6475789B1
(en)
*
|
1996-10-01 |
2002-11-05 |
University Technology Corporation |
Human telomerase catalytic subunit: diagnostic and therapeutic methods
|
|
IL129222A0
(en)
|
1996-10-01 |
2000-02-17 |
Geron Corp |
Telomerase reverse transcriptase
|
|
US6808880B2
(en)
*
|
1996-10-01 |
2004-10-26 |
Geron Corporation |
Method for detecting polynucleotides encoding telomerase
|
|
US6610839B1
(en)
*
|
1997-08-14 |
2003-08-26 |
Geron Corporation |
Promoter for telomerase reverse transcriptase
|
|
US6261836B1
(en)
|
1996-10-01 |
2001-07-17 |
Geron Corporation |
Telomerase
|
|
US7585622B1
(en)
|
1996-10-01 |
2009-09-08 |
Geron Corporation |
Increasing the proliferative capacity of cells using telomerase reverse transcriptase
|
|
GB9907461D0
(en)
|
1999-03-31 |
1999-05-26 |
King S College London |
Neurite regeneration
|
|
US6479263B1
(en)
|
1996-11-14 |
2002-11-12 |
Baylor College Of Medicine |
Method for detection of micrometastatic prostate cancer
|
|
GB2335984B
(en)
|
1996-11-15 |
2000-11-29 |
Univ Texas |
Genetic test for equine severe combined immunodeficiency disease
|
|
PT1114864E
(pt)
|
1996-12-13 |
2008-10-08 |
Schering Corp |
Antigénios de superfície de células de mamífero, reagentes relacionados
|
|
US5840322A
(en)
*
|
1996-12-19 |
1998-11-24 |
Ramot-University Authority For Applied Research & Industrial Devel. Ltd. |
Anti-oral-microbial adhesion fraction derived from vaccinium
|
|
PT966533E
(pt)
|
1997-02-07 |
2010-01-26 |
Univ Ramot |
Factor neurotrófico iii dependente da actividade (adnf iii)
|
|
US6268165B1
(en)
|
1997-03-19 |
2001-07-31 |
The Board Of Trustees Of The University Of Arkansas |
Methods for the early diagnosis of ovarian cancer
|
|
CA2285452A1
(fr)
*
|
1997-04-01 |
1998-10-08 |
Calyx Therapeutics, Inc. |
Fraction du momordica charantia active par voie orale, ses peptides actifs, et leur utilisation dans le traitement du diabete
|
|
US7622549B2
(en)
*
|
1997-04-18 |
2009-11-24 |
Geron Corporation |
Human telomerase reverse transcriptase polypeptides
|
|
US7413864B2
(en)
*
|
1997-04-18 |
2008-08-19 |
Geron Corporation |
Treating cancer using a telomerase vaccine
|
|
US20050013825A1
(en)
*
|
1997-04-18 |
2005-01-20 |
Geron Corporation |
Vaccine containing the catalytic subunit of telomerase for treating cancer
|
|
ES2331622T3
(es)
|
1997-05-07 |
2010-01-11 |
Schering Corporation |
Proteinas receptoras humanas similares a toll, reactivos y metodos relacionados.
|
|
US7115722B1
(en)
|
1997-05-22 |
2006-10-03 |
Viventia Biotech, Inc. |
Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
|
|
US7541151B2
(en)
|
1997-06-05 |
2009-06-02 |
Duke University |
Single-cell biosensor for the measurement of GPCR ligands in a test sample
|
|
US5891646A
(en)
*
|
1997-06-05 |
1999-04-06 |
Duke University |
Methods of assaying receptor activity and constructs useful in such methods
|
|
US6528271B1
(en)
*
|
1997-06-05 |
2003-03-04 |
Duke University |
Inhibition of βarrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia
|
|
WO1998059073A1
(fr)
|
1997-06-20 |
1998-12-30 |
Mayo Foundation For Medical Education And Research |
Procede de detection du cancer du sein
|
|
US20020122807A1
(en)
*
|
1998-07-07 |
2002-09-05 |
Dan Michael D. |
Antigen binding fragments, designated 4B5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
|
|
KR20010021597A
(ko)
|
1997-07-09 |
2001-03-15 |
둘락 노먼 씨. |
분리된 덴드라이틱 세포막 단백질 유전자
|
|
WO1999002721A1
(fr)
|
1997-07-11 |
1999-01-21 |
University Of North Texas |
GENE csrB DE L'ESCHERICHIA COLI, ARN CODE PAR CE GENE ET PROCEDES D'UTILISATION
|
|
US6506579B1
(en)
|
1997-07-15 |
2003-01-14 |
Genencor International, Inc. |
Increasing production of proteins in gram-positive microorganisms using SecG
|
|
US20030157642A1
(en)
*
|
1997-07-15 |
2003-08-21 |
Caldwell Robert M. |
Increasing production of proteins in gram-positive microorganisms
|
|
US6723550B1
(en)
|
1997-07-15 |
2004-04-20 |
Genencor International, Inc. |
Proteases from gram-positive organisms
|
|
US6762039B2
(en)
*
|
1997-07-15 |
2004-07-13 |
Genencor International, Inc. |
Bacillus subtillis with an inactivated cysteine protease-1
|
|
US6521421B1
(en)
*
|
1997-07-16 |
2003-02-18 |
Genencor International, Inc. |
Expression vectors encoding Bacillus subtilis disulfide bond isomerase and methods of secreting proteins in gram-positive microorganisms using the same
|
|
ZA986596B
(en)
|
1997-07-25 |
1999-02-08 |
Schering Corp |
Mammalian cytokine related reagents
|
|
EP1003861B1
(fr)
|
1997-08-01 |
2006-10-04 |
Schering Corporation |
Proteines de membrane cellulaire mammalienne et reactifs associes
|
|
US6180411B1
(en)
|
1997-08-01 |
2001-01-30 |
The Regents Of The University Of California |
Light-triggered indicators that memorize analyte concentrations
|
|
US7252950B1
(en)
|
1997-09-04 |
2007-08-07 |
The Regents Of The University Of California |
Assays for detecting modulators of cytoskeletal function
|
|
US6300117B1
(en)
*
|
1997-09-15 |
2001-10-09 |
Genencor International, Inc. |
Proteases from gram-positive organisms
|
|
US6521440B1
(en)
|
1997-09-15 |
2003-02-18 |
Genencor International, Inc. |
Proteases from gram-positive organisms
|
|
US7378244B2
(en)
*
|
1997-10-01 |
2008-05-27 |
Geron Corporation |
Telomerase promoters sequences for screening telomerase modulators
|
|
US6284496B1
(en)
|
1997-10-03 |
2001-09-04 |
University Of South Florida |
DNA vector for determining the presence of out-of-reading-frame mutations
|
|
WO1999020788A1
(fr)
|
1997-10-17 |
1999-04-29 |
University Of South Florida |
Procede de diagnostic et de surveillance des deficiences immunitaires cellulaires
|
|
US6316241B1
(en)
*
|
1997-11-20 |
2001-11-13 |
Genencor International, Inc. |
Alpha/beta hydrolase-fold enzymes
|
|
GB9724629D0
(en)
*
|
1997-11-20 |
1998-01-21 |
Genencor Int Bv |
Alpha/beta hydrolase-fold enzymes
|
|
GB9724627D0
(en)
|
1997-11-20 |
1998-01-21 |
Genencor Int Bv |
Gram positive microorganism formate pathway
|
|
US6528255B1
(en)
*
|
1997-12-30 |
2003-03-04 |
Genencor International, Inc. |
Proteases from gram positive organisms
|
|
US6599731B1
(en)
*
|
1997-12-30 |
2003-07-29 |
Genencor International, Inc. |
Proteases from gram positive organisms
|
|
GB9727470D0
(en)
*
|
1997-12-30 |
1998-02-25 |
Genencor Int Bv |
Proteases from gram positive organisms
|
|
US6465186B1
(en)
*
|
1997-12-30 |
2002-10-15 |
Genecor International, Inc. |
Proteases from gram positive organisms
|
|
US7687057B2
(en)
|
1998-01-09 |
2010-03-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
In vitro micro-organs, and uses related thereto
|
|
US6780609B1
(en)
|
1998-10-23 |
2004-08-24 |
Genome Therapeutics Corporation |
High bone mass gene of 1.1q13.3
|
|
US6759243B2
(en)
|
1998-01-20 |
2004-07-06 |
Board Of Trustees Of The University Of Illinois |
High affinity TCR proteins and methods
|
|
US6673914B1
(en)
|
1998-01-22 |
2004-01-06 |
John Wayne Cancer Institute |
Human tumor-associated gene
|
|
WO2000018885A1
(fr)
|
1998-09-29 |
2000-04-06 |
Gamida Cell Ltd. |
Procedes de regulation de la proliferation et de la differentiation de cellules souches et precurseurs
|
|
US6596501B2
(en)
|
1998-02-23 |
2003-07-22 |
Fred Hutchinson Cancer Research Center |
Method of diagnosing autoimmune disease
|
|
US6060260A
(en)
*
|
1998-02-27 |
2000-05-09 |
Dade Behring Inc. |
Methods for reducing adsorption in an assay
|
|
JP2002505108A
(ja)
|
1998-03-04 |
2002-02-19 |
ジェネンコア インターナショナル インコーポレーテッド |
プルラナーゼの修飾形態
|
|
US6869770B1
(en)
|
1998-03-20 |
2005-03-22 |
The Curators Of The University Of Missouri |
Compositions and methods for early pregnancy diagnosis
|
|
US8062908B2
(en)
*
|
1999-03-29 |
2011-11-22 |
Orasure Technologies, Inc. |
Device for collection and assay of oral fluids
|
|
US6303081B1
(en)
*
|
1998-03-30 |
2001-10-16 |
Orasure Technologies, Inc. |
Device for collection and assay of oral fluids
|
|
AU3219099A
(en)
*
|
1998-03-30 |
1999-10-18 |
Epitope, Inc. |
Collection device for single step assay of oral fluids
|
|
EP1095183B1
(fr)
*
|
1998-03-31 |
2012-02-22 |
Esoterix Genetic Laboratories, LLC |
Methodes de diagnostic et de traitement de cancer du poumon
|
|
US6337200B1
(en)
*
|
1998-03-31 |
2002-01-08 |
Geron Corporation |
Human telomerase catalytic subunit variants
|
|
US7108968B2
(en)
*
|
1998-04-03 |
2006-09-19 |
Affymetrix, Inc. |
Mycobacterial rpoB sequences
|
|
EP1071943A4
(fr)
|
1998-04-14 |
2005-08-10 |
Univ California |
Dosages de detection d'inhibiteurs de depolymerisation de microtubules
|
|
US6699969B1
(en)
|
1998-04-14 |
2004-03-02 |
The Regents Of The University Of California |
Assays for the detection of microtubule depolymerization inhibitors
|
|
US6872537B1
(en)
|
1998-04-14 |
2005-03-29 |
Regents Of The University Of California |
Assays for the detection of microtubule depolymerization inhibitors
|
|
US20080206206A1
(en)
|
1998-05-07 |
2008-08-28 |
University Of South Florida |
Bone marrow-derived neuronal cells
|
|
US6344443B1
(en)
|
1998-07-08 |
2002-02-05 |
University Of South Florida |
Peptide antagonists of tumor necrosis factor alpha
|
|
US7605149B1
(en)
|
1998-07-13 |
2009-10-20 |
University Of South Florida |
Modulation of the phospholipase A2 pathway as a therapeutic
|
|
EP1097378A2
(fr)
*
|
1998-07-21 |
2001-05-09 |
Burstein Laboratories Inc. |
Dispositifs de dosage utilisant des disques optiques et methodes correspondantes
|
|
ATE231186T1
(de)
|
1998-07-21 |
2003-02-15 |
Danisco |
Lebensmittel
|
|
US6312689B1
(en)
|
1998-07-23 |
2001-11-06 |
Millennium Pharmaceuticals, Inc. |
Anti-CCR2 antibodies and methods of use therefor
|
|
US6187563B1
(en)
|
1998-08-07 |
2001-02-13 |
Yale University |
βIV-spectrin-polypeptides and nucleic acids encoding same
|
|
SE9803099D0
(sv)
|
1998-09-13 |
1998-09-13 |
Karolinska Innovations Ab |
Nucleic acid transfer
|
|
AU6394399A
(en)
*
|
1998-09-18 |
2000-04-10 |
Rockefeller University, The |
Lynx, a novel family of receptor ligands in the central nervous system, corresponding nucleic acids and proteins and uses thereof
|
|
JP2002526079A
(ja)
|
1998-09-21 |
2002-08-20 |
シェーリング コーポレイション |
ヒトインターロイキン−ｂ５０、治療的使用
|
|
EP0997476A3
(fr)
|
1998-09-25 |
2000-07-19 |
Schering-Plough |
Anticorps contre un antigène de cellules Langerhans mammifères et leurs utilisations
|
|
EP2341144A1
(fr)
|
1999-01-11 |
2011-07-06 |
Schering Corporation |
Cytokines de mammifère associés à l'interleukine 17, Polynucléotides les encodant, et utilisations
|
|
BR0009403A
(pt)
|
1999-02-04 |
2001-11-27 |
Technion Res & Dev Foundation |
Método de expansão/conservação das células detronco hemopoiéticas indiferenciadas ou dascélulas progenitoras, método de preparação deum meio condicionado de célula estomacal útil naexpansão/conservação das células de troncohemopoiéticas indiferenciadas ou das célulasprogenitoras, método de transplante de célulasde tronco hemopoiéticas indiferenciadas ou decélulas progenitoras em um recipiente, tampão debiorreator e biorreator
|
|
US6156515A
(en)
*
|
1999-02-09 |
2000-12-05 |
Urocor, Inc. |
Prostate-specific gene for diagnosis, prognosis and management of prostate cancer
|
|
DE60041393D1
(de)
|
1999-03-11 |
2009-03-05 |
Schering Corp |
Cytokine aus säugetieren, verwandte reagenzien und verfahren
|
|
MXPA01011519A
(es)
|
1999-05-13 |
2003-08-20 |
Medical Res Council |
Homologos del receptor ox2.
|
|
AU5011200A
(en)
|
1999-05-14 |
2000-12-05 |
Arbor Vita Corporation |
Molecular interactions in hematopoietic cells
|
|
US6440682B1
(en)
*
|
1999-05-28 |
2002-08-27 |
Detroit R&D Inc. |
Detection of hypertension using immunoreactive metabolic products
|
|
US6787318B1
(en)
*
|
1999-06-01 |
2004-09-07 |
Roskamp Research Institute, Llc |
Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
|
|
PT1181366E
(pt)
|
1999-06-01 |
2009-05-25 |
Schering Corp |
Proteínas receptoras de mamífero; reagentes e métodos relacionados
|
|
US7534605B2
(en)
|
1999-06-08 |
2009-05-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
|
|
GB9914210D0
(en)
|
1999-06-17 |
1999-08-18 |
Danisco |
Promoter
|
|
JP2003535025A
(ja)
*
|
1999-06-25 |
2003-11-25 |
イッサム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム |
微小器官で血管新生を誘発する方法
|
|
US20060127366A1
(en)
*
|
1999-06-25 |
2006-06-15 |
Mitrani Eduardo N |
Method and device for inducing biological processes by micro-organs
|
|
US6531130B1
(en)
*
|
1999-07-06 |
2003-03-11 |
The Board Of Trustees Of The Leland Stanford University |
Treatment of demyelinating autoimmune disease with ordered peptides
|
|
MXPA02001146A
(es)
|
1999-07-30 |
2002-08-20 |
Schering Corp |
Citosinas de mamifero, reactivos relacionados.
|
|
US6875582B1
(en)
|
1999-08-19 |
2005-04-05 |
Omniscience Pharmaceuticals, Inc. |
Methods and targets of antibiotic resistance
|
|
US7811981B2
(en)
*
|
1999-08-30 |
2010-10-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
|
US7101839B1
(en)
|
1999-08-30 |
2006-09-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
|
EP1905832A3
(fr)
|
1999-09-09 |
2009-09-09 |
Schering Corporation |
Interleukin-12 P40 et interleukin B30 de mammifères, anticorps, utilisation dans des compositions pharmaceutiques
|
|
NZ518601A
(en)
|
1999-09-24 |
2004-10-29 |
Morphogen Pharmaceuticals Inc |
Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
|
|
US6998232B1
(en)
|
1999-09-27 |
2006-02-14 |
Quark Biotech, Inc. |
Methods of diagnosing bladder cancer
|
|
US7668658B2
(en)
|
1999-10-13 |
2010-02-23 |
Sequenom, Inc. |
Methods for generating databases and databases for identifying polymorphic genetic markers
|
|
US7030228B1
(en)
*
|
1999-11-15 |
2006-04-18 |
Miltenyi Biotec Gmbh |
Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
|
|
US7223902B1
(en)
|
1999-11-19 |
2007-05-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Method of producing recombinant Aspergillus niger β-glucosidase and an aroma spreading plant
|
|
EP2261256A3
(fr)
|
1999-11-24 |
2011-03-02 |
Schering Corporation |
Procedes d'inhibition de metastases
|
|
MXPA02005559A
(es)
|
1999-12-06 |
2004-09-10 |
Univ Illinois |
Proteinas de tcr de alta afinidad y metodos.
|
|
US6544792B1
(en)
|
1999-12-21 |
2003-04-08 |
Genencor International, Inc. |
Production of secreted polypeptides
|
|
US6544506B2
(en)
*
|
2000-01-05 |
2003-04-08 |
Yeda Research & Development Co. Ltd. |
Veto cells effective in preventing graft rejection and devoid of graft versus host potential
|
|
AU2001225441A1
(en)
*
|
2000-01-24 |
2001-07-31 |
Agricultural Research Organization The Volcani Center |
Plants tolerant of environmental stress conditions, methods of generating same and novel polynucleotide sequence utilized thereby
|
|
DE10003734A1
(de)
*
|
2000-01-28 |
2001-08-02 |
Bosch Gmbh Robert |
Detektionsverfahren und -vorrichtung
|
|
AU2001239884B2
(en)
*
|
2000-02-25 |
2006-08-10 |
Vegenics Limited |
Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins and screening methods for modulators
|
|
US20040002068A1
(en)
|
2000-03-01 |
2004-01-01 |
Corixa Corporation |
Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
|
|
US7829313B2
(en)
*
|
2000-03-24 |
2010-11-09 |
Eppendorf Array Technologies |
Identification and quantification of a plurality of biological (micro)organisms or their components
|
|
US8288128B2
(en)
*
|
2004-11-18 |
2012-10-16 |
Eppendorf Array Technologies S.A. |
Real-time quantification of multiple targets on a micro-array
|
|
US7875442B2
(en)
*
|
2000-03-24 |
2011-01-25 |
Eppendorf Array Technologies |
Identification and quantification of a plurality of biological (micro)organisms or their components
|
|
IL151860A0
(en)
|
2000-03-27 |
2003-04-10 |
Technion Res & Dev Foundation |
Single chain class i major histocompatibility complexes, constructs encoding same and methods of generating same
|
|
US20040191260A1
(en)
|
2003-03-26 |
2004-09-30 |
Technion Research & Development Foundation Ltd. |
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
|
|
WO2001075078A1
(fr)
|
2000-03-31 |
2001-10-11 |
The Scripps Research Institute |
POLYPEPTIDES D'AMINOACYL-ARNt SYNTHETASE HUMAINE UTILISES POUR REGULER L'ANGIOGENESE
|
|
US20030108927A1
(en)
*
|
2000-04-03 |
2003-06-12 |
Kathryn Leishman |
Compositions and methods for the prevention, treatment and detection of tuberculosis and other diseases
|
|
DE60136921D1
(de)
|
2000-04-18 |
2009-01-22 |
Schering Corp |
Medizinische Verwendung von IL-174 Agonisten und Antagonisten
|
|
IL135884A
(en)
*
|
2000-04-30 |
2005-08-31 |
Yissum Res Dev Co |
Method for measuring non-transferrin bound iron
|
|
US7422743B2
(en)
|
2000-05-10 |
2008-09-09 |
Schering Corporation |
Mammalian receptor protein DCRS5;methods of treatment
|
|
US6756481B2
(en)
|
2000-05-10 |
2004-06-29 |
Schering Corporation |
IL-23 receptor binding compositions
|
|
NZ534666A
(en)
|
2000-05-25 |
2006-01-27 |
Schering Corp |
Mammalian DNAX Toll-like receptor protein, DTLR9, antibodies and medicaments made therefrom and use in treating immunological disorders
|
|
WO2005000087A2
(fr)
*
|
2003-06-03 |
2005-01-06 |
Chiron Corporation |
Produits genetiques exprimes de facon differentielle dans des cellules cancereuses du colon et leurs methodes d'utilisation ii
|
|
US20030031675A1
(en)
|
2000-06-06 |
2003-02-13 |
Mikesell Glen E. |
B7-related nucleic acids and polypeptides useful for immunomodulation
|
|
US6958214B2
(en)
*
|
2000-07-10 |
2005-10-25 |
Sequenom, Inc. |
Polymorphic kinase anchor proteins and nucleic acids encoding the same
|
|
HUP0300810A2
(hu)
|
2000-07-20 |
2003-08-28 |
M.G.V.S. Ltd. |
Mesterséges értranszplantátum, valamint ennek létrehozása és alkalmazása
|
|
US20040037828A1
(en)
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
|
EP2359854B1
(fr)
|
2000-08-08 |
2013-10-09 |
Technion Research and Development Foundation, Ltd. |
Compositions pharmaceutiques et procédés utiles pour la modulation d'angiogénèse
|
|
WO2002012294A2
(fr)
|
2000-08-08 |
2002-02-14 |
St. Jude Children's Research Hospital |
Acides nucleiques de streptocoque de groupe b, polypeptides, compositions therapeutiques et vaccins correspondants
|
|
US20030114410A1
(en)
|
2000-08-08 |
2003-06-19 |
Technion Research And Development Foundation Ltd. |
Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
|
|
GB0020498D0
(en)
|
2000-08-18 |
2000-10-11 |
Sterix Ltd |
Compound
|
|
EP1683874A3
(fr)
|
2000-08-29 |
2006-10-11 |
YEDA RESEARCH AND DEVELOPMENT Co. LTD. |
Méthode pour l'isolement de gènes codant pour des protéines à fonction spécifique et pour le criblage d'agents pharmaceutiques actifs
|
|
ATE549347T1
(de)
|
2000-09-08 |
2012-03-15 |
Schering Corp |
Gene von säugetiere, und damit verbundene reagentien, methoden
|
|
EP2028187A1
(fr)
|
2000-09-08 |
2009-02-25 |
Board Of Regents, The University Of Texas System |
Peptides cibles chez l'homme et la souris identifiées par l'affichage de phases
|
|
US6673623B1
(en)
|
2000-09-12 |
2004-01-06 |
Novocure, Inc. |
Methods and compositions that control lipid production
|
|
EP1356060B1
(fr)
*
|
2000-09-18 |
2005-12-14 |
Genencor International, Inc. |
Translocation des arginines couplees dans bacillus
|
|
US7632522B2
(en)
|
2000-09-28 |
2009-12-15 |
Nanocyte Inc. |
Use of stinging cells/capsules for the delivery of active agents to keratinous substances
|
|
EP1379127B1
(fr)
*
|
2000-09-28 |
2013-04-17 |
Nanocyte Inc. |
Procedes, compositions et dispositifs utilisant des cellules/capsules urticantes pour administrer un agent therapeutique ou cosmetique dans un tissu
|
|
US20070281037A9
(en)
*
|
2000-09-28 |
2007-12-06 |
Nanocyte Inc. |
Sterile preparations and compositions including stinging capsules and methods of producing and using same
|
|
US7045283B2
(en)
|
2000-10-18 |
2006-05-16 |
The Regents Of The University Of California |
Methods of high-throughput screening for internalizing antibodies
|
|
US7018812B2
(en)
|
2000-11-03 |
2006-03-28 |
Duke University |
Modified G-protein coupled receptors
|
|
US7163800B2
(en)
*
|
2000-11-03 |
2007-01-16 |
Molecular Devices Corporation |
Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity
|
|
US20050136431A1
(en)
*
|
2000-11-03 |
2005-06-23 |
Oakley Robert H. |
Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity
|
|
US6890734B2
(en)
|
2000-11-10 |
2005-05-10 |
Schering Corporation |
Nucleic acids encoding a cytokine receptor complex
|
|
US8071740B2
(en)
|
2000-11-17 |
2011-12-06 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
|
|
ES2425321T3
(es)
|
2000-11-17 |
2013-10-14 |
Vascular Biogenics Ltd. |
Promotores que muestran especificidad por células endoteliales y métodos de utilización de los mismos
|
|
WO2002041827A2
(fr)
|
2000-11-24 |
2002-05-30 |
Vascular Biogenics Ltd. |
Procedes faisant appels a des phospholipides oxydes definis, ainsi que compositions contenant ces derniers, pour la prevention et le traitement de l'atherosclerose
|
|
US20040248093A1
(en)
*
|
2000-11-27 |
2004-12-09 |
Coombs James Howard |
Magneto-optical bio-discs and systems including related methods
|
|
US20020172980A1
(en)
*
|
2000-11-27 |
2002-11-21 |
Phan Brigitte Chau |
Methods for decreasing non-specific binding of beads in dual bead assays including related optical biodiscs and disc drive systems
|
|
US20030003464A1
(en)
*
|
2000-11-27 |
2003-01-02 |
Phan Brigitte C. |
Dual bead assays including optical biodiscs and methods relating thereto
|
|
CA2430082A1
(fr)
*
|
2000-11-29 |
2002-06-06 |
Lynkeus Biotech Gmbh |
Nouvelles proteines humaines specifiques de la retine c7orf9, c12orf7, mpp4 et f379
|
|
US20040106120A1
(en)
|
2000-11-30 |
2004-06-03 |
Rachid Tazi-Ahnini |
Diagnosis and treatment of disease
|
|
IL155941A0
(en)
*
|
2000-11-30 |
2003-12-23 |
Yeda Res & Dev |
Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease
|
|
US20020165149A1
(en)
*
|
2000-12-08 |
2002-11-07 |
Kranz David M. |
Mutated class II major histocompatibility proteins
|
|
US7087395B1
(en)
|
2001-01-16 |
2006-08-08 |
Quest Diagnostics Investments Incorporated |
Vitamin D assay
|
|
GB0101762D0
(en)
*
|
2001-01-23 |
2001-03-07 |
Medical Res Council |
Method
|
|
US20050202098A1
(en)
*
|
2001-01-31 |
2005-09-15 |
Tolaren |
Disease therapy using dying or dead cells
|
|
AU2002230061A1
(en)
*
|
2001-01-31 |
2002-08-12 |
Tolaren |
Induction of tolerance by apoptotic and/or necrotic cells
|
|
AU2002244247B2
(en)
|
2001-03-01 |
2007-12-13 |
Harbor Biosciences, Inc. |
Use of certain steroids for treatment of blood cell deficiencies
|
|
CA2440615A1
(fr)
*
|
2001-03-12 |
2002-09-19 |
Affymetrix, Inc. |
Composes de marquage d'acide nucleique
|
|
US20030104410A1
(en)
*
|
2001-03-16 |
2003-06-05 |
Affymetrix, Inc. |
Human microarray
|
|
US20030003454A1
(en)
|
2001-03-23 |
2003-01-02 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer
|
|
US20030220475A1
(en)
*
|
2001-04-03 |
2003-11-27 |
Fields Howard A. |
Neutralizing immunogenic hev polypepetides
|
|
AU2002254524A1
(en)
*
|
2001-04-06 |
2002-10-21 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health A |
Use of semenogelin in the diagnosis, prognosis and treatment of cancer
|
|
AU2002311919B8
(en)
|
2001-05-11 |
2007-03-22 |
Ludwig Institute For Cancer Research Ltd |
Specific binding proteins and uses thereof
|
|
US20100056762A1
(en)
|
2001-05-11 |
2010-03-04 |
Old Lloyd J |
Specific binding proteins and uses thereof
|
|
US20110313230A1
(en)
|
2001-05-11 |
2011-12-22 |
Terrance Grant Johns |
Specific binding proteins and uses thereof
|
|
BR0209154A
(pt)
|
2001-05-18 |
2004-07-20 |
Danisco |
Processo de preparação de uma massa com uma enzima
|
|
CA2448142A1
(fr)
|
2001-05-22 |
2002-11-28 |
Merck & Co., Inc. |
Substrats de beta-secretase et leurs utilisations
|
|
US7553484B2
(en)
*
|
2001-06-05 |
2009-06-30 |
The Regents Of The University Of California |
Modulating neuronal outgrowth via the major histocompatibility complex class I (MHC I) molecule
|
|
US20090324612A1
(en)
*
|
2001-06-05 |
2009-12-31 |
Kaufman Daniel L |
Modulating neuronal outgrowth via the major histocompatibility complex class i (mhc i) molecule
|
|
US6770622B2
(en)
|
2001-06-08 |
2004-08-03 |
Gary A. Jarvis |
N-terminally truncated galectin-3 for use in treating cancer
|
|
US20070190534A1
(en)
*
|
2001-06-11 |
2007-08-16 |
Genesis Genomics Inc. |
Mitochondrial sites and genes associated with prostate cancer
|
|
IL159944A0
(en)
*
|
2001-07-19 |
2004-06-20 |
Yissum Res Dev Co |
Polypeptides having carotenoid isomerase catalytic activity, nucleic acids encoding same and uses thereof
|
|
EP1430140B1
(fr)
*
|
2001-08-01 |
2010-09-15 |
University of Utah |
Isoformes tronquees a l'extremite n-terminale de phosphodiesterases cycliques pde3a.
|
|
US6833441B2
(en)
|
2001-08-01 |
2004-12-21 |
Abmaxis, Inc. |
Compositions and methods for generating chimeric heteromultimers
|
|
US20030082596A1
(en)
*
|
2001-08-08 |
2003-05-01 |
Michael Mittmann |
Methods of genetic analysis of probes: test3
|
|
US20060073530A1
(en)
*
|
2001-08-15 |
2006-04-06 |
Olaf Schneewind |
Methods and compositions involving sortase B
|
|
US7442781B2
(en)
|
2001-08-16 |
2008-10-28 |
Urifer Ltd. |
Diagnosis, prevention and treatment of cancer
|
|
US7138144B2
(en)
*
|
2001-09-07 |
2006-11-21 |
Nadir Askenasy |
Method of inducing immune tolerance via blood/lymph flow-restricted bone marrow transplantation
|
|
US20040136972A1
(en)
|
2001-09-07 |
2004-07-15 |
Yeda Research And Development Co. Ltd. |
Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
|
|
JP4424987B2
(ja)
|
2001-09-20 |
2010-03-03 |
ボード オブ リージェンツ， ザ ユニバーシティ オブ テキサス システム |
Ｅｌｉｓａアッセイを用いた循環する治療抗体、抗原および抗原／抗体複合体の測定
|
|
US7393696B2
(en)
*
|
2001-09-28 |
2008-07-01 |
Aspenbio Pharma, Inc. |
Bovine pregnancy test
|
|
US7138370B2
(en)
|
2001-10-11 |
2006-11-21 |
Amgen Inc. |
Specific binding agents of human angiopoietin-2
|
|
US7521053B2
(en)
|
2001-10-11 |
2009-04-21 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
|
CA2462883A1
(fr)
|
2001-10-12 |
2003-04-17 |
Schering Corporation |
Utilisation d'anticorps bispecifiques pour reguler des reponses immunitaires
|
|
CN100506284C
(zh)
|
2001-10-19 |
2009-07-01 |
脉管生物生长有限公司 |
多核苷酸构建体、药物组合物以及靶向的下调血管生成和抗癌的治疗方法
|
|
US7175983B2
(en)
*
|
2001-11-02 |
2007-02-13 |
Abmaxis, Inc. |
Adapter-directed display systems
|
|
MXPA04004880A
(es)
|
2001-11-20 |
2004-09-03 |
Monsanto Technology Llc |
Composiciones y metodos para el diagnostico temprano y preciso de prenez.
|
|
US6952704B2
(en)
*
|
2001-11-26 |
2005-10-04 |
Microsoft Corporation |
Extending a directory schema independent of schema modification
|
|
WO2003048298A2
(fr)
*
|
2001-12-05 |
2003-06-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nanoparticules contenant des homologues d'acides nucleiques polymeres, compositions pharmaceutiques et articles fabriques contenant ces nanoparticules, et procedes d'utilisation de celles-ci
|
|
EP1463807A4
(fr)
*
|
2001-12-19 |
2006-04-12 |
Bristol Myers Squibb Co |
Pichia pastoris formate deshydrogenase et ses utilisations
|
|
US20050085432A1
(en)
*
|
2001-12-26 |
2005-04-21 |
Aviva Lapidot |
Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
|
|
WO2003063110A1
(fr)
*
|
2002-01-16 |
2003-07-31 |
Regents Of The University Of Minnesota |
Marqueur d'etats psychiatriques
|
|
IL152904A0
(en)
|
2002-01-24 |
2003-06-24 |
Gamida Cell Ltd |
Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
|
|
WO2003062404A1
(fr)
|
2002-01-25 |
2003-07-31 |
Gamida-Cell Ltd. |
Methodes de developpement de cellules souches et de cellules precurseurs, populations de cellules multipliees obtenues a l'aide de ces methodes
|
|
US8071096B2
(en)
|
2002-01-25 |
2011-12-06 |
G2 Therapies Ltd |
Anti-C5aR antibodies and uses thereof
|
|
US20040052928A1
(en)
*
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
|
US20070021345A1
(en)
*
|
2003-06-30 |
2007-01-25 |
Ehud Gazit |
Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
|
|
US7781396B2
(en)
*
|
2002-01-31 |
2010-08-24 |
Tel Aviv University Future Technology Development L.P. |
Peptides directed for diagnosis and treatment of amyloid-associated disease
|
|
AU2003208888B2
(en)
|
2002-02-01 |
2006-10-19 |
Merck Sharp & Dohme Llc |
Uses of mammalian cytokine; related reagents
|
|
US6992176B2
(en)
*
|
2002-02-13 |
2006-01-31 |
Technion Research & Development Foundation Ltd. |
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
|
|
AU2003216341A1
(en)
*
|
2002-02-20 |
2003-09-09 |
Dyax Corporation |
Mhc-peptide complex binding ligands
|
|
US7053188B2
(en)
|
2002-02-22 |
2006-05-30 |
Purdue Research Foundation |
Monoclonal antibodies specific for neoplasia-specific NADH:disulfide reductase
|
|
AU2003225589A1
(en)
|
2002-02-22 |
2003-09-09 |
The Government Of The United States Of America, As Represented By The Secretary, Dept. Of Health And |
Brother of the regulator of imprinted sites (boris)
|
|
WO2003078567A2
(fr)
*
|
2002-03-18 |
2003-09-25 |
Gamida-Cell Ltd. |
Procedes permettant d'induire la differenciation dans des cellules souches expansees ex vivo
|
|
US20030182669A1
(en)
*
|
2002-03-19 |
2003-09-25 |
Rockman Howard A. |
Phosphoinositide 3-kinase mediated inhibition of GPCRs
|
|
EP1519755B1
(fr)
*
|
2002-03-26 |
2008-05-07 |
Nanocyte Inc. |
Cellules urticantes exprimant un polynucleotide exogene qui code pour un agent therapeutique, diagnostic ou cosmetique, et procedes, compositions et dispositifs faisant intervenir l'utilisation de ces cellules urticantes ou de capsules derivees de celles-ci pour administrer l'agent therapeutique, di
|
|
US7332585B2
(en)
|
2002-04-05 |
2008-02-19 |
The Regents Of The California University |
Bispecific single chain Fv antibody molecules and methods of use thereof
|
|
US7534580B2
(en)
*
|
2002-05-01 |
2009-05-19 |
Ambrilia Biopharma Inc. |
PSP94 diagnostic reagents and assays
|
|
CA2391438A1
(fr)
*
|
2002-05-01 |
2003-11-01 |
Procyon Biopharma Inc. |
Reactifs et methodes diagnostiques a base de psp94
|
|
WO2003093296A2
(fr)
|
2002-05-03 |
2003-11-13 |
Sequenom, Inc. |
Muteines de proteines d'ancrage de kinase, leurs peptides, et procedes associes
|
|
US20040121442A1
(en)
*
|
2002-05-05 |
2004-06-24 |
Ilan Chet |
Fungal chitinase, polynucleotide sequences encoding same, promoters of same, and uses thereof
|
|
US7528116B2
(en)
|
2002-05-30 |
2009-05-05 |
Memorial Sloan Kettering Cancer Center |
Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis
|
|
EP1532453B1
(fr)
*
|
2002-05-31 |
2013-08-21 |
Genetic Technologies Limited |
Anticorps maternels servant de marqueurs de cellules foetales permettant d'identifier et d'enrichir les cellules foetales du sang maternel
|
|
US7290215B2
(en)
*
|
2002-06-03 |
2007-10-30 |
Microsoft Corporation |
Dynamic wizard interface system and method
|
|
US7504215B2
(en)
|
2002-07-12 |
2009-03-17 |
Affymetrix, Inc. |
Nucleic acid labeling methods
|
|
AU2003304195B8
(en)
|
2002-07-15 |
2008-08-28 |
Board Of Regents, The University Of Texas System |
Combinatorial protein library screening by periplasmic expression
|
|
KR20120068769A
(ko)
|
2002-07-15 |
2012-06-27 |
더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 |
음이온성 인지질 및 아미노인지질에 결합하는 선택된 항체 및 치료하는데 있어서 이의 용도
|
|
US7794716B2
(en)
|
2002-07-25 |
2010-09-14 |
Glenveigh Pharmaceuticals, Llc |
Antibody composition and passive immunization against pregnancy-induced hypertension
|
|
AU2003247143B2
(en)
|
2002-08-01 |
2009-07-16 |
Yeda Research And Development Co. Ltd. |
Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
|
|
ES2346868T3
(es)
*
|
2002-08-10 |
2010-10-21 |
Yale University |
Antagonistas de receptor nogo.
|
|
EP2298315A1
(fr)
|
2002-08-28 |
2011-03-23 |
Harbor BioSciences, Inc. |
Procédés de traitement thérapeutique
|
|
JP4694840B2
(ja)
|
2002-09-09 |
2011-06-08 |
アルボー ビータ コーポレーション |
子宮頸部癌を検査する方法
|
|
AU2003273633A1
(en)
|
2002-09-26 |
2004-04-19 |
K.U.Leuven Research And Development |
Integrase cofactor
|
|
US7267981B2
(en)
|
2002-10-07 |
2007-09-11 |
Technion Research & Development Foundation Ltd. |
Human foreskin fibroblasts for culturing ES cells
|
|
WO2004037251A1
(fr)
|
2002-10-24 |
2004-05-06 |
Sterix Limited |
Inhibiteurs de 11-beta-hydroxy steroide dehydrogenase de type 1 et de type 2
|
|
US20040146949A1
(en)
*
|
2002-10-25 |
2004-07-29 |
Jun Tan |
Methods and compounds for disruption of CD40R/CD40L signaling in the treatment of alzheimer's disease
|
|
CA2504512A1
(fr)
|
2002-10-30 |
2004-05-13 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Molecules et leurs procedes d'utilisation pour la mesure de fer non lie par la transferrine
|
|
US20050054097A1
(en)
*
|
2002-11-17 |
2005-03-10 |
Tony Peled |
EX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures
|
|
AU2002352938B8
(en)
*
|
2002-11-26 |
2009-10-08 |
The University Of Chicago |
Materials and methods for preventing and treating microbe-mediated epithelial disorders
|
|
WO2004050826A2
(fr)
*
|
2002-11-29 |
2004-06-17 |
Technion Research & Development Foundation Ltd. |
Procede de mise en culture dynamique de cellules souches embryonnaires
|
|
EP2031070B1
(fr)
|
2002-12-04 |
2013-07-17 |
Life Technologies Corporation |
Amplification multiplexe de polynucléotides
|
|
US7491699B2
(en)
*
|
2002-12-09 |
2009-02-17 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures and methods of generating and using the same
|
|
SI2338896T1
(sl)
|
2002-12-12 |
2015-08-31 |
R.B.T. (Rakuto Bio Technologies) Ltd. |
Uporaba lignin peroksidaze za posvetlitev kože in las
|
|
AU2003303071B2
(en)
|
2002-12-16 |
2009-04-23 |
Technion Research & Development Foundation Ltd. |
Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and stem cell cultures prepared using same
|
|
AU2002953431A0
(en)
*
|
2002-12-19 |
2003-01-09 |
Murdoch University |
BmpB Novel Nucleotide and Amino Acid Sequences and Diagnostic and Therapeutic Uses Thereof
|
|
CA2512499A1
(fr)
|
2003-01-02 |
2004-07-22 |
Rappaport Family Institute For Research In The Medical Sciences |
Methodes de prediction de potentiel a tirer benefice d'un traitement antioxydant pour la prevention de maladies cardiovasculaires chez des patients hyperglycemiques
|
|
US20040229245A1
(en)
*
|
2003-01-06 |
2004-11-18 |
Anton Bittner |
Methods and algorithms for performing quality control during gene expression profiling on DNA microarray technology
|
|
ATE426575T1
(de)
*
|
2003-01-07 |
2009-04-15 |
Univ Ramot |
Peptidenanostrukturen die fremdmaterial enthalten,und verfahren zur herstellung derselben
|
|
DK1599278T3
(da)
|
2003-01-17 |
2011-07-18 |
Danisco |
Fremgangsmåde til fremstilling af en hydroxysyreester
|
|
US20050196766A1
(en)
|
2003-12-24 |
2005-09-08 |
Soe Jorn B. |
Proteins
|
|
US7955814B2
(en)
|
2003-01-17 |
2011-06-07 |
Danisco A/S |
Method
|
|
DE602004030000D1
(de)
*
|
2003-01-17 |
2010-12-23 |
Danisco |
Verfahren zur in-situ-herstellung eines emulgators in einem nahrungsmittel
|
|
CA2514179A1
(fr)
*
|
2003-01-24 |
2004-08-12 |
Duke University |
Modeles de trafic modifies pour l'arrestine et les recepteurs couples a la proteine g par l'intermediaire d'une chimere d'arrestine-ubiquitine
|
|
CA2518677A1
(fr)
*
|
2003-03-03 |
2004-12-09 |
Nagaoka & Co., Ltd. |
Procedes et appareil utilises pour la detection et la quantification de divers types de cellules et utilisation d'un bio-disque optique pour leur mise en oeuvre
|
|
EP2319857A3
(fr)
|
2003-03-04 |
2012-06-27 |
Yeda Research And Development Co., Ltd. |
Polypeptides pon, polynucleotides les codant et compositions et procédés utilisant ces derniers
|
|
EP1599608A4
(fr)
*
|
2003-03-05 |
2007-07-18 |
Genetic Technologies Ltd |
Identification d'adn foetal et de marqueurs de cellule foetale dans du plasma ou du serum maternel
|
|
JP5438886B2
(ja)
|
2003-03-07 |
2014-03-12 |
タフツ メディカル センター インコーポレイテッド |
ＩｇＡ１沈着症の治療
|
|
US20050054103A1
(en)
*
|
2003-03-07 |
2005-03-10 |
Tony Peled |
Expansion of renewable stem cell populations using modulators of PI 3-kinase
|
|
US8017113B2
(en)
|
2003-03-12 |
2011-09-13 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions and methods for diagnosing and treating an inflammation
|
|
US7294701B2
(en)
*
|
2003-04-02 |
2007-11-13 |
Technion Research & Development Foundation Ltd. |
Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
|
|
ATE517926T1
(de)
|
2003-04-04 |
2011-08-15 |
Yeda Res & Dev |
Antikörper zur hemmung der aktivität von mmp-2 und mmp-9
|
|
EP1611233B1
(fr)
|
2003-04-08 |
2016-01-06 |
Yeda Research And Development Co., Ltd. |
Cellules souches presentant une sensibilite accrue au sdf-1 et procedes pour leur obtention et utilisation
|
|
FR2853551B1
(fr)
|
2003-04-09 |
2006-08-04 |
Lab Francais Du Fractionnement |
Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
|
|
US20040209246A1
(en)
*
|
2003-04-15 |
2004-10-21 |
Agouron Pharmaceuticals, Inc. |
Dual reporter/dye reduction methodology for evaluating antiviral and cytotoxicity of hepatitis C virus inhibitors
|
|
EA009643B1
(ru)
*
|
2003-04-16 |
2008-02-28 |
Йейл Юниверсити |
Лечение состояний, включающих амилоидные бляшки
|
|
US7321065B2
(en)
*
|
2003-04-18 |
2008-01-22 |
The Regents Of The University Of California |
Thyronamine derivatives and analogs and methods of use thereof
|
|
CA2978152C
(fr)
|
2003-05-22 |
2021-01-26 |
Evogene Ltd. |
Procedes d'augmentation de la tolerance du stress abiotique des plantes et plantes ainsi produites
|
|
US7554007B2
(en)
|
2003-05-22 |
2009-06-30 |
Evogene Ltd. |
Methods of increasing abiotic stress tolerance and/or biomass in plants
|
|
AU2005234725B2
(en)
|
2003-05-22 |
2012-02-23 |
Evogene Ltd. |
Methods of Increasing Abiotic Stress Tolerance and/or Biomass in Plants and Plants Generated Thereby
|
|
US20050020499A1
(en)
*
|
2003-05-27 |
2005-01-27 |
Bar Ilan University |
Methods of attenuating cocaine seeking behavior employing glial cell-derived neurotrophic factor (GDNF) and pharmaceutical compositions and articles of manufacture suited for use in practice of the method
|
|
US8129514B2
(en)
*
|
2003-06-19 |
2012-03-06 |
Evogene Ltd. |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
|
EP1636333A4
(fr)
*
|
2003-06-19 |
2007-10-24 |
Evogene Ltd |
Sequences nucleotidiques pour reguler l'expression genetique chez des trichromes vegetaux, et genes hybrides et procedes dans lesquels elles interviennent
|
|
EP2128270B1
(fr)
|
2003-08-08 |
2012-10-03 |
Genenews Inc. |
Biomarqueurs d'ostéoarthrite et leur utilisations
|
|
US20050064479A1
(en)
*
|
2003-08-12 |
2005-03-24 |
Affymetrix, Inc. |
Compounds and methods for post incorporation labeling of nucleic acids
|
|
CA2535951A1
(fr)
*
|
2003-08-14 |
2005-03-03 |
The Bio Balance Corporation |
Souches bacteriennes, compositions les comprenant et leur utilisation dans un traitement probiotique
|
|
JP2007502119A
(ja)
|
2003-08-14 |
2007-02-08 |
エクセリクシス， インク． |
βカテニン経路のモディファイヤーとしてのＵＰｓ及び使用方法
|
|
ATE491953T1
(de)
|
2003-09-15 |
2011-01-15 |
Oklahoma Med Res Found |
Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis
|
|
US20050064435A1
(en)
*
|
2003-09-24 |
2005-03-24 |
Xing Su |
Programmable molecular barcodes
|
|
WO2005031362A2
(fr)
|
2003-10-02 |
2005-04-07 |
Ramot At Tel Aviv University Ltd. |
Nouveaux agents antibacteriens et procedes permettant de les identifier et de les utiliser
|
|
PT1678209E
(pt)
|
2003-10-07 |
2011-06-30 |
Yeda Res & Dev |
Anticorpos para a nik, a sua preparação e a sua utilização
|
|
IL158287A0
(en)
|
2003-10-07 |
2004-05-12 |
Yeda Res & Dev |
Antibodies to nik, their preparation and use
|
|
JP2007508837A
(ja)
*
|
2003-10-23 |
2007-04-12 |
ファイザー・プロダクツ・インク |
歯周疾患のためのワクチン
|
|
US20050227251A1
(en)
|
2003-10-23 |
2005-10-13 |
Robert Darnell |
Method of purifying RNA binding protein-RNA complexes
|
|
AR046833A1
(es)
|
2003-11-10 |
2005-12-28 |
Schering Corp |
Anticuerpos anti-interleuquina-10
|
|
ES2469670T3
(es)
|
2003-11-30 |
2014-06-18 |
Yeda Research And Development Co., Ltd. |
Métodos y agentes para inmunomodulaci�n y métodos para identificar inmunomoduladores
|
|
MXPA06000176A
(es)
|
2003-12-10 |
2006-06-27 |
Millennium Pharm Inc |
Anticuerpos anti-ccr2 humanizados y sus metodos de uso.
|
|
WO2005059100A2
(fr)
*
|
2003-12-12 |
2005-06-30 |
New York University |
Procedes et compositions se rapportant a la cystatine c
|
|
US20100221233A1
(en)
*
|
2003-12-15 |
2010-09-02 |
University Of South Florida |
Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers
|
|
EP1722834B1
(fr)
|
2003-12-22 |
2012-06-27 |
Regentis Biomaterials Ltd. |
Matrice comprenant un squelette proteique reticule naturel
|
|
WO2005063286A1
(fr)
|
2003-12-23 |
2005-07-14 |
Arbor Vita Corporation |
Anticorps pour des souches oncogenes du hpv et leurs methodes d'utilisation
|
|
GB0716126D0
(en)
*
|
2007-08-17 |
2007-09-26 |
Danisco |
Process
|
|
US7718408B2
(en)
*
|
2003-12-24 |
2010-05-18 |
Danisco A/S |
Method
|
|
BRPI0417533B1
(pt)
|
2003-12-24 |
2016-03-01 |
Danisco |
enzima variante glicolipídio aciltransferase, uso e método para sua produção, método para o preparo de um produto alimentício e produto assado de farinha, processo de refinamento enzimático
|
|
WO2008090395A1
(fr)
|
2007-01-25 |
2008-07-31 |
Danisco A/S |
Production d'une lipide acyltransférase à partir de cellules transformées de bacillus licheniformis
|
|
US8007847B2
(en)
|
2004-01-13 |
2011-08-30 |
Eytan Biderman |
Feeding formula appliance
|
|
US7423139B2
(en)
*
|
2004-01-20 |
2008-09-09 |
Insight Biopharmaceuticals Ltd. |
High level expression of recombinant human erythropoietin having a modified 5′-UTR
|
|
US20050186646A1
(en)
*
|
2004-01-26 |
2005-08-25 |
Cruz Miguel A. |
Rapid assay to detect ADAMTS-13 activity
|
|
EP1713900A4
(fr)
*
|
2004-01-27 |
2009-06-17 |
Compugen Ltd |
Procedes et systemes pour l'annotation de sequences de biomolecules
|
|
US20070178462A1
(en)
*
|
2004-02-18 |
2007-08-02 |
Uebele Victor N |
Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha1h, encoded proteins and methods of use thereof
|
|
GB0403864D0
(en)
|
2004-02-20 |
2004-03-24 |
Ucl Ventures |
Modulator
|
|
US7767792B2
(en)
|
2004-02-20 |
2010-08-03 |
Ludwig Institute For Cancer Research Ltd. |
Antibodies to EGF receptor epitope peptides
|
|
WO2005085475A1
(fr)
|
2004-03-01 |
2005-09-15 |
Applera Corporation |
Techniques, compositions et kits d'amplification de polynucleotide
|
|
EP3006039B1
(fr)
|
2004-03-02 |
2021-01-06 |
Acceleron Pharma Inc. |
Alk7 polypeptides pour stimuler la perte de graisse
|
|
US8352031B2
(en)
|
2004-03-10 |
2013-01-08 |
Impulse Dynamics Nv |
Protein activity modification
|
|
GB0405637D0
(en)
|
2004-03-12 |
2004-04-21 |
Danisco |
Protein
|
|
CN101072797B
(zh)
|
2004-03-12 |
2012-05-09 |
瓦斯基因治疗公司 |
结合ephb4、抑制血管发生和肿瘤生长的抗体
|
|
CN1964725A
(zh)
*
|
2004-04-20 |
2007-05-16 |
芝加哥大学 |
包含高分子量peg－样化合物的治疗输送系统
|
|
EP2400030B1
(fr)
|
2004-05-18 |
2016-01-20 |
The Board of Trustees of the Leland Stanford Junior University |
Détection de translocation de protéines par complémentation de fragment de rapporteur béta-galactosidase
|
|
NZ551627A
(en)
|
2004-05-28 |
2010-02-26 |
Agensys Inc |
Antibodies and related molecules that bind to PSCA proteins
|
|
EP2343373B1
(fr)
*
|
2004-06-14 |
2017-05-10 |
Evogene Ltd. |
Polynucléotides et polypeptides impliqués dans le développement de la fibre végétale et procédés permettant des les utiliser
|
|
US8034553B2
(en)
|
2004-06-24 |
2011-10-11 |
Kimberly-Clark Worldwide, Inc. |
Biomarkers for wound healing
|
|
ITBO20040412A1
(it)
*
|
2004-07-01 |
2004-10-01 |
Eurodent Spa |
Lampada dentale particolarmente per ambulatori medico-dentistici
|
|
US8680062B2
(en)
|
2004-07-06 |
2014-03-25 |
Deliversir Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
|
US20090156471A1
(en)
*
|
2004-07-15 |
2009-06-18 |
Ramot At Tel Aviv University Ltd. |
Use of anti-amyloid agents for treating and typing pathogen infections
|
|
CN101052702B
(zh)
*
|
2004-07-16 |
2013-01-09 |
杜邦营养生物科学有限公司 |
脂肪分解酶及其在食品工业中的应用
|
|
US20090233986A1
(en)
*
|
2004-07-27 |
2009-09-17 |
Mount Sinai School Of Medicine |
Methods and compositions for using sax2
|
|
EP1789437A4
(fr)
*
|
2004-07-30 |
2008-11-05 |
Sinai School Medicine |
Inhibiteurs de npc1l1 et npc1l1 et procédés d'utilisation associés
|
|
US20060073168A1
(en)
*
|
2004-08-11 |
2006-04-06 |
Stephens David S |
Neisseria meningitidis serogroup a capsular polysaccharide acetyltransferase, methods and compositions
|
|
HUE024999T2
(en)
|
2004-08-26 |
2016-02-29 |
Engeneic Molecular Delivery Pty Ltd |
Introducing functional nucleic acids into mammalian cells with bacterial intact minicells
|
|
FI20050753A7
(fi)
|
2004-09-03 |
2006-03-04 |
Licentia Oy |
Uudet peptidit
|
|
CA2581086C
(fr)
|
2004-09-14 |
2023-11-07 |
The Regents Of The University Of Colorado, A Body Corporate |
Procede de traitement faisant intervenir du bucindolol fonde sur le ciblage genetique
|
|
WO2006030442A2
(fr)
|
2004-09-16 |
2006-03-23 |
Gamida-Cell Ltd. |
Methodes de culture ex vivo de cellules souches et de precurseur par co-culture avec des cellules mesenchymales
|
|
EP1802313B1
(fr)
|
2004-09-18 |
2010-11-03 |
University of Maryland, Baltimore |
Agents therapeutiques ciblant le canal ncca-atp et leurs methodes d'utilisation
|
|
JP5085326B2
(ja)
|
2004-09-18 |
2012-11-28 |
ユニバーシティ オブ メリーランド，ボルチモア |
ＮＣＣａ−ＡＴＰチャネルを標的とする処置剤およびその使用方法
|
|
WO2006036834A2
(fr)
*
|
2004-09-24 |
2006-04-06 |
Amgen Inc. |
Molecules fc modifiees
|
|
ES2524601T3
(es)
*
|
2004-09-29 |
2014-12-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
RNasa T2 humana recombinante y usos de la misma
|
|
DE602005023332D1
(de)
|
2004-09-29 |
2010-10-14 |
Collplant Ltd |
Kollagenproduzierende pflanzen sowie verfahren zu deren erzeugung und verwendung
|
|
GB0422052D0
(en)
|
2004-10-04 |
2004-11-03 |
Dansico As |
Enzymes
|
|
US7390489B2
(en)
*
|
2004-10-08 |
2008-06-24 |
Komed Co., Ltd. |
Monoclonal antibody selectively recognizing listeria monocytogenes, hybridoma producing the antibody, test kit comprising the antibody and detection method of listeria monocytogenes using the antibody
|
|
EP1809374A4
(fr)
*
|
2004-10-12 |
2008-09-10 |
Closed Loop Therapies Ltd |
Methodes et dispositifs implantables pour traiter des arythmies supraventriculaires
|
|
GB0423139D0
(en)
|
2004-10-18 |
2004-11-17 |
Danisco |
Enzymes
|
|
JP5525689B2
(ja)
*
|
2004-11-02 |
2014-06-18 |
ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンティッド バイ ザ セクレタリー デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
過剰増殖性障害を処置するための組成物および方法
|
|
GB0424940D0
(en)
|
2004-11-11 |
2004-12-15 |
Danisco |
Transcription factors
|
|
EP1704258B1
(fr)
|
2004-11-18 |
2010-09-22 |
Eppendorf Array Technologies |
Pcr en temps reel de cibles sur un microreseau
|
|
PT1828249E
(pt)
|
2004-12-03 |
2011-02-25 |
Schering Corp |
Biomarcadores para a pré-selecção de pacientes para terapêutica anti-igf1r
|
|
WO2008109782A2
(fr)
*
|
2007-03-06 |
2008-09-12 |
Cedars-Sinai Medical Center |
Diagnostic d'une affection abdominale inflammatoire chez l'enfant
|
|
US7504769B2
(en)
*
|
2004-12-16 |
2009-03-17 |
E. I. Du Pont De Nemours + Company |
Aromatic chalcogen compounds and their use
|
|
US20060134680A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Alexander Kotlyar |
Homogeneous populations of nucleic acids, methods of synthesyzing same and uses thereof
|
|
WO2006075335A2
(fr)
*
|
2005-01-16 |
2006-07-20 |
Zlango Ltd. |
Systeme de reseau de communication et procedes d'utilisation
|
|
JP2008527563A
(ja)
|
2005-01-16 |
2008-07-24 |
ズランゴー リミテッド |
アイコニック通信
|
|
US9101927B2
(en)
|
2005-01-31 |
2015-08-11 |
Realbio Technologies Ltd. |
Multistep reaction lateral flow capillary device
|
|
CN103497993A
(zh)
|
2005-02-07 |
2014-01-08 |
基因信息公司 |
轻度骨关节炎生物标志物及其用途
|
|
WO2006087722A1
(fr)
|
2005-02-17 |
2006-08-24 |
Hadasit Medical Research Services And Development Ltd. |
Bisphosphonates pour le traitement de l'endometriose
|
|
GB0503546D0
(en)
*
|
2005-02-21 |
2005-03-30 |
Hellenic Pasteur Inst |
Antibody
|
|
JP5432455B2
(ja)
|
2005-02-25 |
2014-03-05 |
ザ ステート オブ イスラエル、ミニストリー オブ アグリカルチャー アンド ルーラル ディベロップメント、アグリカルチュラル リサーチ オーガナイゼイション、（エー．アール．オー．）、ボルカニ センター |
炎症治療用の果実細胞培養抽出物
|
|
US7695927B2
(en)
*
|
2005-03-18 |
2010-04-13 |
Detroit R & D |
Detection of hypertension using glucuronidated metabolic products
|
|
RU2413735C2
(ru)
|
2005-03-31 |
2011-03-10 |
Эдженсис, Инк. |
Антитела и родственные молекулы, связывающиеся с белками 161p2f10b
|
|
DK2645106T4
(da)
|
2005-04-04 |
2024-12-02 |
Biogen Ma Inc |
Fremgangsmåder til evaluering af et immunrespons på et terapeutisk middel
|
|
EP1874334A4
(fr)
*
|
2005-04-15 |
2011-03-30 |
Vascular Biogenics Ltd |
Compositions contenant des peptides derives de la glycoproteine i beta 2 pour la prevention et le traitement de maladie cardiovasculaire
|
|
US20130022979A1
(en)
|
2005-04-18 |
2013-01-24 |
Genesis Genomics Inc. |
3.4kb MITOCHONDRIAL DNA DELETION FOR USE IN THE DETECTION OF CANCER
|
|
EP1877559B1
(fr)
|
2005-04-18 |
2010-10-13 |
Mitomics Inc. |
Réarrangements et mutations mitochondriales utilisés en tant qu'outil de diagnostic pour la détection de l'exposition au soleil, le cancer de la prostate et d'autres cancers
|
|
US8834862B2
(en)
*
|
2005-04-19 |
2014-09-16 |
Nanocyte Inc. |
Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
|
|
PE20061441A1
(es)
|
2005-05-12 |
2007-01-18 |
Novartis Ag |
Genes y proteinas novedosos de brachyspira hyodysenteriae y uso de los mismos para diagnostico y terapia
|
|
US9943481B2
(en)
|
2005-05-26 |
2018-04-17 |
Biorest Ltd. |
Compositions and methods using same for delivering agents into a target organ protected by a blood barrier
|
|
US20070021433A1
(en)
|
2005-06-03 |
2007-01-25 |
Jian-Qiang Fan |
Pharmacological chaperones for treating obesity
|
|
EP2465924A3
(fr)
|
2005-06-16 |
2013-01-02 |
Ramot at Tel-Aviv University Ltd. |
Cellules isolées et populations les comportant pour le traitement des maladies du SNC
|
|
DK2500439T4
(da)
|
2005-06-20 |
2017-11-13 |
Advanced Cell Diagnostics Inc |
Kits og produkter til detektering af nukleinsyrer i individuelle celler og til identifikation af sjældne celler fra store heterogene cellepopulationer
|
|
US20070225242A1
(en)
*
|
2005-06-21 |
2007-09-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method and composition for treating and preventing tumor metastasis in vivo
|
|
US9051379B2
(en)
|
2005-07-07 |
2015-06-09 |
Fulcrum Sp Ltd. |
Sp1 polypeptides, modified Sp1 polypeptides and uses thereof
|
|
ES2435774T3
(es)
*
|
2005-07-07 |
2013-12-23 |
Yissum Research Development Company, Of The Hebrew University Of Jerusalem |
Agentes de ácido nucleico para la regulación negativa de H19, y métodos de uso del mismo
|
|
EP2484768A3
(fr)
|
2005-07-18 |
2012-11-21 |
Protalix Ltd. |
Administration mucosale ou enterale de macromolecules biologiquement actives
|
|
CA2616766A1
(fr)
|
2005-07-26 |
2007-02-01 |
University Of Medicine And Dentistry Of New Jersey |
Profils d'anticorps specifiques d'un etat tuberculeux
|
|
JP2009504659A
(ja)
*
|
2005-08-08 |
2009-02-05 |
オンコノン・リミテッド・ライアビリティ・カンパニー |
抗体組成物、腫瘍性疾患の処置方法、および受胎能の調節方法
|
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
|
US8916147B2
(en)
|
2005-08-24 |
2014-12-23 |
Yeda Research and Devolpment Co. Ltd. |
Universal donor-derived tolerogenic cells for inducing non-syngeneic transplantation tolerance
|
|
EP1962719A4
(fr)
|
2005-08-29 |
2011-05-04 |
Technion Res And Dev Of Foundation Ltd |
Milieux de culture de cellules souches
|
|
PT1931710T
(pt)
|
2005-08-31 |
2017-03-28 |
Merck Sharp & Dohme |
Anticorpos anti-il-23 manipulados
|
|
US7608395B2
(en)
*
|
2005-09-15 |
2009-10-27 |
Baylor Research Institute |
Systemic lupus erythematosus diagnostic assay
|
|
WO2007034487A1
(fr)
|
2005-09-22 |
2007-03-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Constructions d’acide nucléique, compositions pharmaceutiques et procédés utilisant ces dernières dans le cadre des traitements anticancéreux
|
|
WO2007041340A2
(fr)
*
|
2005-09-30 |
2007-04-12 |
The Trustees Of Columbia University In The City Of New York |
Cellules microfluidiques a arrangements paralleles de molecules d'adn individuelles
|
|
WO2007047408A2
(fr)
*
|
2005-10-12 |
2007-04-26 |
Pathologica, Llc. |
Application de signature promac
|
|
US20070087437A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Jifan Hu |
Methods for rejuvenating cells in vitro and in vivo
|
|
TW200730825A
(en)
|
2005-10-21 |
2007-08-16 |
Genenews Inc |
Method and apparatus for correlating levels of biomarker products with disease
|
|
MX338183B
(es)
|
2005-10-24 |
2016-04-06 |
Evogene Ltd |
Polipeptidos aislados, polinucleotidos que los codifican, plantas transgenicas quie expresan los mismos y metodos para usarlos.
|
|
US7842823B2
(en)
*
|
2005-10-27 |
2010-11-30 |
The Regents Of The University Of California |
Fluorogenic probes for reactive oxygen species
|
|
CN101346393B
(zh)
|
2005-11-02 |
2015-07-22 |
普洛体维生物治疗公司 |
修饰的siRNA分子及其应用
|
|
NZ568762A
(en)
|
2005-11-07 |
2011-11-25 |
Scripps Research Inst |
Use of an inhibitor of tissue factor signaling in the manufacture of a medcament for inhibiting or suppressing tissue factor/tissue factor VIIa signaling involving protease activated receptor 2 in a mammal
|
|
DE212006000071U1
(de)
|
2005-11-18 |
2008-07-24 |
Board of Regents, The University of Texas System, Austin |
Quantifizierung von Fusionsproteinen und ihrer Aktivität in Folge chromosomaler Translokation
|
|
US8846393B2
(en)
|
2005-11-29 |
2014-09-30 |
Gamida-Cell Ltd. |
Methods of improving stem cell homing and engraftment
|
|
KR20080072748A
(ko)
|
2005-11-29 |
2008-08-06 |
가미다-셀 리미티드 |
줄기세포 귀소 및 생착을 향상시키는 방법
|
|
KR20080080525A
(ko)
|
2005-12-08 |
2008-09-04 |
노파르티스 아게 |
유전자 전사에 대한 ｆｇｆｒ３의 억제제의 효과
|
|
US20070134814A1
(en)
*
|
2005-12-09 |
2007-06-14 |
Kajander E O |
Methods and compositions for the detection of calcifying nano-particles, identification and quantification of associated proteins thereon, and correlation to disease
|
|
EP2674440B1
(fr)
|
2005-12-16 |
2019-07-03 |
IBC Pharmaceuticals, Inc. |
Ensembles bioactifs à base d'immunoglobuline multivalent
|
|
CN101374860A
(zh)
|
2005-12-23 |
2009-02-25 |
技术转让合伙人公司 |
用作神经递质分泌抑制剂和肌肉松弛诱导物的合成肽
|
|
US7465544B2
(en)
*
|
2006-01-11 |
2008-12-16 |
Wisconsin Alumni Research Foundation |
Synthetic cofactor analogs of S-adenosylmethionine as ligatable probes of biological methylation and methods for their use
|
|
EP1977312A2
(fr)
|
2006-01-16 |
2008-10-08 |
Zlango Ltd. |
Communication iconique
|
|
EP1982450A2
(fr)
*
|
2006-01-16 |
2008-10-22 |
Zlango Ltd. |
Systeme de reseau de communication et ses procedes d'utilisation
|
|
PT1981902E
(pt)
|
2006-01-27 |
2015-11-02 |
Biogen Ma Inc |
Antagonistas dos recetores nogo
|
|
EP1991577A2
(fr)
|
2006-01-31 |
2008-11-19 |
Parkinson, John F. |
Modulation de l'activite mdl-1 pour le traitement de maladies inflammatoires
|
|
US9458444B2
(en)
|
2006-02-03 |
2016-10-04 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
|
US20140113860A1
(en)
|
2006-02-03 |
2014-04-24 |
Prolor Biotech Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
|
US7553941B2
(en)
|
2006-02-03 |
2009-06-30 |
Modigene Inc |
Long-acting polypeptides and methods of producing same
|
|
US10351615B2
(en)
|
2006-02-03 |
2019-07-16 |
Opko Biologics Ltd. |
Methods of treatment with long-acting growth hormone
|
|
US8450269B2
(en)
|
2006-02-03 |
2013-05-28 |
Prolor Biotech Ltd. |
Long-acting growth hormone and methods of producing same
|
|
US20150038413A1
(en)
|
2006-02-03 |
2015-02-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
|
US8048849B2
(en)
|
2006-02-03 |
2011-11-01 |
Modigene, Inc. |
Long-acting polypeptides and methods of producing same
|
|
US8476234B2
(en)
|
2006-02-03 |
2013-07-02 |
Prolor Biotech Inc. |
Long-acting coagulation factors and methods of producing same
|
|
US8946155B2
(en)
|
2006-02-03 |
2015-02-03 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
|
US10221228B2
(en)
|
2006-02-03 |
2019-03-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
|
US8048848B2
(en)
|
2006-02-03 |
2011-11-01 |
Prolor Biotech Ltd. |
Long-acting interferons and derivatives thereof and methods thereof
|
|
US8759292B2
(en)
|
2006-02-03 |
2014-06-24 |
Prolor Biotech, Llc |
Long-acting coagulation factors and methods of producing same
|
|
US9249407B2
(en)
|
2006-02-03 |
2016-02-02 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
|
CN101416063A
(zh)
|
2006-02-06 |
2009-04-22 |
拉帕波特家族医学科学研究所 |
用于诊断t1dm的方法和试剂盒
|
|
AR059371A1
(es)
|
2006-02-08 |
2008-03-26 |
Genzyme Corp |
Terapia genica para la enfermedad de niemann-pick tipo a
|
|
SG169395A1
(en)
|
2006-02-09 |
2011-03-30 |
Univ South Florida |
Detection of cancer by elevated levels of bcl-2
|
|
US20070207141A1
(en)
|
2006-02-28 |
2007-09-06 |
Ivan Lieberburg |
Methods of treating inflammatory and autoimmune diseases with natalizumab
|
|
MX2008011176A
(es)
|
2006-03-03 |
2008-09-10 |
Elan Pharm Inc |
Metodos para tratar padecimientos inflamatorios y autoinmunes con natalizumab.
|
|
AU2007224386B2
(en)
|
2006-03-06 |
2013-12-19 |
Zetiq Technologies Ltd. |
Methods and compositions for identifying a cell phenotype
|
|
WO2007109733A2
(fr)
|
2006-03-21 |
2007-09-27 |
The Johns Hopkins University |
Marqueurs de diagnostic et de pronostic et strategies de traitement de la sclerose en plaques
|
|
EP2366775B1
(fr)
|
2006-03-23 |
2015-04-22 |
Pluristem Ltd. |
Procédés de développement cellulaire et utilisations thérapeutiques des cellules et des milieux conditionnés produits de cette maniere
|
|
WO2007110869A2
(fr)
|
2006-03-28 |
2007-10-04 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Procedes et kits pour determiner la predisposition a la resistance a la warfarine
|
|
US20070232556A1
(en)
*
|
2006-03-31 |
2007-10-04 |
Montine Thomas J |
Methods and compositions for the treatment of neurological diseases and disorders
|
|
KR20090029184A
(ko)
*
|
2006-04-07 |
2009-03-20 |
더 가브먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 |
항체 조성물 및 신생물성 질병의 치료 방법
|
|
AU2007242061B2
(en)
|
2006-04-21 |
2012-11-29 |
Intervet International B.V. |
Pestivirus species
|
|
FR2900341B1
(fr)
*
|
2006-04-27 |
2012-09-14 |
Centre Nat Rech Scient |
Utilisation de ligands synthetiques multivalents de la nucleoline de surface pour le traitement du cancer
|
|
US8790871B2
(en)
*
|
2006-05-09 |
2014-07-29 |
Musc Foundation For Research Development |
Detecting diastolic heart failure by protease and protease inhibitor plasma profiling
|
|
KR101442209B1
(ko)
*
|
2006-05-19 |
2014-11-18 |
테크니온 리서치 엔드 디벨로프먼트 화운데이션 엘티디. |
융합 단백질, 이의 용도 및 이의 제조방법
|
|
WO2007137300A2
(fr)
|
2006-05-23 |
2007-11-29 |
Bellicum Pharmaceuticals, Inc. |
Cellules dendritiques modifiées à survie et immunogénicité améliorées et compositions et procédés connexes
|
|
US20070281883A1
(en)
*
|
2006-06-05 |
2007-12-06 |
Hanna Rosenfeld |
Development of follicle stimulating hormone agonists and antagonists in fish
|
|
CA2656347A1
(fr)
|
2006-07-03 |
2008-01-10 |
Charles David Adair |
Composition servant a moduler l'expression de molecules d'adherence cellulaire
|
|
KR20090046825A
(ko)
*
|
2006-07-11 |
2009-05-11 |
무스크 파운데이션 포 리서치 디벨롭먼트 |
프로테아제 및 프로테아제 저해제 프로파일링으로 심근 경색 후 심부전을 예측하는 방법
|
|
US20080026394A1
(en)
*
|
2006-07-11 |
2008-01-31 |
Antara Biosciences Inc. |
Methods of detecting one or more cancer markers
|
|
WO2008010934A2
(fr)
|
2006-07-14 |
2008-01-24 |
Chemocentryx, Inc. |
Triazolyle phényle benzènesulfonamides
|
|
US8629259B2
(en)
|
2006-07-20 |
2014-01-14 |
Yeda Research And Development Co. Ltd. |
Photosynthetic organisms and compositions and methods of generating same
|
|
WO2008021954A2
(fr)
*
|
2006-08-09 |
2008-02-21 |
Biogen Idec Ma Inc. |
Procédé de distribution d'un médicament
|
|
JP2008043332A
(ja)
|
2006-08-17 |
2008-02-28 |
Panomics Inc |
組織スライドからの核酸定量
|
|
ES2570153T3
(es)
|
2006-08-22 |
2016-05-17 |
Novo Nordisk As |
Anticuerpos anti-C5aR con propiedades mejoradas
|
|
EP2061900A2
(fr)
|
2006-08-25 |
2009-05-27 |
Oncotherapy Science, Inc. |
Marqueurs pronostiques et cibles thérapeutiques s'appliquant au cancer du poumon
|
|
EP2064319B1
(fr)
|
2006-08-28 |
2017-02-22 |
Yeda Research and Development Co. Ltd. |
Méthodes de production de cellules gliales et neuronales et leur utilisation pour le traitement de troubles médicaux du système nerveux central
|
|
JP2008111824A
(ja)
*
|
2006-09-01 |
2008-05-15 |
Nox Technologies Inc |
腫瘍特異的ｔＮＯＸアイソフォーム及び方法
|
|
US7951776B2
(en)
|
2006-09-01 |
2011-05-31 |
American Type Culture Collection |
Methods for treatment of type 1 diabetes
|
|
US7985542B2
(en)
|
2006-09-07 |
2011-07-26 |
Institut Pasteur |
Genomic morse code
|
|
EP2469282A1
(fr)
|
2006-09-08 |
2012-06-27 |
University of Oxford |
Diagnostic clinique de la fibrose hépatique utilisant un nouveau panel de biomarqueurs de protéines du sérum humain
|
|
US8055034B2
(en)
|
2006-09-13 |
2011-11-08 |
Fluidigm Corporation |
Methods and systems for image processing of microfluidic devices
|
|
US8050516B2
(en)
*
|
2006-09-13 |
2011-11-01 |
Fluidigm Corporation |
Methods and systems for determining a baseline during image processing
|
|
US7888059B2
(en)
*
|
2006-10-05 |
2011-02-15 |
Yeda Research And Development Co. Ltd. |
Highly purified and stabilized Na,K-ATPase isoforms and methods of producing same
|
|
AU2007303821B9
(en)
|
2006-10-05 |
2013-06-20 |
Technion Research & Development Foundation Ltd. |
Microtubes and methods of producing same
|
|
CA2665709C
(fr)
|
2006-10-11 |
2018-04-03 |
Janssen Pharmaceutica N.V. |
Compositions et procedes pour le traitement et le diagnostic du syndrome du colon irritable
|
|
EP1912067A1
(fr)
*
|
2006-10-12 |
2008-04-16 |
Eppendorf Array Technologies S.A. |
Procédé de quantification d'un composé cible issu d'un échantillon biologique à l'aide de puces à microreseau
|
|
EP2426199A3
(fr)
|
2006-10-20 |
2012-08-22 |
Danisco US Inc. |
Oxydases de polyol
|
|
US20080305512A1
(en)
*
|
2006-10-26 |
2008-12-11 |
Mattingly Phillip G |
Assay for cardiac troponin autoantibodies
|
|
EP2097750A2
(fr)
*
|
2006-10-26 |
2009-09-09 |
Abbott Laboratories |
Analyse immunologique d'analytes dans des echantillons contenant des anticorps anti-analytes endogenes
|
|
US7776605B2
(en)
*
|
2006-10-26 |
2010-08-17 |
Abbott Laboratories |
Assay for cardiac troponin autoantibodies
|
|
JP2010507384A
(ja)
|
2006-10-27 |
2010-03-11 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
キナーゼ阻害剤のプロファイリング方法
|
|
AU2007325931A1
(en)
|
2006-11-02 |
2008-06-05 |
Yale University |
Assessment of oocyte competence
|
|
US8293684B2
(en)
*
|
2006-11-29 |
2012-10-23 |
Exiqon |
Locked nucleic acid reagents for labelling nucleic acids
|
|
US8473216B2
(en)
*
|
2006-11-30 |
2013-06-25 |
Fluidigm Corporation |
Method and program for performing baseline correction of amplification curves in a PCR experiment
|
|
DK2102239T3
(da)
|
2006-11-30 |
2012-05-29 |
Res Dev Foundation |
Forbedrede immunoglobulin-biblioteker
|
|
JP5059119B2
(ja)
|
2006-12-14 |
2012-10-24 |
シェーリング コーポレイション |
操作された抗ｔｓｌｐ抗体
|
|
BRPI0719602B1
(pt)
|
2006-12-20 |
2021-05-18 |
Evogene Ltd |
construção de ácido nucléicos, e, métodos para aumentar biomassa de uma planta, para aumentar o vigor de uma planta, para aumentar o rendimento de uma planta, para aumentar a tolerância de uma planta ao stress abiótico, para aprimorar a qualidade de fibra e/ou rendimento de uma planta que produz fibra e para produzir fibras de algodão
|
|
WO2008085895A2
(fr)
*
|
2007-01-04 |
2008-07-17 |
Musc Foundation For Research Development |
Prédiction de la récurrence de fibrillation atriale par profilage de protéase et d'inhibiteur de protéase
|
|
PT2121977T
(pt)
*
|
2007-01-11 |
2017-08-18 |
Erasmus Univ Medical Center |
Captura da conformação cromossómica circular (4c)
|
|
US9511075B2
(en)
|
2007-01-12 |
2016-12-06 |
The University Of Maryland, Baltimore |
Targeting NCCA-ATP channel for organ protection following ischemic episode
|
|
WO2008087641A2
(fr)
*
|
2007-01-16 |
2008-07-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Agents nucléotidiques de silençage de h19 destinés au traitement de l'arthrite rhumatoïde
|
|
WO2008092094A2
(fr)
*
|
2007-01-26 |
2008-07-31 |
University Of South Florida |
Procédé et matériaux pour la détection, le diagnostic et la gestion du cancer des ovaires
|
|
ATE535805T1
(de)
|
2007-01-26 |
2011-12-15 |
Univ Louisville Res Found |
Verfahren zur erkennung von autoantikörpern zur diagnostizierung und charakterisierung von erkrankungen
|
|
US20100196403A1
(en)
*
|
2007-01-29 |
2010-08-05 |
Jacob Hochman |
Antibody conjugates for circumventing multi-drug resistance
|
|
WO2008093341A2
(fr)
|
2007-01-31 |
2008-08-07 |
Technion Research & Development Foundation Ltd. |
Échafaudages électrofilés et leurs procédés de génération et d'utilisation
|
|
CA2676932C
(fr)
|
2007-02-01 |
2015-11-24 |
Technion Research & Development Foundation Ltd. |
Fibres et tissus d'albumine et leurs procedes de generation et d'utilisation
|
|
TW201307390A
(zh)
|
2007-02-02 |
2013-02-16 |
Amgen Inc |
海帕西啶（ｈｅｐｃｉｄｉｎ）、海帕西啶拮抗劑及使用方法
|
|
US8143046B2
(en)
*
|
2007-02-07 |
2012-03-27 |
Danisco Us Inc., Genencor Division |
Variant Buttiauxella sp. phytases having altered properties
|
|
US20080220498A1
(en)
*
|
2007-03-06 |
2008-09-11 |
Cervin Marguerite A |
Variant Buttiauxella sp. phytases having altered properties
|
|
KR100855299B1
(ko)
*
|
2007-02-16 |
2008-08-29 |
건국대학교 산학협력단 |
인간 ｉｌ-32 특이 항원결정기를 갖는 단일클론항체,특이항체분비 융합 세포주 및 항체들을 이용한 ｉｌ-32측정법
|
|
JP2008203195A
(ja)
*
|
2007-02-22 |
2008-09-04 |
Japan Science & Technology Agency |
Ｂｓｈの免疫測定用キットおよびｂｓｈの測定方法
|
|
ES2708988T3
(es)
|
2007-02-23 |
2019-04-12 |
Merck Sharp & Dohme |
Anticuerpos anti-IL-23p19 obtenidos por ingeniería genética
|
|
JP2010518858A
(ja)
|
2007-02-23 |
2010-06-03 |
シェーリング コーポレイション |
操作された抗−ｉｌ−２３ｐ１９抗体
|
|
WO2008106149A1
(fr)
*
|
2007-02-28 |
2008-09-04 |
Children's Medical Center Corporation |
Procédés de prédiction du début de la ménarche
|
|
NZ579251A
(en)
|
2007-02-28 |
2012-06-29 |
Schering Corp |
Engineered anti-il-23r antibodies
|
|
WO2008104979A2
(fr)
|
2007-02-28 |
2008-09-04 |
Yeda Research And Development Co. Ltd. |
Séquences de ciblage du noyau
|
|
EP2136843A1
(fr)
|
2007-03-12 |
2009-12-30 |
Miraculins Inc. |
Biomarqueurs du cancer de la prostate et utilisations de ceux-ci
|
|
WO2008116150A2
(fr)
|
2007-03-21 |
2008-09-25 |
Cedars-Sinai Medical Center |
Facteurs d'anastomose iléoanale avec réservoir (ippa) dans le traitement des maladies inflammatoires de l'intestin
|
|
EP2144935A2
(fr)
|
2007-03-29 |
2010-01-20 |
Technion Research & Development Foundation Ltd. |
Anticorps, procédés et kits de diagnostic et de traitement de mélanomes
|
|
HRP20150328T1
(hr)
|
2007-03-30 |
2015-05-22 |
Engeneic Molecular Delivery Pty Ltd. |
Bakterijski dobivene, intaktne mini-stanice koje obuhvaä†aju funkcionalnu nukleinsku kiselinu, bez plazmida, za in vivo dopremu do stanica sisavaca
|
|
CN101702920B
(zh)
|
2007-04-02 |
2013-03-13 |
特拉维夫大学拉莫特有限公司 |
癌细胞的检测方法及其在诊断和监测疾病治疗中的应用
|
|
ATE534753T1
(de)
|
2007-04-06 |
2011-12-15 |
Becton Dickinson Co |
Zusammensetzungen und verfahren zur identifikation eines carbapenemase-gens
|
|
EP2154946B1
(fr)
|
2007-04-09 |
2013-06-05 |
Evogene Ltd. |
Polynucléotides, polypeptides et procédés permettant d'augmenter la teneur en huile, la vitesse de croissance et la biomasse de plantes
|
|
WO2008127707A1
(fr)
*
|
2007-04-13 |
2008-10-23 |
Dana Farber Cancer Institute, Inc. |
Établissement du profil de récepteurs tyrosine kinases
|
|
AU2008239594B2
(en)
|
2007-04-13 |
2013-10-24 |
Beth Israel Deaconess Medical Center |
Methods for treating cancer resistant to ErbB therapeutics
|
|
US8003314B2
(en)
|
2007-04-16 |
2011-08-23 |
Diagnostic Hybrids, Inc. |
Methods for direct fluorescent antibody virus detection in liquids
|
|
US9556210B2
(en)
|
2007-04-23 |
2017-01-31 |
Sabag-Rfa Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
|
US9156865B2
(en)
|
2007-04-23 |
2015-10-13 |
Deliversir Ltd |
System for delivering therapeutic agents into living cells and cells nuclei
|
|
EP2144633B1
(fr)
*
|
2007-04-23 |
2014-07-16 |
Deliversir Ltd |
Système pour administrer des agents thérapeutiques dans des cellules vivantes et noyaux de cellules
|
|
ES2564312T3
(es)
|
2007-05-01 |
2016-03-21 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Métodos y kits para detectar células fetales en la sangre materna
|
|
EP2155789B1
(fr)
|
2007-05-01 |
2013-07-24 |
Research Development Foundation |
Banques d'immunoglobulines fc
|
|
EP2152730A4
(fr)
*
|
2007-05-02 |
2011-08-03 |
Univ Emory |
Amelioration d'incorporation de glycoproteine dans des particules de type viral
|
|
EP2150276B1
(fr)
|
2007-05-03 |
2014-05-21 |
Agency For Science, Technology And Research |
Fixation d'anticorps sur un polypeptide prl-1 ou prl-3 intracellulaire
|
|
AU2008246928B2
(en)
|
2007-05-07 |
2014-04-17 |
Protalix Ltd. |
Large scale disposable bioreactor
|
|
US20090081639A1
(en)
*
|
2007-05-31 |
2009-03-26 |
Phil Hill |
Assay for sensitivity to chemotherapeutic agents
|
|
US7776877B2
(en)
|
2007-06-22 |
2010-08-17 |
Chemocentryx, Inc. |
N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides
|
|
US9102754B2
(en)
*
|
2007-06-28 |
2015-08-11 |
University Of Saskatchewan |
Immunomodulatory compositions and methods for treating disease with modified host defense peptides
|
|
WO2009009662A1
(fr)
*
|
2007-07-10 |
2009-01-15 |
University Of South Florida |
Procédé de prédiction d'une non-réponse à une chimiothérapie de première intention
|
|
EP2176409B1
(fr)
|
2007-07-11 |
2012-01-04 |
Yeda Research And Development Co. Ltd. |
Systèmes de produits de construction d'acide nucléique pouvant diagnostiquer ou traiter un état cellulaire
|
|
JP5306344B2
(ja)
*
|
2007-07-12 |
2013-10-02 |
ケモセントリックス， インコーポレイテッド |
炎症の治療のためのｃｃｒ２モジュレーターとしての縮合ヘテロアリールピリジルおよびフェニルベンゼンスルホンアミド
|
|
EP2200628A2
(fr)
|
2007-07-15 |
2010-06-30 |
Yitzchak Hillman |
Traitement de maladie par des peptides antimicrobien ou leurs inhibiteurs
|
|
IL184627A0
(en)
|
2007-07-15 |
2008-12-29 |
Technion Res & Dev Foundation |
Agents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue
|
|
US8686227B2
(en)
|
2007-07-24 |
2014-04-01 |
Evogene Ltd. |
Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance and/or biomass and/or yield in plants expressing same
|
|
US8293685B2
(en)
|
2007-07-26 |
2012-10-23 |
The Regents Of The University Of California |
Methods for enhancing bacterial cell display of proteins and peptides
|
|
ES2700141T3
(es)
|
2007-08-02 |
2019-02-14 |
Gilead Biologics Inc |
Anticuerpos inhibidores LOXL2 y usos de los mismos
|
|
AU2008284015B2
(en)
|
2007-08-03 |
2014-05-15 |
Musc Foundation For Research Development |
Human monoclonal antibodies and methods for producing the same
|
|
KR20140120946A
(ko)
|
2007-08-03 |
2014-10-14 |
베링거 인겔하임 베트메디카 게엠베하 |
브라키스피라 하이오디센테리애의 유전자와 단백질 및 이의 용도
|
|
EP2185726B1
(fr)
|
2007-08-06 |
2014-01-08 |
Orion Genomics, LLC |
Nouveaux polymorphismes nucléotidiques uniques et combinaisons de nouveaux polymorphismes connus permettant de déterminer l'expression spécifique d'allèle du gène igf2
|
|
EP2283028A2
(fr)
|
2007-08-08 |
2011-02-16 |
The Board of Regents of The University of Texas System |
Peptides ciblant vegfr-1/nrp-1
|
|
WO2009023676A1
(fr)
|
2007-08-12 |
2009-02-19 |
Integrated Dna Technologies, Inc. |
Système de microréseau avec spécificité de séquence améliorée
|
|
US20090136916A1
(en)
*
|
2007-08-13 |
2009-05-28 |
Trustees Of Tufts College |
Methods and microarrays for detecting enteric viruses
|
|
KR20100071972A
(ko)
|
2007-08-15 |
2010-06-29 |
예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 |
Ｍｍｐ-9의 조절인자 및 그의 용도
|
|
WO2009072001A2
(fr)
*
|
2007-09-12 |
2009-06-11 |
Aurelium Biopharma Inc. |
Diagnostics dirigés contre slc9a3r1 pour une maladie néoplasique
|
|
US8741315B2
(en)
|
2007-09-12 |
2014-06-03 |
Yeda Research And Development Co. Ltd. |
Methods of treating tumors in immune-privileged sites
|
|
MX2010003019A
(es)
|
2007-09-19 |
2010-04-30 |
Pluristem Ltd |
Celulas adherentes de los tejidos adiposo y de placenta y uso de las mismas en la terapia.
|
|
EP3136103B1
(fr)
|
2007-10-05 |
2018-08-29 |
Affymetrix, Inc. |
Dosages hautement multiplexés
|
|
EP2781223B1
(fr)
|
2007-10-19 |
2017-02-22 |
Rappaport Family Institute for Research in the Medical Sciences |
Compositions comprenant des sémaphorines pour l'utilisation dans le traitement du cancer
|
|
JP2011504374A
(ja)
|
2007-11-26 |
2011-02-10 |
イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム リミテッド |
繊維状ポリペプチドおよび多糖を含む組成物
|
|
ES2535419T3
(es)
|
2007-12-27 |
2015-05-11 |
Protiva Biotherapeutics Inc. |
Silenciamiento de expresión de quinasa tipo polo usando ARN interferente
|
|
AU2008344935C1
(en)
|
2007-12-27 |
2016-07-14 |
Evogene Ltd. |
Isolated polypeptides, polynucleotides useful for modifying water user efficiency, fertilizer use efficiency, biotic/abiotic stress tolerance, yield and biomass in plants
|
|
BRPI0906429B1
(pt)
|
2008-01-10 |
2021-08-03 |
Research Development Foundation |
Método de identificação de uma infecção por e. chaffeensis em um indivíduo, uso de um ou mais polipeptídeo sintético e kit
|
|
WO2009094551A1
(fr)
|
2008-01-25 |
2009-07-30 |
Amgen Inc. |
Anticorps anti-ferroportine et procédés d'utilisation
|
|
US20090233295A1
(en)
*
|
2008-01-29 |
2009-09-17 |
Elias Georges |
Trim59 directed diagnostics for neoplastic disease
|
|
AU2009208607B2
(en)
*
|
2008-01-31 |
2013-08-01 |
Compugen Ltd. |
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
|
|
EP2712620A1
(fr)
|
2008-02-07 |
2014-04-02 |
Cornell University |
Procédés de prévention ou de traitement de la résistance à l'insuline
|
|
RU2010138612A
(ru)
|
2008-02-20 |
2012-03-27 |
Джи2 ИНФЛЕММЕЙШН ПТИ ЛТД (AU) |
ГУМАНИЗИРОВАННЫЕ АНТИТЕЛА ПРОТИВ C5аR
|
|
JO2913B1
(en)
|
2008-02-20 |
2015-09-15 |
امجين إنك, |
Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
|
|
EP2265751B1
(fr)
|
2008-02-21 |
2015-04-01 |
Technion Research & Development Foundation Ltd. |
Méthode pour séparer ou isoler une molecule d'une solution
|
|
EP2363407A1
(fr)
|
2008-02-28 |
2011-09-07 |
Murdoch University |
Nouvelles séquences de Brachyspira, compositions immunogènes, procédés pour leur préparation et utilisation
|
|
US20090311695A1
(en)
*
|
2008-03-12 |
2009-12-17 |
Talat Nasim |
Method
|
|
EP2271664A4
(fr)
|
2008-03-27 |
2011-11-23 |
Prionics Ag |
Nouvelles séquences de brachyspira, compositions immunogènes, leurs procédés de fabrication et d'utilisation
|
|
CA2719718C
(fr)
|
2008-03-28 |
2019-07-02 |
Mdna Life Sciences Inc. |
Adn mitochondrial aberrant, produits de transcription de fusion associes et sondes d'hybridation pour celui-ci
|
|
EP2107125A1
(fr)
|
2008-03-31 |
2009-10-07 |
Eppendorf Array Technologies SA (EAT) |
PCR en temps réel de cibles sur un micro-réseau
|
|
EP2280731A1
(fr)
*
|
2008-04-09 |
2011-02-09 |
Technion Research and Development Foundation, Ltd. |
Anticorps anti-immunodéficience humaine et leurs utilisations
|
|
WO2009125395A1
(fr)
*
|
2008-04-09 |
2009-10-15 |
Technion Research & Development Foundation Ltd. |
Anticorps antigrippe et leurs utilisations
|
|
EP2508325A3
(fr)
*
|
2008-04-10 |
2013-05-22 |
Objet Ltd. |
Système et procédé pour l' impression de modèles en trois dimensions
|
|
CA2721333C
(fr)
|
2008-04-15 |
2020-12-01 |
Protiva Biotherapeutics, Inc. |
Nouvelles formulations lipidiques pour l'administration d'acides nucleiques
|
|
EP2281041B1
(fr)
|
2008-04-15 |
2014-07-02 |
Protiva Biotherapeutics Inc. |
Réduction au silence de l'expression du gène csn5 au moyen d'arn interférant
|
|
GB0807161D0
(en)
*
|
2008-04-18 |
2008-05-21 |
Danisco |
Process
|
|
US9095569B2
(en)
|
2008-04-18 |
2015-08-04 |
Collplant Ltd. |
Methods of generating and using procollagen
|
|
AU2009239333A1
(en)
|
2008-04-21 |
2009-10-29 |
Danziger Innovations Ltd. |
Plant viral expression vectors and use of same for generating genotypic variations in plant genomes
|
|
WO2009132100A2
(fr)
*
|
2008-04-23 |
2009-10-29 |
Luminex Corporation |
Méthode de création d’un étalon pour plusieurs analytes présents dans une matière première d’origine biologique
|
|
WO2009132124A2
(fr)
*
|
2008-04-24 |
2009-10-29 |
The Trustees Of Columbia University In The City Of New York |
Motifs géométriques et bicouches lipidiques utilisables pour l'organisation de molécules d'adn et leurs utilisations
|
|
WO2009133464A2
(fr)
|
2008-04-30 |
2009-11-05 |
Danisco A/S |
Procédé d'oxydation
|
|
US9315577B2
(en)
|
2008-05-01 |
2016-04-19 |
Amgen Inc. |
Anti-hepcidin antibodies and methods of use
|
|
SG157299A1
(en)
|
2008-05-09 |
2009-12-29 |
Agency Science Tech & Res |
Diagnosis and treatment of kawasaki disease
|
|
US8847008B2
(en)
|
2008-05-22 |
2014-09-30 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant utility
|
|
EP2291390B1
(fr)
*
|
2008-05-22 |
2014-11-05 |
Centre National de la Recherche Scientifique (CNRS) |
Nouveaux composés optiquement purs pour une efficacité thérapeutique améliorée
|
|
BRPI0909541A2
(pt)
|
2008-05-27 |
2016-10-11 |
Pluristem Ltd |
''método para tratamento de doenças inflamatórias do cólon''
|
|
EP2620493B1
(fr)
|
2008-05-28 |
2019-03-27 |
Ramot at Tel Aviv University Ltd. |
Cellules souches mésenchymateuses destinées au traitement de troubles du SNC
|
|
US8791258B2
(en)
*
|
2008-06-10 |
2014-07-29 |
The Regents Of The University Of California |
Pro-fluorescent probes
|
|
EP2326419B1
(fr)
|
2008-06-29 |
2021-04-07 |
Realbio Technologies Ltd. |
Dispositif de transfert de liquide particulièrement utile comme dispositif de capture dans un processus de dosage biologique
|
|
WO2010016806A1
(fr)
|
2008-08-08 |
2010-02-11 |
Agency For Science, Technology And Research (A*Star) |
Vhz pour le diagnostic et le traitement de cancers
|
|
US20120122800A1
(en)
|
2008-08-08 |
2012-05-17 |
Genisphere, LLC Hatfield, Pennsylvania |
Long-Acting DNA Dendrimers and Methods Thereof
|
|
US9018445B2
(en)
|
2008-08-18 |
2015-04-28 |
Evogene Ltd. |
Use of CAD genes to increase nitrogen use efficiency and low nitrogen tolerance to a plant
|
|
CN105708862B
(zh)
|
2008-09-02 |
2020-11-06 |
普拉里斯坦有限公司 |
来自胎盘组织的粘附细胞及其在治疗中的用途
|
|
US8367392B2
(en)
*
|
2008-09-05 |
2013-02-05 |
Transalgae Ltd. |
Genetic transformation of algal and cyanobacteria cells by microporation
|
|
US20110305682A1
(en)
|
2008-09-11 |
2011-12-15 |
Ben Gurion University Of The Negev Research And Development Authority |
Compositions and Methods for Treating S. Pneumonia Infection
|
|
EP2331679B1
(fr)
|
2008-09-12 |
2017-04-19 |
Cryopraxis Criobiologia LTDA. |
Thérapie cellulaire de tissus ischémiques
|
|
ES2690348T3
(es)
|
2008-09-24 |
2018-11-20 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Péptidos y composiciones para la prevención de la adhesión celular y métodos de uso de los mismos
|
|
US9434985B2
(en)
|
2008-09-25 |
2016-09-06 |
University Of Massachusetts |
Methods of identifying interactions between genomic loci
|
|
US20110178024A1
(en)
|
2008-09-29 |
2011-07-21 |
Ben Gurion University Of The Negev Research And Development Authority |
Amyloid beta-peptides and methods of use thereof
|
|
US9207242B2
(en)
|
2008-10-09 |
2015-12-08 |
The University Of Hong Kong |
Cadherin-17 as diagnostic marker and therapeutic target for liver cancer
|
|
EP2347014B1
(fr)
|
2008-10-30 |
2016-09-21 |
Evogene Ltd. |
Polynucléotides et polypeptides isolés et procédés pour les utiliser pour augmenter le rendement, la biomasse, la vitesse de croissance, la vigueur, la teneur en huile, la tolérance au stress abiotique de plantes et l'efficacité d'utilisation de l'azote
|
|
EP2350131B1
(fr)
|
2008-11-07 |
2017-06-07 |
Research Development Foundation |
Compositions et méthodes pour l'inhibition de la formation et de la signalisation du complexe cripto/grp78
|
|
US20110229892A1
(en)
|
2008-11-17 |
2011-09-22 |
Yehuda G Assaraf |
Method for predicting a patient's responsiveness to anti-folate therapy
|
|
WO2010058396A1
(fr)
|
2008-11-19 |
2010-05-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Anticorps anti-cd44vra et procédés diagnostiques et thérapeutiques l'utilisant
|
|
US20110229471A1
(en)
|
2008-11-26 |
2011-09-22 |
Cedars-Sinai Medical Center |
Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease
|
|
WO2010061383A1
(fr)
|
2008-11-26 |
2010-06-03 |
Biodalia Microbiological Technologies Ltd. |
Procédé permettant d’enrichir in-situ des aliments avec des fructanes
|
|
WO2010064231A1
(fr)
|
2008-12-02 |
2010-06-10 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Procédés d’analyse d’édition d’arn a-i et constructions d’acide nucléique capables de ceux-ci
|
|
WO2010064247A1
(fr)
|
2008-12-03 |
2010-06-10 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Procédés et trousses pour déterminer une prédisposition au cancer
|
|
WO2010065437A1
(fr)
|
2008-12-03 |
2010-06-10 |
Research Development Foundation |
Modulation de l'angiogenèse à médiation par olfml-3
|
|
ES2554765T3
(es)
|
2008-12-05 |
2015-12-23 |
Yeda Research And Development Co. Ltd. |
miRNA-9 o miRNA-9* para uso en el tratamiento de ELA
|
|
BRPI0923155A2
(pt)
|
2008-12-05 |
2018-10-23 |
Abraxis Bioscience Llc |
scfcs de ligação a sparc
|
|
WO2010066252A1
(fr)
|
2008-12-09 |
2010-06-17 |
Dako Denmark A/S |
Procédé d'évaluation de prétraitement
|
|
WO2010068757A1
(fr)
|
2008-12-12 |
2010-06-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compositions et procédés utiles pour détecter et traiter des maladies associées à des ruptures du chromosome 16p
|
|
WO2010071610A1
(fr)
|
2008-12-19 |
2010-06-24 |
Agency For Science, Technology And Research (A*Star) |
Marqueurs biologiques de chikungunya sévère
|
|
US9580752B2
(en)
|
2008-12-24 |
2017-02-28 |
Cedars-Sinai Medical Center |
Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy
|
|
US8552147B2
(en)
|
2008-12-29 |
2013-10-08 |
Tel Hashomer Medical Research, Infrastructure And Services Ltd. |
Peptides and compositions for prevention of cell adhesion and methods of using same
|
|
MX350550B
(es)
|
2008-12-29 |
2017-09-08 |
Evogene Ltd |
Polinucleotidos, polipeptidos codificados, y metodos para utilizarlos para aumentar la tolerancia al estres, abiotico, biomasa y/o rendimiento en plantas que los expresan.
|
|
EP2808402A3
(fr)
|
2008-12-29 |
2015-03-25 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Méthodes de prédiction de la réponse au traitement par interférons
|
|
WO2010076794A1
(fr)
|
2008-12-31 |
2010-07-08 |
Technion Research & Development Foundation Ltd. |
Procédé pour dénitrifier une saumure et systèmes aptes à une telle dénitrification
|
|
WO2010080769A2
(fr)
|
2009-01-06 |
2010-07-15 |
Arresto Biosciences, Inc. |
Procédés et compositions chimiothérapeutiques
|
|
IL196820A0
(en)
|
2009-02-01 |
2009-11-18 |
Yissum Res Dev Co |
Devitalized, acellular scaffold matrices derived from micro-organs seeded with various cells
|
|
EP2391377A2
(fr)
|
2009-02-02 |
2011-12-07 |
Ramot at Tel-Aviv University Ltd. |
Peptides, compositions pharmaceutiques en contenant et leurs utilisations
|
|
WO2010089707A1
(fr)
|
2009-02-04 |
2010-08-12 |
Yeda Research And Development Co. Ltd. |
Procédé et trousses pour déterminer la sensibilité ou la résistance d'un cancer prostatique à une radiothérapie
|
|
EP3722810A3
(fr)
|
2009-02-11 |
2021-01-13 |
Caris MPI, Inc. |
Profilage moléculaire de tumeurs
|
|
WO2010093450A2
(fr)
|
2009-02-11 |
2010-08-19 |
Ludwing Institute For Cancer Research Ltd. |
Résistance assurée par la phosphorylation de pten au traitement du cancer et prognostic de patient modifié
|
|
CA2751758A1
(fr)
|
2009-02-11 |
2010-08-19 |
Orion Genomics Llc |
Combinaisons de polymorphismes destinees a determiner l'expression specifique des alleles d'igf2
|
|
WO2010096658A1
(fr)
|
2009-02-19 |
2010-08-26 |
The Cleveland Clinic Foundation |
Corine en tant que marqueur pour une insuffisance cardiaque
|
|
EP2401362B1
(fr)
|
2009-02-26 |
2017-04-12 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Populations isolées de cellules souches rénales et leurs procédés d'isolement et d'utilisation
|
|
EP3862433A3
(fr)
|
2009-03-02 |
2021-11-17 |
Evogene Ltd. |
Polynucléotides et polypeptides isolés, et procédés d'utilisation de ceux-ci pour augmenter un rendement végétal et/ou des caractéristiques agricoles
|
|
HRP20160385T1
(hr)
|
2009-03-09 |
2016-05-06 |
Ramot At Tel-Aviv University Ltd. |
Pripravci za prevenciju i liječenje neurodegenerativnih bolesti
|
|
WO2010103517A1
(fr)
|
2009-03-12 |
2010-09-16 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions solubles pour le traitement de maladies associées aux ligands cxcr3
|
|
US20100240065A1
(en)
*
|
2009-03-18 |
2010-09-23 |
Boehringer Ingelheim International Gmbh |
Prolyl Hydroxylase Compositions and Methods of Use Thereof
|
|
US8481698B2
(en)
*
|
2009-03-19 |
2013-07-09 |
The President And Fellows Of Harvard College |
Parallel proximity ligation event analysis
|
|
WO2010126670A2
(fr)
|
2009-03-27 |
2010-11-04 |
Gojo Industries, Inc. |
Compositions et procédés pour cribler et utiliser des composés antagonistes des interactions spore-surface
|
|
RU2011137486A
(ru)
|
2009-03-27 |
2013-05-10 |
Митомикс Инк. |
Аберрантная митохондриальная днк, ассоциированные с ней слитые транскрипты, продукты трансляции и гибрадизационные зонды
|
|
DK2414542T3
(da)
|
2009-03-30 |
2017-11-27 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Fremgangsmåder til forudsigelse af klinisk forløb for og behandling af multipel sklerose
|
|
AU2010231514A1
(en)
|
2009-04-01 |
2011-11-03 |
Rappaport Family Institute For Research In The Medical Sciences |
A method of regulating proliferation and differentiation of keratinocytes
|
|
WO2010116375A1
(fr)
|
2009-04-08 |
2010-10-14 |
Yeda Research And Development Co. Ltd. |
Peptides isolés pour réguler l'apoptose
|
|
WO2010121294A1
(fr)
|
2009-04-21 |
2010-10-28 |
Genetic Technologies Limited |
Procédés d'obtention de matériel génétique foetal
|
|
GB0908770D0
(en)
|
2009-04-24 |
2009-07-01 |
Danisco |
Method
|
|
KR20180077322A
(ko)
|
2009-04-30 |
2018-07-06 |
텔 하쇼머 메디컬 리서치 인프라스트럭쳐 앤드 서비시스 리미티드． |
항-ｃｅａｃａｍ1 항체들과 이를 이용하는 방법들
|
|
US9040667B2
(en)
|
2009-05-01 |
2015-05-26 |
Dako Denmark A/S |
Antibody cocktail
|
|
JP5813630B2
(ja)
*
|
2009-05-14 |
2015-11-17 |
ザ チャンセラー，マスターズ アンド スカラーズ オブ ザ ユニバーシティ オブ オックスフォード |
微量ヒト血漿タンパク質バイオマーカーの新規なパネルを使用した肝線維症の臨床診断
|
|
CN102428177B
(zh)
|
2009-05-19 |
2015-01-14 |
杜邦营养生物科学有限公司 |
提高面包耐码垛性的方法及其产品
|
|
WO2010134073A1
(fr)
|
2009-05-19 |
2010-11-25 |
Zetiq Technologies Ltd. |
Kits et procédés pour coloration différentielle de cellules et/ou tissus cancéreux du col de l'utérus
|
|
WO2011019423A2
(fr)
|
2009-05-20 |
2011-02-17 |
Schering Corporation |
Modulation de récepteurs pilr pour traiter les infections microbiennes
|
|
WO2010137013A1
(fr)
|
2009-05-27 |
2010-12-02 |
Ramot At Tel Aviv University Ltd. |
Unités cristallisées de photosystème i dérivées du pois et leur utilisation dans des dispositifs solides
|
|
EP2435072A2
(fr)
|
2009-05-27 |
2012-04-04 |
Yeda Research and Development Co. Ltd. |
Inhibiteurs des protéasomes et leurs utilisations
|
|
WO2010137021A2
(fr)
|
2009-05-27 |
2010-12-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédé de génération de tissu conjonctif
|
|
US20120070449A1
(en)
|
2009-05-28 |
2012-03-22 |
Yeda Research And Development Co. Ltd. |
Methods of treating inflammation
|
|
CA2764153C
(fr)
|
2009-06-02 |
2021-07-27 |
The Board Of Regents Of The University Of Texas System |
Identification de petites molecules reconnues par des anticorps chez des sujets atteints de maladies neurodegeneratives
|
|
BRPI1009032B1
(pt)
|
2009-06-10 |
2019-05-28 |
Evogene Ltd. |
Método de aumento de eficiência no uso de nitrogênio, biomassa, taxa de crescimento, e/ou tolerância a deficiência de nitrogênio de uma planta
|
|
EP2446267A1
(fr)
|
2009-06-24 |
2012-05-02 |
Health Corporation - Rambam |
Méthodes et kits d'isolement de microparticules placentaires et utilisation dans le diagnostic des affections placentaires
|
|
CA2766009A1
(fr)
|
2009-06-25 |
2010-12-29 |
Danisco A/S |
Enzymes lipolytiques variantes avec expression, fonctionnalite ou activite amelioree
|
|
CA2766810C
(fr)
|
2009-06-29 |
2017-10-10 |
The University Of Western Australia |
Terpenes synthases issues du bois de santal
|
|
WO2011000107A1
(fr)
|
2009-07-01 |
2011-01-06 |
Protiva Biotherapeutics, Inc. |
Formulations lipidiques inédites permettant l'administration d'agents thérapeutiques en direction de tumeurs solides
|
|
US9663778B2
(en)
|
2009-07-09 |
2017-05-30 |
OPKO Biologies Ltd. |
Long-acting coagulation factors and methods of producing same
|
|
US12203113B2
(en)
|
2009-07-09 |
2025-01-21 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
|
WO2011004379A1
(fr)
|
2009-07-10 |
2011-01-13 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Compositions et méthodes de traitement du cancer
|
|
SG10201700096VA
(en)
|
2009-07-17 |
2017-02-27 |
Bioatla Llc |
Simultaneous, Integrated Selection And Evolution Of Antibody/Protein Performance And Expression In Production Hosts
|
|
US8716464B2
(en)
|
2009-07-20 |
2014-05-06 |
Thomas W. Geisbert |
Compositions and methods for silencing Ebola virus gene expression
|
|
ES2753986T3
(es)
|
2009-07-21 |
2020-04-15 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Un método de diagnóstico de cáncer
|
|
GB0913442D0
(en)
|
2009-07-31 |
2009-09-16 |
Univ Ramot |
Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
|
|
WO2011021194A2
(fr)
|
2009-08-17 |
2011-02-24 |
Technion Research & Development Foundation Ltd. |
Cellules progénitrices de péricyte et leurs procédés de génération et d'utilisation
|
|
MX2012002189A
(es)
|
2009-08-21 |
2012-03-16 |
Beeologics Inc |
Prevencion y cura de las enfermedades de los insectos beneficiosos a traves de moleculas.
|
|
SG178845A1
(en)
|
2009-08-21 |
2012-04-27 |
Gilead Biologics Inc |
Catalytic domains from lysyl oxidase and loxl2
|
|
WO2011024172A2
(fr)
|
2009-08-27 |
2011-03-03 |
Technion Research & Development Foundation Ltd. |
Compositions liposomales et leurs utilisations
|
|
KR101790802B1
(ko)
|
2009-09-03 |
2017-10-27 |
머크 샤프 앤드 돔 코포레이션 |
항-ｇｉｔｒ 항체
|
|
WO2011030336A1
(fr)
|
2009-09-08 |
2011-03-17 |
Ramot At Tel-Aviv University Ltd. |
Procédés de diagnostic de la sclérose latérale amyotrophique (sla)
|
|
WO2011030332A2
(fr)
|
2009-09-08 |
2011-03-17 |
Yeda Research And Development Co. Ltd. |
Procédés pour la mobilisation de précurseur hématopoïétique
|
|
WO2011030329A1
(fr)
|
2009-09-10 |
2011-03-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Méthode de traitement de tumeurs
|
|
JP2013505022A
(ja)
|
2009-09-16 |
2013-02-14 |
バクサート インコーポレーティッド |
Ｈ１ｎ１感染を予防するための免疫戦略の方法
|
|
WO2011033506A2
(fr)
|
2009-09-17 |
2011-03-24 |
Yeda Research And Development Co. Ltd. |
Polypeptides pon1 isolés, polynucléotides codant pour ceux-ci et utilisations de ceux-ci dans le traitement ou la prévention des dommages associés à l'exposition à un organophosphate
|
|
BR112012006005A2
(pt)
|
2009-09-17 |
2017-09-19 |
Univ Ramot |
"peptídeos no tratamento de transtorno associados ao estresse oxidativo"
|
|
US8735124B2
(en)
|
2009-09-17 |
2014-05-27 |
Yeda Research And Development Co. Ltd. |
Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
|
US9222086B2
(en)
|
2009-09-23 |
2015-12-29 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing genes expressed in cancer
|
|
WO2011038403A1
(fr)
|
2009-09-28 |
2011-03-31 |
Yuling Luo |
Procédés de détection de séquences d'acide nucléique à spécificité élevée
|
|
US20110076232A1
(en)
|
2009-09-29 |
2011-03-31 |
Ludwig Institute For Cancer Research |
Specific binding proteins and uses thereof
|
|
WO2011040973A2
(fr)
|
2009-10-02 |
2011-04-07 |
Ludwig Institute For Cancer Research Ltd. |
Immunoconjugués de tnf avec des anticorps de protéine d'activation des fibroblastes et procédés et utilisations de ceux-ci
|
|
US20110081706A1
(en)
*
|
2009-10-02 |
2011-04-07 |
TransAlgae Ltd |
Method and system for efficient harvesting of microalgae and cyanobacteria
|
|
CA2776037A1
(fr)
|
2009-10-02 |
2011-04-07 |
Ludwig Institute For Cancer Research Ltd |
Anticorps diriges contre la proteine d'activation du fibroblaste, et utilisations et procedes correspondants
|
|
EP2486049A1
(fr)
|
2009-10-06 |
2012-08-15 |
The Board Of Trustees Of The UniversityOf Illinois |
Récepteurs de lymphocytes t à chaîne unique humains
|
|
ES2666372T3
(es)
|
2009-10-11 |
2018-05-04 |
Biogen Ma Inc. |
Ensayos relacionados con anti-VLA-4
|
|
EP3272869B1
(fr)
|
2009-10-14 |
2020-06-24 |
Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. |
Compositions pour commander les mites varroas dans les abeilles
|
|
US8962584B2
(en)
|
2009-10-14 |
2015-02-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Compositions for controlling Varroa mites in bees
|
|
ES2609006T3
(es)
|
2009-10-16 |
2017-04-18 |
Rutgers, The State University Of New Jersey |
Procedimeinto de tratamiento de lesión crónica de tejido nervioso usando una estrategia de terapia celular
|
|
WO2011048600A1
(fr)
|
2009-10-21 |
2011-04-28 |
Danziger Innovations Ltd. |
Génération de variations génotypiques dans des génomes de plantes par infection d'un gamète
|
|
EP2494077A4
(fr)
|
2009-10-27 |
2013-08-21 |
Caris Mpi Inc |
Profilage moléculaire pour médecine personnalisée
|
|
IL201999A
(en)
|
2009-11-08 |
2017-10-31 |
Medical Res & Development Fund For Health Services Bnai Zion Medical Center The State Of Israel |
A knockout mouse of the 1 – mo gene, a gene associated with morbidly extreme obesity
|
|
US9018010B2
(en)
|
2009-11-12 |
2015-04-28 |
Technion Research & Development Foundation Limited |
Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
|
|
EP2498806B1
(fr)
|
2009-11-12 |
2014-12-31 |
Ramot at Tel-Aviv University Ltd. |
Compositions contenant du pedf et leurs utilisations dans le traitement et la prévention de syndromes liés aux ovaires
|
|
WO2011058555A1
(fr)
|
2009-11-12 |
2011-05-19 |
Yeda Research And Development Co. Ltd. |
Procédé d'édition de l'adn dans une cellule et constructions ayant cette capacité
|
|
US9260517B2
(en)
|
2009-11-17 |
2016-02-16 |
Musc Foundation For Research Development |
Human monoclonal antibodies to human nucleolin
|
|
US20120230974A1
(en)
|
2009-11-17 |
2012-09-13 |
Protalix Ltd |
Alkaline alpha galactosidase for the treatment of fabry disease
|
|
GB0920089D0
(en)
|
2009-11-17 |
2009-12-30 |
Danisco |
Method
|
|
US8592151B2
(en)
*
|
2009-11-17 |
2013-11-26 |
Musc Foundation For Research Development |
Assessing left ventricular remodeling via temporal detection and measurement of microRNA in body fluids
|
|
EP2504472A1
(fr)
|
2009-11-24 |
2012-10-03 |
Collplant Ltd. |
Procédé de production de fibres de collagène
|
|
US9733242B2
(en)
|
2012-10-07 |
2017-08-15 |
Sevident, Inc. |
Devices for capturing analyte
|
|
US9910040B2
(en)
|
2012-07-09 |
2018-03-06 |
Sevident, Inc. |
Molecular nets comprising capture agents and linking agents
|
|
EP2977445B1
(fr)
|
2009-11-30 |
2018-07-25 |
Pluristem Ltd. |
Cellules adhérentes du placenta et leur utilisation dans le traitement de pathologies
|
|
US8652788B2
(en)
*
|
2009-12-02 |
2014-02-18 |
Abbott Laboratories |
Assay for diagnosis of cardiac myocyte damage
|
|
US8835120B2
(en)
*
|
2009-12-02 |
2014-09-16 |
Abbott Laboratories |
Assay for cardiac troponin-T (cTnT)
|
|
US20110136141A1
(en)
*
|
2009-12-03 |
2011-06-09 |
Abbott Laboratories |
Peptide reagents and method for inhibiting autoantibody antigen binding
|
|
US8183002B2
(en)
|
2009-12-03 |
2012-05-22 |
Abbott Laboratories |
Autoantibody enhanced immunoassays and kits
|
|
WO2011067745A2
(fr)
|
2009-12-06 |
2011-06-09 |
Rosetta Green Ltd. |
Compositions et procédés d'amélioration de résistance de plantes au stress abiotique
|
|
EP2862929B1
(fr)
|
2009-12-09 |
2017-09-06 |
Quark Pharmaceuticals, Inc. |
Compositions et procédés pour le traitement de maladies, troubles ou lésions du système nerveux central
|
|
EP2513308B1
(fr)
|
2009-12-17 |
2017-01-18 |
Merck Sharp & Dohme Corp. |
Modulation de pilr pour le traitement de troubles immunitaires
|
|
GB0922377D0
(en)
|
2009-12-22 |
2010-02-03 |
Arab Gulf University The |
Mutant LDL receptor
|
|
AU2010337936B2
(en)
|
2009-12-28 |
2016-06-23 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
|
|
EP3184109B1
(fr)
|
2009-12-29 |
2020-11-18 |
Gamida-Cell Ltd. |
Procédés d'amplification de la prolifération et de l'activité des cellules tueuses naturelles
|
|
US9005579B2
(en)
|
2010-01-05 |
2015-04-14 |
Contrafect Corporation |
Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
|
|
NZ601324A
(en)
|
2010-01-05 |
2014-10-31 |
Vascular Biogenics Ltd |
Methods for use of a specific anti-angiogenic adenoviral agent
|
|
US11287423B2
(en)
|
2010-01-11 |
2022-03-29 |
Biogen Ma Inc. |
Assay for JC virus antibodies
|
|
CN102906278A
(zh)
|
2010-01-11 |
2013-01-30 |
比奥根艾迪克Ma公司 |
用于jc病毒抗体的测定
|
|
JP6009357B2
(ja)
|
2010-01-12 |
2016-10-19 |
バスキュラー バイオジェニックス リミテッド |
アデノウイルスベクターの生産方法およびそれによって生成されるウイルス調製物
|
|
CA2787311C
(fr)
|
2010-01-27 |
2017-08-15 |
Yeda Research And Development Co. Ltd. |
Anticorps inhibant les metalloproteines
|
|
US20130171621A1
(en)
|
2010-01-29 |
2013-07-04 |
Advanced Cell Diagnostics Inc. |
Methods of in situ detection of nucleic acids
|
|
US8574832B2
(en)
|
2010-02-03 |
2013-11-05 |
Massachusetts Institute Of Technology |
Methods for preparing sequencing libraries
|
|
BR112012019693A2
(pt)
|
2010-02-04 |
2017-06-20 |
Gilead Biologics Inc |
anticorpos que se ligam à lisil oxidase-like 2 (loxl2) e métodos de uso para eles.
|
|
CN102844045A
(zh)
|
2010-02-08 |
2012-12-26 |
艾更斯司股份有限公司 |
结合于161p2f10b蛋白的抗体药物偶联物(adc)
|
|
WO2011099006A2
(fr)
|
2010-02-11 |
2011-08-18 |
Yeda Research And Development Co. Ltd. |
Systèmes enzymatiques pour la fixation du carbone et procédés de production associés
|
|
AU2011219426A1
(en)
|
2010-02-24 |
2012-10-04 |
Ben Gurion University Of The Negev Research And Development Authority |
Methods for inhibiting necrosis
|
|
WO2011107939A1
(fr)
|
2010-03-01 |
2011-09-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Méthodes de prédiction de l'efficacité d'un traitement par anti-vegfa pour des tumeurs solides
|
|
WO2011107994A1
(fr)
|
2010-03-04 |
2011-09-09 |
Yeda Research And Development Co. Ltd. |
Procédés de mesure de la stabilité d'une protéine
|
|
WO2011111034A1
(fr)
|
2010-03-08 |
2011-09-15 |
Yeda Research And Development Co. Ltd. |
Production de protéines recombinantes dans des systèmes hétérologues
|
|
ES2641642T3
(es)
|
2010-03-08 |
2017-11-10 |
Monsanto Technology Llc |
Moléculas de polinucleótido para regulación génica en plantas
|
|
WO2011111050A2
(fr)
|
2010-03-11 |
2011-09-15 |
Jacob Edrei |
Procédés de génération d'hydrogène
|
|
WO2011114251A1
(fr)
|
2010-03-18 |
2011-09-22 |
Danisco A/S |
Produits alimentaires
|
|
WO2011125015A2
(fr)
|
2010-04-05 |
2011-10-13 |
Bar-Ilan University |
Polypeptides formant des pores pouvant être activés par une protéase
|
|
US9125931B2
(en)
|
2010-04-06 |
2015-09-08 |
Massachusetts Institute Of Technology |
Post-transcriptional regulation of RNA-related processes using encoded protein-binding RNA aptamers
|
|
CN103168118A
(zh)
|
2010-04-06 |
2013-06-19 |
麻省理工学院 |
用减少数量的转录物测量进行的基因表达概况分析
|
|
WO2011128897A1
(fr)
|
2010-04-12 |
2011-10-20 |
Technion Research & Development Foundation Ltd. |
Population de cellules progénitrices pancréatiques et leurs méthodes d'isolement et d'utilisation
|
|
EP2557913B1
(fr)
|
2010-04-12 |
2016-08-03 |
Ben Gurion University Of The Negev Research And Development Authority |
Sulfotransférase d'une microalgue rouge et utilisations de celle-ci
|
|
WO2011129382A1
(fr)
|
2010-04-16 |
2011-10-20 |
Abbott Japan Co. Ltd. |
Procédés et réactifs pour diagnostiquer la polyarthrite rhumatoïde
|
|
RU2012148398A
(ru)
|
2010-04-18 |
2014-05-27 |
Иеда Рисеч Энд Девелопмент Ко. Лтд. |
МОЛЕКУЛЫ И СПОСОБЫ ПРИМЕНЕНИЯ МОЛЕКУЛ ДЛЯ ЛЕЧЕНИЯ БОЛЕЗНЕЙ, АССОЦИИРОВАННЫХ С ErbB/ErbB ЛИГАНДАМИ
|
|
EP2563112A4
(fr)
|
2010-04-28 |
2014-03-05 |
Evogene Ltd |
Polynucléotides et polypeptides isolés et procédés d'utilisation de ceux-ci pour l'augmentation du rendement végétal et/ou des caractéristiques agricoles
|
|
WO2011138778A2
(fr)
|
2010-05-04 |
2011-11-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédés permettant d'identifier des inhibiteurs de polypeptides d'intérêt
|
|
US9352000B2
(en)
|
2010-05-05 |
2016-05-31 |
Rappaport Family Institute For Research In The Medical Sciences |
Use of CCL1 in therapy
|
|
IL208820A0
(en)
|
2010-10-19 |
2011-01-31 |
Rachel Teitelbaum |
Biologic female contraceptives
|
|
MX2012012986A
(es)
|
2010-05-07 |
2013-03-05 |
Abbvie Inc |
Metodos para predecir la sensibilidad al tratamiento con un inhibidor de cinasa de tirosina dirigido.
|
|
US20120190563A1
(en)
|
2010-05-07 |
2012-07-26 |
Abbott Laboratories |
Methods for predicting sensitivity to treatment with a targeted tyrosine kinase inhibitor
|
|
WO2011141914A1
(fr)
|
2010-05-13 |
2011-11-17 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Populations isolées de cellules rénales adultes et procédés d'isolement et d'utilisation desdites populations
|
|
WO2011146479A1
(fr)
|
2010-05-18 |
2011-11-24 |
The Texas A&M University System |
Procédé et composition pour le diagnostic et le suivi de maladies inflammatoires
|
|
EP2576622A4
(fr)
|
2010-06-01 |
2013-11-27 |
Univ Monash |
Anticorps dirigés contre le récepteur tyrosine kinase c-met
|
|
WO2011151833A1
(fr)
|
2010-06-03 |
2011-12-08 |
Ramot At Tel-Aviv University Ltd. |
Méthodes de traitement du diabète et compositions capables de traiter le diabète
|
|
MX2012014284A
(es)
|
2010-06-07 |
2013-04-29 |
Osnat Ashur-Fabian |
Metodos y kits para diagnosticar afecciones relacionadas con hipoxia.
|
|
BR112012032126A2
(pt)
|
2010-06-16 |
2017-10-17 |
Futuragene Israel Ltd Empresa Isralense |
polinucleotídeo isolado, estrutura de ácido nucléico, sistema de estrutura de ácido nucléico, polipeptídeo isolado, planta, composição inseticida, e método para controlar ou exterminar um inseto
|
|
WO2011158243A2
(fr)
|
2010-06-16 |
2011-12-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédé de diagnostic et de traitement du cancer
|
|
WO2012006056A2
(fr)
|
2010-06-29 |
2012-01-12 |
Oregon Health & Science University |
Ccr6 en tant que biomarqueur de la maladie d'alzheimer
|
|
GB201011513D0
(en)
|
2010-07-08 |
2010-08-25 |
Danisco |
Method
|
|
EP2593468B1
(fr)
|
2010-07-12 |
2020-06-10 |
The State of Israel, Ministry of Agriculture and Rural Development, Agricultural Research Organization, (A.R.O.), Volcani Center |
Polynucléotides isolés et procédés et plantes les utilisant pour la régulation de l'acidité des plantes
|
|
EP2407242A1
(fr)
|
2010-07-13 |
2012-01-18 |
Dublin City University |
Analyse de clone directe et technologie de sélection
|
|
CA2805478A1
(fr)
|
2010-07-15 |
2012-01-19 |
Technion Research & Development Foundation Ltd. |
Entites de haute affinite isolees presentant une specificite de type recepteur des lymphocytes t pour les complexes natifs du mhc de classe ii et les peptides auto-antigeniques associes au diabete
|
|
US9695410B2
(en)
|
2010-07-15 |
2017-07-04 |
Technion Research & Development Foundation Limited |
Isolated high affinity entities with T-cell receptor like specificity towards native complexes of MHC class II and glutamic acid decarboxylase (GAD) autoantigenic peptides
|
|
BR112013000984A2
(pt)
|
2010-07-15 |
2017-10-03 |
Technion Res & Dev Foundation |
Estrutura de ácido nucleico para o aumento da tolerância ao estresse abiótico em plantas
|
|
WO2012009627A2
(fr)
|
2010-07-16 |
2012-01-19 |
Vanderbilt University |
Processeur à faible ressource utilisant des valves de tension superficielle pour extraire, concentrer et détecter des espèces moléculaires
|
|
ES2741175T3
(es)
|
2010-07-16 |
2020-02-10 |
Bioatla Llc |
Nuevos métodos de evolución de proteínas
|
|
WO2012011113A2
(fr)
|
2010-07-22 |
2012-01-26 |
Shai Yarkoni |
Cellules immunitaires régulatrices possédant un effet de destruction cellulaire ciblé accru
|
|
CN103026230B
(zh)
|
2010-07-23 |
2015-01-14 |
卢米耐克斯公司 |
共偶联以控制免疫测定中试剂的反应性
|
|
US9120862B2
(en)
|
2010-07-26 |
2015-09-01 |
Abbott Laboratories |
Antibodies relating to PIVKA-II and uses thereof
|
|
WO2012014207A2
(fr)
|
2010-07-27 |
2012-02-02 |
Technion Research & Development Foundation Ltd. |
Procédé de génération de cellules souches pluripotentes induites à partir de kératinocytes dérivés de follicules pileux prélevés
|
|
US20130130311A1
(en)
|
2010-07-27 |
2013-05-23 |
Yeda Research And Development Co., Ltd. |
Methods and systems for assessing clonality of cell cultures
|
|
WO2012014205A1
(fr)
|
2010-07-27 |
2012-02-02 |
Technion Research & Development Foundation Ltd. |
Cellules progénitrices mésenchymateuses isolées et matrice extra-cellulaire produite au moyen de celles-ci
|
|
WO2012017439A2
(fr)
|
2010-08-04 |
2012-02-09 |
Ramot At Tel-Aviv University Ltd. |
Procédés de traitement de maladies auto-immunes du système nerveux central (snc) et de maladies neurodégénératives
|
|
US8956859B1
(en)
|
2010-08-13 |
2015-02-17 |
Aviex Technologies Llc |
Compositions and methods for determining successful immunization by one or more vaccines
|
|
WO2012025914A1
(fr)
|
2010-08-22 |
2012-03-01 |
Ramot At Tel-Aviv University Ltd. |
Cellules souches pluripotentes induites dérivées de cellules bêta pancréatiques humaines
|
|
WO2012025925A1
(fr)
|
2010-08-24 |
2012-03-01 |
Rappaport Family Institute For Research In The Medical Sciences |
Procédés d'amélioration de la transplantation en utilisant des sdf-1alpha
|
|
BR122019017037B1
(pt)
|
2010-08-30 |
2022-05-31 |
Evogene Ltd |
Método de aumento de eficiência do uso de nitrogênio, rendimento, biomassa, taxa de crescimento, vigor e/ou tolerância ao estresse à deficiência de nitrogênio de uma planta
|
|
JP6283223B2
(ja)
|
2010-09-07 |
2018-02-21 |
テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド |
多能性幹細胞を培養するための新規な方法および培養培地
|
|
WO2012032510A1
(fr)
|
2010-09-07 |
2012-03-15 |
Yeda Research And Development Co. Ltd. |
Amorces pour l'amplification d'adn et procédés de sélection de ces dernières
|
|
WO2012032520A1
(fr)
|
2010-09-07 |
2012-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Translecture d'acétylcholinestérase (ache-r) pour le traitement ou la prévention de la maladie de parkinson
|
|
WO2012032519A2
(fr)
|
2010-09-07 |
2012-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Méthodes de diagnostic de la maladie de parkinson
|
|
JP2013540731A
(ja)
|
2010-09-08 |
2013-11-07 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
安定かつ長期間の生着のための免疫抑制薬物組合せ
|
|
CN103282047B
(zh)
|
2010-09-08 |
2016-08-24 |
耶达研究及发展有限公司 |
抗第三方中枢记忆性t细胞在抗白血病/淋巴瘤治疗中的用途
|
|
CN103210082A
(zh)
|
2010-09-15 |
2013-07-17 |
雷蒙特亚特特拉维夫大学有限公司 |
扩增胰岛β细胞和使其再分化的方法
|
|
US20130210901A1
(en)
|
2010-09-20 |
2013-08-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of treating neurodegenerative diseases
|
|
EP2619321B1
(fr)
|
2010-09-20 |
2018-08-01 |
Advanced Cell Diagnostics, Inc. |
Marqueurs biologiques permettant de différencier un mélanome d'un nævus bénin sur la peau
|
|
MX347954B
(es)
|
2010-09-29 |
2017-05-19 |
Agensys Inc |
Conjugados de anticuerpo farmaco (adc) que enlazan a proteinas 191p4d12.
|
|
EP2624848A2
(fr)
|
2010-10-04 |
2013-08-14 |
Centre National De La Recherche Scientifique CNRS |
Compositions comprenant des ligands synthétiques polyvalents de glycosaminoglycanes et de nucléoline
|
|
EP2441520A1
(fr)
|
2010-10-12 |
2012-04-18 |
Eppendorf AG |
Application en temps réel et détection basée sur un micro-réseau de cibles d'acides nucléiques dans un dosage sur puce de flux
|
|
EP2627766B1
(fr)
|
2010-10-17 |
2016-05-25 |
Yeda Research and Development Co. Ltd. |
Procédés et compositions utilisables en vue du traitement de pathologies médicales associées à l'insuline
|
|
WO2012052878A1
(fr)
|
2010-10-19 |
2012-04-26 |
Vascular Biogenics Ltd. |
Polynucléotides isolés et constructions d'acide nucléique pour diriger l'expression d'un gène d'intérêt dans des cellules
|
|
US8658361B2
(en)
|
2010-10-21 |
2014-02-25 |
Advanced Cell Diagnostics, Inc. |
Ultra sensitive method for in situ detection of nucleic acids
|
|
US20130216603A1
(en)
|
2010-10-27 |
2013-08-22 |
Nanocyte (Israel) Ltd. |
Pharmaceutical compositions and delivery devices comprising stinging cells or capsules
|
|
WO2012056455A1
(fr)
|
2010-10-28 |
2012-05-03 |
Yeda Research And Development Co. Ltd. |
Procédés de génération d'anticorps anti-métalloenzymes
|
|
CN103237895A
(zh)
|
2010-11-03 |
2013-08-07 |
耶路撒冷希伯来大学伊森姆研究发展有限公司 |
具有提高的糖化产率的转基因植物以及产生其的方法
|
|
US9410132B2
(en)
|
2010-11-04 |
2016-08-09 |
Ben-Gurion University Of The Negev Research And Development Authority |
Acyl-CoA: diacylglycerol acyltransferase 1-like gene (PtDGAT1) and uses thereof
|
|
TW201225972A
(en)
|
2010-11-15 |
2012-07-01 |
Univ Ramot |
Dipeptide analogs for treating conditions associated with amyloid fibril formation
|
|
WO2012066495A2
(fr)
|
2010-11-17 |
2012-05-24 |
Ben Gurion University Of The Negev Research And Development Authority |
Thérapie à base de cellules t pour les maladies neurodégénératives
|
|
JP6139410B2
(ja)
|
2010-12-02 |
2017-05-31 |
テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド |
角膜細胞の作製方法および該角膜細胞を含む細胞集団
|
|
AU2011253984A1
(en)
|
2010-12-07 |
2012-06-28 |
Biobalance Llc |
Method For Identifying E. Coli M-17
|
|
EP2652125B1
(fr)
|
2010-12-15 |
2017-04-26 |
Kadimastem Ltd. |
Cellules produisant de l'insuline dérivées de cellules souches pluripotentes
|
|
WO2012085862A2
(fr)
|
2010-12-22 |
2012-06-28 |
Evogene Ltd. |
Polynucléotides et polypeptides isolés, et procédés d'utilisation de ceux-ci pour augmenter la tolérance vis-à-vis du stress abiotique, le rendement, le taux de croissance, la vigueur, la biomasse, la teneur en huile et/ou l'efficacité d'utilisation d'azote de plantes
|
|
AR084358A1
(es)
|
2010-12-27 |
2013-05-08 |
Lilly Co Eli |
Composiciones y metodos para identificar y diferenciar componentes virales de vacunas multivalentes de la “fiebre de embarque” (complejo de enfermedad respiratoria bovina (brdc))
|
|
KR101947126B1
(ko)
|
2010-12-28 |
2019-02-13 |
카메디스 리미티드 |
감염의 치료 및 예방을 위한 식물 추출물
|
|
AU2011352207B2
(en)
|
2010-12-31 |
2016-03-03 |
Bioatla, Llc |
Comprehensive monoclonal antibody generation
|
|
EP3567121B1
(fr)
|
2011-01-17 |
2023-08-30 |
Life Technologies Corporation |
Workflow pour la détection de ligands à l'aide d'acides nucléiques
|
|
KR101883803B1
(ko)
|
2011-01-20 |
2018-07-31 |
프로탈릭스 리미티드 |
식물 및 식물 세포에서 알파-갈락토시다제의 발현용 핵산 작제물
|
|
EP2668290B1
(fr)
|
2011-01-28 |
2017-05-31 |
Advanced Cell Diagnostics, Inc. |
Dosage pvh rnascope® pour la détermination du statut pvh dans les cancers de la tête et du cou et les lésions cervicales
|
|
US20130316358A1
(en)
|
2011-01-31 |
2013-11-28 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing disease using overlap extension pcr
|
|
EP2671086B1
(fr)
|
2011-02-03 |
2018-04-25 |
Pop Test Oncology LLC |
Système et méthode de diagnostic et de traitement
|
|
US8952132B2
(en)
|
2011-02-07 |
2015-02-10 |
Research Development Foundation |
Engineered immunoglobulin FC polypeptides
|
|
WO2012114339A1
(fr)
|
2011-02-23 |
2012-08-30 |
Rappaport Family Institute For Research In The Medical Sciences |
Molécules de haute affinité capables de se lier à un récepteur plexine de type a et leurs utilisations
|
|
US9212258B2
(en)
|
2011-02-23 |
2015-12-15 |
The Board Of Trustees Of The University Of Illinois |
Amphiphilic dendron-coils, micelles thereof and uses
|
|
UA113843C2
(xx)
|
2011-03-02 |
2017-03-27 |
|
Стійка до бактерій трансгенна рослина, яка містить дисфункціональні білки t3ss
|
|
WO2012117373A1
(fr)
|
2011-03-03 |
2012-09-07 |
Ramot At Tel-Aviv University Ltd. |
Cellules musculaires génétiquement modifiées qui expriment des facteurs neurotrophiques
|
|
CA2829110C
(fr)
|
2011-03-06 |
2019-01-15 |
Merck Serono S.A. |
Lignees cellulaires a basse teneur de fucose et leurs utilisations
|
|
US9061006B2
(en)
|
2011-03-08 |
2015-06-23 |
Ramot At Tel-Aviv University Ltd. |
Compositions and methods for diagnosing and treating phenylketonuria (PKU)
|
|
AU2012226530B2
(en)
|
2011-03-08 |
2016-12-01 |
King Abdullah University Of Science And Technology |
Molecular biomarker set for early detection of ovarian cancer
|
|
CN105388287A
(zh)
|
2011-03-11 |
2016-03-09 |
内布拉斯加大学董事委员会 |
冠状动脉疾病的生物标志物
|
|
IN2013MN01438A
(fr)
|
2011-03-17 |
2015-06-12 |
Univ Ramot |
|
|
US20140086839A1
(en)
|
2011-03-17 |
2014-03-27 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Quinolone analogs for treating autoimmune diseases
|
|
JP2014511677A
(ja)
|
2011-03-22 |
2014-05-19 |
コーネル・ユニバーシティー |
鑑別困難な良性甲状腺病変と悪性甲状腺病変との識別法
|
|
EP3260533B1
(fr)
|
2011-03-22 |
2019-09-11 |
Pluristem Ltd. |
Les méthodes de traitement des rayonnements ou des blessures causées par des produits chimiques
|
|
US20140045764A1
(en)
|
2011-03-24 |
2014-02-13 |
Neurim Pharmaceuticals (1991) Ltd. |
Neuroprotective peptides
|
|
US20140005070A1
(en)
|
2011-03-28 |
2014-01-02 |
Novartis Ag |
Markers associated with cyclin-dependent kinase inhibitors
|
|
WO2012131680A2
(fr)
|
2011-03-28 |
2012-10-04 |
Yeda Research And Development Co. Ltd. |
Compositions et procédés pour le traitement de l'inflammation
|
|
BR112013025415B1
(pt)
|
2011-04-01 |
2021-03-16 |
Immunogen, Inc |
uso de um imunoconjugado antirreceptor de folato 1 (folr1)
|
|
DK2694095T3
(en)
|
2011-04-05 |
2018-05-28 |
Longevity Biotech Inc |
COMPOSITIONS COMPREHENSIVE GLUCAGON ANALOGS AND METHODS FOR PREPARING AND USING THE SAME
|
|
WO2012137202A1
(fr)
|
2011-04-05 |
2012-10-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Composition comprenant un indicateur de fer attaché à une microparticule et utilisations de celle-ci pour quantifier du fer non lié à la transferrine (ntbi) et du fer labile cellulaire (lci)
|
|
JP5990254B2
(ja)
|
2011-04-06 |
2016-09-07 |
ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッドＲａｍｏｔ Ａｔ Ｔｅｌ Ａｖｉｖ Ｕｎｉｖｅｒｓｉｔｙ Ｌｔｄ． |
代謝活性プロフィルのモニタリング方法および分析方法ならびにそれらの診断使用および治療使用
|
|
CA2830579A1
(fr)
|
2011-04-08 |
2012-10-11 |
Danisco Us Inc. |
Compositions
|
|
US9150644B2
(en)
|
2011-04-12 |
2015-10-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
|
|
CN103476924A
(zh)
|
2011-04-15 |
2013-12-25 |
普拉里斯坦有限公司 |
收获细胞的方法和系统
|
|
CA2833409A1
(fr)
|
2011-04-21 |
2012-10-26 |
The Rockefeller University |
Lysines de bacteriophages de streptocoques pour la detection et le traitement de bacteries gram-positives
|
|
CA2834027C
(fr)
|
2011-05-03 |
2021-12-21 |
Evogene Ltd. |
Polynucleotides et polypeptides isoles et leurs procedes d'utilisation pour augmenter le rendement de plantes, la biomasse, la vitesse de croissance, la vigueur, la teneur en huile, la tolerance au stress abiotique de plantes et l'efficacite d'utilisation de l'azote
|
|
EP2704793B1
(fr)
|
2011-05-04 |
2019-07-17 |
Ramot at Tel Aviv University, Ltd. |
Régulation de la composition moléculaire des bêta amyloïdes pour le traitement de la maladie d'azheimer
|
|
WO2012153333A1
(fr)
|
2011-05-09 |
2012-11-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Régénération et réparation de tissu mésenchymateux par utilisation d'amélogénine
|
|
WO2012153336A2
(fr)
|
2011-05-12 |
2012-11-15 |
Rakuto Bio Technologies Ltd. |
Procédés et dispositifs pour éclaircir la carnation de la peau
|
|
WO2012156976A1
(fr)
|
2011-05-16 |
2012-11-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédés de préparation d'artémisinine dans des plantes non-hôtes et vecteurs destinés à une utilisation dans celles-ci
|
|
JP6457263B2
(ja)
|
2011-05-20 |
2019-01-23 |
オリゴメリックス インコーポレイテッド |
タウプロテアーゼ組成物および使用方法
|
|
CN107102135A
(zh)
|
2011-05-20 |
2017-08-29 |
阿波特日本有限公司 |
用于减少非特异性结合的免疫检验方法和试剂
|
|
WO2012160526A2
(fr)
|
2011-05-23 |
2012-11-29 |
Ofir Menashe |
Formulations à base de particules contenant des micro-organismes et leurs utilisations
|
|
CA2836503C
(fr)
|
2011-05-23 |
2020-09-22 |
Yeda Research And Development Co. Ltd. |
Utilisation de la phosphorylation d'akt en tant que biomarqueur pour le pronostic et le traitement de maladies neurodegeneratives
|
|
SG10201604103SA
(en)
|
2011-05-31 |
2016-07-28 |
Hutchison Biofilm Medical Solutions Ltd |
Dispersion and detachment of cell aggregates
|
|
DK2715352T3
(da)
|
2011-05-31 |
2019-05-20 |
Biogen Ma Inc |
Fremgangsmåde til vurdering af risiko for pml
|
|
WO2012164565A1
(fr)
|
2011-06-01 |
2012-12-06 |
Yeda Research And Development Co. Ltd. |
Compositions et procédés pour la régulation à la baisse de gènes procaryotes
|
|
US10166295B2
(en)
|
2011-06-02 |
2019-01-01 |
Opko Biologics Ltd. |
Pegylated OXM variants
|
|
DK3424953T3
(en)
|
2011-06-06 |
2020-11-02 |
Novo Nordisk As |
Terapeutiske antistoffer
|
|
US9415103B2
(en)
|
2011-06-14 |
2016-08-16 |
Yeda Research And Development Co. Ltd. |
Combination therapy to prevent DCIS formation and progression to breast cancer
|
|
US20140130199A1
(en)
|
2011-06-23 |
2014-05-08 |
Kaiima Bio Agritech Ltd. |
Common wheat, plants or parts thereof having partially or fully multiplied genome, hybrids and products thereof and methods of generating and using same
|
|
US9835621B2
(en)
|
2011-07-14 |
2017-12-05 |
University Of Kentucky Research Foundation |
Process for detection of alzheimer's disease from a serum sample
|
|
GB201112091D0
(en)
|
2011-07-14 |
2011-08-31 |
Gt Biolog Ltd |
Bacterial strains isolated from pigs
|
|
AU2012284097B2
(en)
|
2011-07-18 |
2017-08-03 |
President And Fellows Of Harvard College |
Engineered microbe-targeting molecules and uses thereof
|
|
US20140143905A1
(en)
|
2011-07-20 |
2014-05-22 |
Amit Avidov |
Maize plants having a partially or fully multiplied genome and uses thereof
|
|
EP2550982A1
(fr)
|
2011-07-27 |
2013-01-30 |
Technion Research & Development Foundation Ltd. |
Dispositifs pour applications chirurgicales
|
|
CN107115352B
(zh)
|
2011-08-04 |
2020-10-30 |
耶达研究及发展有限公司 |
微rna和包含微rna的组合物
|
|
HUE039009T2
(hu)
|
2011-08-05 |
2018-12-28 |
Res Found Dev |
Javított eljárások és készítmények Olfml3-mediált angiogenesis modulálására
|
|
EP2741753A2
(fr)
|
2011-08-09 |
2014-06-18 |
Yeda Research and Development Co. Ltd. |
Régulation à la baisse de mir-7 pour favoriser la différenciation des cellules bêta et la production d'insuline
|
|
AR087524A1
(es)
|
2011-08-14 |
2014-03-26 |
Kaiima Bio Agritech Ltd |
Plantas de trigo durum que tienen un genoma parcial completamente multiplicado y sus usos
|
|
BR112014003315A2
(pt)
|
2011-08-15 |
2017-03-01 |
Univ Chicago |
composições e métodos relacionados a anticorpos para a proteína a estafilocócica
|
|
WO2013025479A1
(fr)
|
2011-08-16 |
2013-02-21 |
Emory University |
Agents spécifiques de liaison à jaml, anticorps, et leurs utilisations associées
|
|
EP2753367A4
(fr)
|
2011-09-07 |
2015-10-14 |
Yeda Res & Dev |
Signature olfactive et mélange odorant la contenant
|
|
WO2013035099A1
(fr)
|
2011-09-08 |
2013-03-14 |
Yeda Research And Development Co. Ltd. |
Lymphocytes t mémoires centraux anti-tierce partie, leurs procédés de production et leur utilisation dans le cadre d'une transplantation ou du traitement d'une maladie
|
|
CN103890195A
(zh)
|
2011-09-08 |
2014-06-25 |
耶达研究及发展有限公司 |
用于肺癌的新型风险生物标志物
|
|
BR112014005958A2
(pt)
|
2011-09-13 |
2020-10-13 |
Monsanto Technology Llc |
métodos e composições químicas agrícolas para controle de planta, método de redução de expressão de um gene accase em uma planta, cassete de expressão microbiana, método para fazer um polinucleotídeo, método de identificação de polinucleotídeos úteis na modulação de expressão do gene accase e composição herbicida
|
|
CN103974967A
(zh)
|
2011-09-13 |
2014-08-06 |
孟山都技术公司 |
用于杂草控制的方法和组合物
|
|
US10829828B2
(en)
|
2011-09-13 |
2020-11-10 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
|
MX342856B
(es)
|
2011-09-13 |
2016-10-13 |
Monsanto Technology Llc |
Metodos y composiciones para el control de malezas.
|
|
UA116089C2
(uk)
|
2011-09-13 |
2018-02-12 |
Монсанто Текнолоджи Ллс |
Спосіб та композиція для боротьби з бур'янами (варіанти)
|
|
US10806146B2
(en)
|
2011-09-13 |
2020-10-20 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
|
US9840715B1
(en)
|
2011-09-13 |
2017-12-12 |
Monsanto Technology Llc |
Methods and compositions for delaying senescence and improving disease tolerance and yield in plants
|
|
US10760086B2
(en)
|
2011-09-13 |
2020-09-01 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
|
US9920326B1
(en)
|
2011-09-14 |
2018-03-20 |
Monsanto Technology Llc |
Methods and compositions for increasing invertase activity in plants
|
|
US9249467B2
(en)
|
2011-09-16 |
2016-02-02 |
Steven Goodison |
Bladder cancer detection composition, kit and associated methods
|
|
EP2764093B1
(fr)
|
2011-10-05 |
2018-04-18 |
The Rockefeller University |
Lysines bactériophagiques dimères
|
|
GB201117313D0
(en)
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
|
WO2013054320A1
(fr)
|
2011-10-11 |
2013-04-18 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Anticorps dirigés contre la molécule d'adhésion cellulaire associée à l'antigène carcino-embryonnaire (ceacam)
|
|
PT2768851T
(pt)
|
2011-10-21 |
2017-09-08 |
Augurex Life Sciences Corp |
Antigénios derivados de 14-3-3 citrulinada e utilizações dos mesmos no diagnóstico de artrite reumatoide
|
|
WO2013061328A2
(fr)
|
2011-10-27 |
2013-05-02 |
Yeda Research And Development Co. Ltd. |
Procédé de traitement du cancer
|
|
WO2013064163A1
(fr)
|
2011-11-01 |
2013-05-10 |
Academisch Medisch Centrum |
Marqueurs de méthylation pour le cancer colorectal
|
|
AU2012332517B9
(en)
|
2011-11-03 |
2017-08-10 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for neuroprotection
|
|
US20140323549A1
(en)
|
2011-11-08 |
2014-10-30 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for treating diseases, disorders or injury of the nervous system
|
|
WO2013076729A1
(fr)
|
2011-11-23 |
2013-05-30 |
Danziger Dan Flower Farm |
Plantes de type otomeria
|
|
US9617331B2
(en)
|
2011-11-27 |
2017-04-11 |
Yeda Research And Development Co. Ltd. |
Methods of regulating angiogenesis by administering agents which increase apoB-100 polypeptide
|
|
PT2788009T
(pt)
|
2011-12-08 |
2016-08-31 |
Yeda Res & Dev |
Células pulmonares fetais de mamíferos e uso terapêutico das mesmas
|
|
WO2013090407A2
(fr)
|
2011-12-12 |
2013-06-20 |
Step Ahead Innovations, Inc. |
Appareils et systèmes de dosage et de surveillance en environnement aquatique et procédés et logiciel associés à ceux-ci
|
|
WO2013093921A1
(fr)
|
2011-12-20 |
2013-06-27 |
Collplant Ltd. |
Fibres de polymère synthétique enrobées de collagène
|
|
US9035039B2
(en)
|
2011-12-22 |
2015-05-19 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing SMAD4
|
|
WO2013095729A1
(fr)
|
2011-12-22 |
2013-06-27 |
Life Technologies Corporation |
Dispositif capillaire à écoulement latéral séquentiel pour la détermination d'un analyte
|
|
JP2015504047A
(ja)
|
2011-12-22 |
2015-02-05 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
安定かつ長期の生着のための併用療法
|
|
WO2013098820A1
(fr)
|
2011-12-28 |
2013-07-04 |
Kaiima Bio Agritech Ltd. |
Sorgho agricole à génome partiellement ou complètement multiplié, et utilisations correspondantes
|
|
CN104160039B
(zh)
|
2011-12-29 |
2021-08-03 |
贝勒研究院 |
川崎病的生物标志物
|
|
JP2015509085A
(ja)
|
2012-01-01 |
2015-03-26 |
キュービーアイ エンタープライゼズ リミテッドＱｂｉ Ｅｎｔｅｒｐｒｉｓｅｓ Ｌｔｄ． |
治療剤および診断剤の選択的送達のためのｅｎｄｏ１８０を標的とする粒子
|
|
AU2012367247B2
(en)
|
2012-01-24 |
2018-04-05 |
Cd Diagnostics, Inc. |
System for detecting infection in synovial fluid
|
|
WO2013114363A2
(fr)
|
2012-01-30 |
2013-08-08 |
Yeda Research And Development Co.Ltd. |
Agents antimicrobiens
|
|
US9603907B2
(en)
|
2012-02-01 |
2017-03-28 |
Protalix Ltd. |
Dry powder formulations of dNase I
|
|
WO2013118120A2
(fr)
|
2012-02-06 |
2013-08-15 |
Rosetta Green Ltd. |
Polynucléotides isolés exprimant ou modulant des microarn ou des cibles de ceux-ci, plantes transgéniques comprenant ceux-ci et leurs utilisations dans l'amélioration de l'efficacité d'utilisation de l'azote, de la tolérance au stress abiotique, de la biomasse, de la vigueur ou du rendement d'une plante
|
|
HK1202581A1
(en)
|
2012-02-13 |
2015-10-02 |
Gamida-Cell Ltd. |
Mesenchymal stem cells conditioned medium and methods of generating and using the same
|
|
PL3791890T3
(pl)
|
2012-02-14 |
2025-04-14 |
Opko Biologics Ltd. |
Długo działające czynniki krzepnięcia i ich zastosowania
|
|
EP2814838A1
(fr)
|
2012-02-19 |
2014-12-24 |
Protalix Ltd. |
Formes galéniques unitaires administrées par voie orale et utilisations de celles-ci pour le traitement de la maladie de gaucher
|
|
WO2013124817A2
(fr)
|
2012-02-22 |
2013-08-29 |
Brainstem Biotec Ltd. |
Microarn pour la génération d'astrocytes
|
|
EP2844745A2
(fr)
|
2012-02-22 |
2015-03-11 |
Brainstem Biotec Ltd. |
Génération de cellules souches neuronales et de motoneurones
|
|
EP2817287B1
(fr)
|
2012-02-24 |
2018-10-03 |
Arbutus Biopharma Corporation |
Lipides cationiques trialkylés et leurs procédés d'utilisation
|
|
RU2627268C2
(ru)
|
2012-02-29 |
2017-08-04 |
Хемоцентрикс, Инк. |
Аза-арил-1Н-пиразол-1-ил-сульфонамиды
|
|
WO2013128454A1
(fr)
|
2012-03-01 |
2013-09-06 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), Volcani Center |
Plantes d'ail stérile mâle, descendance hybride de celles-ci et procédés de génération et d'utilisation de celles-ci
|
|
EP3483184A1
(fr)
|
2012-03-07 |
2019-05-15 |
Yeda Research and Development Co. Ltd |
Compositions inhibitrices de la quiescine sulfhydryle oxydase (qsox1) et leurs utilisations
|
|
ES2731757T3
(es)
|
2012-03-20 |
2019-11-18 |
Biogen Ma Inc |
Anticuerpos neutralizantes de JCV
|
|
EP2828280B1
(fr)
|
2012-03-22 |
2018-05-02 |
Ramot at Tel-Aviv University Ltd. |
Peptides multimères plif et utilisations de ceux-ci
|
|
CA2868883C
(fr)
|
2012-03-30 |
2022-10-04 |
Sorrento Therapeutics Inc. |
Anticorps completement humains qui se lient a vegfr2
|
|
US20140178869A1
(en)
|
2012-04-05 |
2014-06-26 |
Advanced Cell Diagnostics, Inc. |
Detection of immunoglobulin light chain restriction by rna in situ hybridization
|
|
CA2868238A1
(fr)
|
2012-04-18 |
2013-10-24 |
Ramot At Tel Aviv University Ltd. |
Particules de glycosaminoglycane lipide pour la liberation d'acides nucleiques
|
|
HK1207564A1
(en)
|
2012-04-19 |
2016-02-05 |
Opko Biologics Ltd |
Long-acting oxyntomodulin variants and methods of producing same
|
|
US20130280696A1
(en)
|
2012-04-23 |
2013-10-24 |
Elliott Millenson |
Devices and methods for detecting analyte in bodily fluid
|
|
EP2841084B1
(fr)
|
2012-04-24 |
2018-05-30 |
Biokine Therapeutics Ltd. |
Peptide antagoniste de cxcr4 et son utilisation pour le traitment de tumeurs pulmonaires
|
|
CN104703622B
(zh)
|
2012-04-26 |
2017-05-24 |
芝加哥大学 |
与金黄色葡萄球菌疾病期间抵消凝固酶活性的抗体相关的组合物和方法
|
|
WO2013168164A1
(fr)
|
2012-05-09 |
2013-11-14 |
Yeda Research And Development Co. Ltd. |
VARIANTS DE PRO-DOMAINE TACE EN TANT QU'INHIBITEUR DE TNF-α ET LEUR UTILISATION MÉDICALE
|
|
AU2013259276B2
(en)
|
2012-05-10 |
2018-03-22 |
Bioatla Llc |
Multi-specific monoclonal antibodies
|
|
US8865158B2
(en)
|
2012-05-22 |
2014-10-21 |
Ramot At Tel-Aviv University Ltd. |
Bacteriophages for reducing toxicity of bacteria
|
|
IN2014KN02831A
(fr)
|
2012-05-24 |
2015-05-08 |
Mountgate Group Ltd |
|
|
US10240161B2
(en)
|
2012-05-24 |
2019-03-26 |
A.B. Seeds Ltd. |
Compositions and methods for silencing gene expression
|
|
KR20220084444A
(ko)
|
2012-05-31 |
2022-06-21 |
소렌토 쎄라퓨틱스, 인코포레이티드 |
Pd-l1에 결합하는 항원 결합 단백질
|
|
ES2897825T3
(es)
|
2012-06-01 |
2022-03-02 |
Icahn School Med Mount Sinai |
Niveles de ceramida en el tratamiento y prevención de infecciones
|
|
EP2855507B1
(fr)
|
2012-06-03 |
2018-01-03 |
Ben-Gurion University of The Negev Research and Development Authority |
Peptides de liaison au titane fonctionnalisés et implants revêtus par ceux-ci
|
|
EA201492269A1
(ru)
|
2012-06-04 |
2016-02-29 |
Опко Байолоджикс Лтд. |
Пегилированные варианты oxm
|
|
CN105050618B
(zh)
|
2012-06-21 |
2018-11-16 |
索伦托治疗有限公司 |
与c-Met结合的抗原结合蛋白
|
|
WO2013192596A2
(fr)
|
2012-06-22 |
2013-12-27 |
Sorrento Therapeutics Inc. |
Protéines de liaison à un antigène qui se lient à ccr2
|
|
US9758829B2
(en)
|
2012-06-22 |
2017-09-12 |
Htg Molecular Diagnostics, Inc. |
Molecular malignancy in melanocytic lesions
|
|
WO2014006621A1
(fr)
|
2012-07-03 |
2014-01-09 |
Nanospun Technologies Ltd. |
Procédés et dispositifs pour l'adsorption et la biodégradation de pétrole
|
|
EP2870261B1
(fr)
|
2012-07-09 |
2017-12-06 |
Novartis AG |
Biomarqueurs associes aux inhibiteurs de kinases cycline-dependantes.
|
|
JP6277187B2
(ja)
|
2012-07-11 |
2018-02-07 |
イムステム バイオテクノロジー，インコーポレイテッド |
ヒト胚性幹細胞由来の間葉系様幹細胞、方法およびその使用
|
|
EP3327090A1
(fr)
|
2012-07-18 |
2018-05-30 |
President and Fellows of Harvard College |
Modification de surfaces pour une répulsion et une liaison ciblée simultanées de fractions désirées
|
|
WO2014018375A1
(fr)
|
2012-07-23 |
2014-01-30 |
Xenon Pharmaceuticals Inc. |
Cyp8b1 et ses utilisations dans des méthodes thérapeutiques et diagnostiques
|
|
US9175266B2
(en)
|
2012-07-23 |
2015-11-03 |
Gamida Cell Ltd. |
Enhancement of natural killer (NK) cell proliferation and activity
|
|
US9567569B2
(en)
|
2012-07-23 |
2017-02-14 |
Gamida Cell Ltd. |
Methods of culturing and expanding mesenchymal stem cells
|
|
KR102499753B1
(ko)
|
2012-07-27 |
2023-02-16 |
더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 |
Ｔ 세포 수용체 조작
|
|
EP3594331A1
(fr)
|
2012-07-29 |
2020-01-15 |
Yeda Research and Development Co. Ltd. |
Utilisation de la voie de la glycine réductrice en vue de la génération de microorganismes formatotrophes et autotrophes
|
|
JP6340366B2
(ja)
|
2012-07-31 |
2018-06-06 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
運動ニューロン疾患を診断および処置する方法
|
|
ES2742285T3
(es)
|
2012-07-31 |
2020-02-13 |
Novartis Ag |
Marcadores asociados con la sensibilidad a inhibidores del doble minuto humano 2 (MDM2)
|
|
DK2880151T3
(da)
|
2012-08-06 |
2020-08-17 |
Brainstorm Cell Therapeutics Ltd |
Fremgangsmåder til frembringelse af mesenkymale stemceller, som udskiller neurotrofiske faktorer
|
|
TWI606063B
(zh)
|
2012-08-23 |
2017-11-21 |
艾澤西公司 |
結合至１５８ｐ１ｄ７蛋白之抗體藥物結合物（ａｄｃ）
|
|
WO2014033723A1
(fr)
|
2012-09-03 |
2014-03-06 |
A.B. Seeds Ltd. |
Procédé d'amélioration de la tolérance au stress abiotique des plantes et plantes ainsi produites
|
|
US10543278B2
(en)
|
2012-09-12 |
2020-01-28 |
Ramot At Tel-Aviv University Ltd. |
Immunoparticles and methods of generating and using same
|
|
EP3677310A1
(fr)
|
2012-10-08 |
2020-07-08 |
St. Jude Children's Research Hospital |
Thérapies fondées sur la régulation de la stabilité et de la fonction des lymphocytes t régulateurs par l'intermédiaire d'un axe neuropiline-1:sémaphorine
|
|
EP2906954B1
(fr)
|
2012-10-09 |
2018-04-11 |
Ramot at Tel-Aviv University Ltd. |
Procédés et trousses utilisant la mortaline soluble dans le sang pour prédire un pronostic de cancer
|
|
EP2906596B1
(fr)
|
2012-10-12 |
2023-12-27 |
Arizona Board of Regents on behalf of Arizona State University |
Réactifs à base d'anticorps qui reconnaissent spécifiquement des formes oligomériques toxiques de tau
|
|
MX364070B
(es)
|
2012-10-18 |
2019-04-10 |
Monsanto Technology Llc |
Métodos y composiciones para el control de plagas vegetales.
|
|
US9395369B2
(en)
|
2012-10-19 |
2016-07-19 |
Regents Of The University Of Minnesota |
Guinea pig cytomegalovirus (CIDMTR strain)
|
|
WO2014063097A1
(fr)
|
2012-10-19 |
2014-04-24 |
Danisco Us Inc. |
Stabilisation de membranes biomimétiques
|
|
US20150354006A1
(en)
|
2012-10-19 |
2015-12-10 |
Novartis Ag |
Markers for acute lymphoblastic leukemia
|
|
AU2013336237A1
(en)
|
2012-10-22 |
2015-06-11 |
Sabag-Rfa Ltd |
A system for delivering therapeutic agents into living cells and cells nuclei
|
|
WO2014066590A1
(fr)
|
2012-10-24 |
2014-05-01 |
Research Development Foundation |
Anticorps anti-jam-c et procédés pour le traitement du cancer
|
|
EP2912062A1
(fr)
|
2012-10-24 |
2015-09-02 |
Yeda Research and Development Co. Ltd. |
Combinaisons d'anticorps ciblant les récepteurs du facteur de croissance épidermique pour traiter le cancer
|
|
WO2014068553A1
(fr)
|
2012-10-29 |
2014-05-08 |
Yeda Research And Development Co. Ltd. |
Aptamères, aptamères multimères et leurs utilisations
|
|
HUE055348T2
(hu)
|
2012-11-20 |
2021-11-29 |
Opko Biologics Ltd |
Eljárás polipeptidek hidrodinamikus térfogatának növelésére gonadotropin karboxil-terminális peptidekhez való kapcsolással
|
|
CA2877847A1
(fr)
|
2012-11-29 |
2014-06-05 |
Yeda Research And Development Co. Ltd. |
Methodes de prevention d'une metastase tumorale, de traitement et de pronostic du cancer, et d'identification d'agents susceptibles de constituer des inhibiteurs de metastase
|
|
US10683505B2
(en)
|
2013-01-01 |
2020-06-16 |
Monsanto Technology Llc |
Methods of introducing dsRNA to plant seeds for modulating gene expression
|
|
WO2014106837A2
(fr)
|
2013-01-01 |
2014-07-10 |
A. B. Seeds Ltd. |
Molécules d'arnds isolées et procédés pour les utiliser pour le silençage de molécules d'intérêt cibles
|
|
US10047399B2
(en)
|
2013-01-07 |
2018-08-14 |
The Cleveland Clinic Foundation |
ABCA1 downregulation in prostate cancer
|
|
WO2014108854A1
(fr)
|
2013-01-09 |
2014-07-17 |
Fusimab Ltd. |
Anticorps anti-hgf et anti-ang2 monospécifiques, et anticorps anti-hgf/anti-ang2 bispécifiques
|
|
WO2014108850A2
(fr)
|
2013-01-09 |
2014-07-17 |
Yeda Research And Development Co. Ltd. |
Analyse de transcriptome à haut débit
|
|
CN104937412B
(zh)
|
2013-01-17 |
2018-05-25 |
诺威尔卢斯德克有限公司 |
用于鉴定患者特定驱动突变物的方法和系统
|
|
US10125373B2
(en)
|
2013-01-22 |
2018-11-13 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Geminiviral vector for expression of rituximab
|
|
US10000767B2
(en)
|
2013-01-28 |
2018-06-19 |
Monsanto Technology Llc |
Methods and compositions for plant pest control
|
|
EP2951290B1
(fr)
|
2013-02-01 |
2017-11-29 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Procédé de génération de cellules épithéliales pigmentaires rétiniennes (epr) à partir de cellules souches pluripotentes induites (cspi)
|
|
US9411930B2
(en)
|
2013-02-01 |
2016-08-09 |
The Regents Of The University Of California |
Methods for genome assembly and haplotype phasing
|
|
WO2014121091A1
(fr)
|
2013-02-01 |
2014-08-07 |
The Regents Of The University Of California |
Procédés pour assemblage du génome et phasage d'haplotype
|
|
US10000737B2
(en)
|
2013-02-04 |
2018-06-19 |
Ramot At Tel-Aviv University Ltd. |
Generation of cytotoxic tumor specific cell lines and uses thereof
|
|
WO2014130846A1
(fr)
|
2013-02-22 |
2014-08-28 |
Seungpyo Hong |
Administration d'un médicament par voie transdermique faisant appel à des micelles amphiphiles « dendron-coil »
|
|
US20160017021A1
(en)
|
2013-03-06 |
2016-01-21 |
Protalix Ltd. |
TNF alpha INHIBITOR POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME, CELLS EXPRESSING SAME AND METHODS OF PRODUCING SAME
|
|
AU2014224174B2
(en)
|
2013-03-06 |
2018-08-30 |
Hadasit Medical Research Services And Development Ltd. |
Use of plant cells expressing a TNFalpha polypeptide inhibitor in therapy
|
|
TWI582239B
(zh)
|
2013-03-11 |
2017-05-11 |
諾華公司 |
與ｗｎｔ抑制劑相關之標記
|
|
BR112015022797A2
(pt)
|
2013-03-13 |
2017-11-07 |
Monsanto Technology Llc |
método para controle de ervas daninhas, composição herbicida, cassete de expressão microbiano e método de produção de polinucleotídeo
|
|
EP2971185A4
(fr)
|
2013-03-13 |
2017-03-08 |
Monsanto Technology LLC |
Procédés et compositions utilisables pour lutter contre les mauvaises herbes
|
|
EP3611189A1
(fr)
|
2013-03-14 |
2020-02-19 |
Novartis AG |
Anticorps dirigés contre notch 3
|
|
US9273349B2
(en)
|
2013-03-14 |
2016-03-01 |
Affymetrix, Inc. |
Detection of nucleic acids
|
|
PE20151893A1
(es)
|
2013-03-14 |
2015-12-30 |
Parkash Gill |
Tratamiento del cancer usando anticuerpos que se unen a grp78 en la superficie celular
|
|
WO2014159242A1
(fr)
|
2013-03-14 |
2014-10-02 |
Novartis Ag |
Mutants de notch 3 et leurs utilisations
|
|
US20140283211A1
(en)
|
2013-03-14 |
2014-09-18 |
Monsanto Technology Llc |
Methods and Compositions for Plant Pest Control
|
|
US9944992B2
(en)
|
2013-03-15 |
2018-04-17 |
The University Of Chicago |
Methods and compositions related to T-cell activity
|
|
WO2014145718A2
(fr)
|
2013-03-15 |
2014-09-18 |
Longevity Biotech, Inc. |
Peptides comprenant des acides aminés non endogènes et procédés de fabrication et d'utilisation associés
|
|
US10568328B2
(en)
|
2013-03-15 |
2020-02-25 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
|
US20140273031A1
(en)
|
2013-03-15 |
2014-09-18 |
The Cleveland Clinic Foundation |
In-vitro method for monoclonal antibody production
|
|
BR112015021866A2
(pt)
|
2013-03-15 |
2017-08-29 |
Bayer Healthcare Llc |
Domínios de gla como agentes direcionadores
|
|
ES2883580T3
(es)
|
2013-03-21 |
2021-12-09 |
Collplant Ltd |
Composiciones que comprenden colágeno y PRP para la regeneración de tejidos y su método de producción
|
|
US20160051693A1
(en)
|
2013-03-21 |
2016-02-25 |
Genisphere, Llc |
Cellular Delivery of DNA Intercalating Agents
|
|
JP6294459B2
(ja)
|
2013-03-24 |
2018-03-14 |
バイオカイン・セラピューティクス・リミテッドＢｉｏｋｉｎｅ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｔｄ． |
骨髄性白血病の処置方法
|
|
KR20230109779A
(ko)
|
2013-03-27 |
2023-07-20 |
세다르스-신나이 메디칼 센터 |
Tl1a 기능 및 관련된 신호전달 경로의 저해에 의한섬유증 및 염증의 완화 및 반전
|
|
GB201306536D0
(en)
|
2013-04-10 |
2013-05-22 |
Gt Biolog Ltd |
Polypeptide and immune modulation
|
|
RU2015149680A
(ru)
|
2013-04-21 |
2017-05-24 |
Йеда Ресеарч Энд Девелопмент Ко. Лтд. |
Агенты для подавления активности и/или снижения количества bcl-xl и/или bcl-w
|
|
CN105531365A
(zh)
|
2013-04-23 |
2016-04-27 |
耶达研究及发展有限公司 |
分离的幼稚多能干细胞和产生所述细胞的方法
|
|
WO2014176047A1
(fr)
|
2013-04-25 |
2014-10-30 |
Novartis Ag |
Marqueurs pour des inhibiteurs de l'ezh2
|
|
US9714268B2
(en)
|
2013-04-25 |
2017-07-25 |
Yeda Research And Development Co. Ltd. |
Use of inhibitory peptides for the treatment of inflammatory diseases
|
|
WO2014188423A1
(fr)
|
2013-05-21 |
2014-11-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Traitement de pathologies associées aux mastocytes
|
|
JP6649250B2
(ja)
|
2013-05-21 |
2020-02-19 |
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ |
操作されたヘム結合性構成物およびその使用
|
|
ES2771048T3
(es)
|
2013-05-27 |
2020-07-06 |
Rakuto Bio Tech Ltd |
Composiciones cosméticas que contienen sistemas enzimáticos
|
|
WO2014193804A1
(fr)
|
2013-05-28 |
2014-12-04 |
Biogen Idec Ma Inc. |
Méthodes d'évaluation de risque de développement d'une lemp
|
|
ES2754177T3
(es)
|
2013-06-12 |
2020-04-16 |
Massachusetts Gen Hospital |
Métodos para la detección multiplexada de moléculas diana y sus usos
|
|
EP3010519B1
(fr)
|
2013-06-18 |
2021-04-07 |
Dnatrix Inc. |
Adénovirus oncolytique pour l'utilisation dans le traitement du cancer du cerveau
|
|
WO2014205230A1
(fr)
|
2013-06-19 |
2014-12-24 |
Step Ahead Innovations Inc. |
Systèmes et procédés de test de paramètres relatifs à l'eau dans un environnement aquatique
|
|
ES2938044T3
(es)
|
2013-06-24 |
2023-04-04 |
Univ Ramot |
Estructura a base de epiplón y sistema de suministro
|
|
CN105555303A
(zh)
|
2013-06-28 |
2016-05-04 |
贝勒研究院 |
用于多发性硬化症的树突细胞asgpr靶向免疫治疗剂
|
|
EP3022295A4
(fr)
|
2013-07-19 |
2017-03-01 |
Cedars-Sinai Medical Center |
Signature de la voie de signalisation de tl1a (tnfsf15)
|
|
US9850496B2
(en)
|
2013-07-19 |
2017-12-26 |
Monsanto Technology Llc |
Compositions and methods for controlling Leptinotarsa
|
|
RU2703498C2
(ru)
|
2013-07-19 |
2019-10-17 |
Монсанто Текнолоджи Ллс |
Композиции и способы борьбы с leptinotarsa
|
|
WO2015015489A1
(fr)
|
2013-07-30 |
2015-02-05 |
Biolinerx Ltd. |
Anticorps convenant au traitement du diabète et de maladies autoimmunes
|
|
WO2015017552A1
(fr)
|
2013-08-01 |
2015-02-05 |
Agensys, Inc. |
Conjugués anticorps-médicament (adc) se liant à la protéine cd37
|
|
CA2921652A1
(fr)
|
2013-08-21 |
2015-02-26 |
Manuel A. Riquelme |
Compositions et methodes de ciblage de semi-canaux de connexine
|
|
US9938316B2
(en)
|
2013-08-29 |
2018-04-10 |
Yeda Research And Development Co. Ltd. |
Selective inhibitors of α2 isoform of Na,K-ATPase and use thereof for reduction of intra-ocular pressure and as cardiotonic agents
|
|
CN113150145B
(zh)
|
2013-08-30 |
2025-02-14 |
伊缪诺金公司 |
用于检测叶酸受体1的抗体和测定
|
|
WO2015033343A1
(fr)
|
2013-09-03 |
2015-03-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Compositions et procédés utilisables en vue de l'expression de polypeptides recombinés
|
|
IL228284A
(en)
|
2013-09-03 |
2016-12-29 |
Technion Res & Dev Foundation |
Implants from cellular scaffolding and blood vessel stalk
|
|
WO2015033344A1
(fr)
|
2013-09-05 |
2015-03-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédés et nécessaires permettant d'inhiber la pathogénicité d'un streptocoque du groupe a (sga) ou d'un streptocoque du groupe g (sgg)
|
|
WO2015037009A1
(fr)
|
2013-09-16 |
2015-03-19 |
Plexicure Ltd. |
Protéines isolées capables de se lier à la plexine-a4, et procédés de production et d'utilisation
|
|
US9695402B2
(en)
|
2013-09-17 |
2017-07-04 |
Yeda Research And Development Co. Ltd. |
ERK-derived peptides and uses thereof
|
|
CN119587584A
(zh)
|
2013-10-01 |
2025-03-11 |
卡迪马干细胞有限公司 |
从人多能干细胞定向分化星形胶质细胞用于肌萎缩侧索硬化(als)的治疗和药物筛选
|
|
MX2016004283A
(es)
|
2013-10-03 |
2016-10-12 |
Oklahoma Med Res Found |
Biomarcadores para la actividad, e intesidad y arrebato de la enfermedad lupus eritematoso sistemico.
|
|
US9476884B2
(en)
|
2013-10-04 |
2016-10-25 |
University Of Massachusetts |
Hybridization- independent labeling of repetitive DNA sequence in human chromosomes
|
|
US11396012B2
(en)
|
2013-10-07 |
2022-07-26 |
Yeda Research And Development Co. Ltd. |
Microfluidic device for analyzing gene expression
|
|
EP3060239B1
(fr)
|
2013-10-21 |
2020-05-13 |
OPKO Biologics Ltd. |
Polypeptides à action prolongée et procédés de production et d'administration de ceux-ci
|
|
US20150158926A1
(en)
|
2013-10-21 |
2015-06-11 |
Opko Biologics, Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
|
WO2015059690A1
(fr)
|
2013-10-24 |
2015-04-30 |
Yeda Research And Development Co. Ltd. |
Polynucléotides codant pour des polypeptides de système brex et leurs méthodes d'utilisation
|
|
ES2811804T3
(es)
|
2013-10-31 |
2021-03-15 |
Biokine Therapeutics Ltd |
Un inhibidor peptídico de CXCR4 para su uso en el tratamiento de la leucemia mieloide aguda con una mutación de FLT3
|
|
HUE070313T2
(hu)
|
2013-11-04 |
2025-05-28 |
Greenlight Biosciences Inc |
Ízeltlábú paraziták és kártevõfertõzöttség szabályozására szolgáló készítmények és eljárások
|
|
US20170002064A1
(en)
|
2013-11-08 |
2017-01-05 |
The Board Of Regents Of The University Of Texas System |
Vh4 antibodies against gray matter neuron and astrocyte
|
|
CA2930693A1
(fr)
|
2013-11-15 |
2015-05-21 |
The Board Of Trustees Of The Leland Stanford Junior Unversity |
Procedes de traitement d'une insuffisance cardiaque avec des agonistes de recepteur 2 d'hypocretine
|
|
IL245703B
(en)
|
2013-11-20 |
2022-07-01 |
Univ Iowa Res Found |
Methods and compositions for treating amyloid deposits
|
|
KR102415259B1
(ko)
|
2013-11-22 |
2022-06-30 |
더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 |
조작된 고-친화도의 인간 t 세포 수용체
|
|
EP3074044A2
(fr)
|
2013-11-28 |
2016-10-05 |
Yeda Research and Development Co., Ltd. |
Inhibiteurs de synaptojanine-2 et leurs utilisations
|
|
ES2754207T3
(es)
|
2013-11-28 |
2020-04-16 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Inhibidores de la ARN polimerasa I y usos de los mismos
|
|
UA119253C2
(uk)
|
2013-12-10 |
2019-05-27 |
Біолоджикс, Інк. |
Спосіб боротьби із вірусом у кліща varroa та у бджіл
|
|
US10053712B2
(en)
|
2013-12-10 |
2018-08-21 |
Yeda Research And Development Co. Ltd. |
Use of enzymes which catalyze pyruvate synthesis from formate and acetyl-CoA and bacteria expressing same
|
|
US20150191744A1
(en)
|
2013-12-17 |
2015-07-09 |
University Of Massachusetts |
Cas9 effector-mediated regulation of transcription, differentiation and gene editing/labeling
|
|
US10513546B2
(en)
|
2013-12-18 |
2019-12-24 |
President And Fellows Of Harvard College |
CRP capture/detection of gram positive bacteria
|
|
EP3083936B1
(fr)
|
2013-12-19 |
2018-07-04 |
Danisco US Inc. |
Utilisation d'hydrophobines pour augmenter le transfert de gaz dans des processus de fermentation aérobie
|
|
EP3447493B1
(fr)
|
2014-01-07 |
2020-05-13 |
Bioatla, LLC |
Orthologues ciblant les protéines
|
|
CN120939216A
(zh)
|
2014-01-13 |
2025-11-14 |
贝勒研究院 |
抗hpv和hpv相关的疾病的新疫苗
|
|
AU2015206585A1
(en)
|
2014-01-15 |
2016-07-21 |
Monsanto Technology Llc |
Methods and compositions for weed control using EPSPS polynucleotides
|
|
WO2015116753A1
(fr)
|
2014-01-29 |
2015-08-06 |
Dana-Farber Cancer Institute, Inc. |
Anticorps contre le domaine extracellulaire de muc1-c (muc1-c/ecd)
|
|
US20160340659A1
(en)
|
2014-01-30 |
2016-11-24 |
Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. |
Actin binding peptides and compositions comprising same for inhibiting angiogenesis and treating medical conditions associated with same
|
|
AU2015212341A1
(en)
|
2014-02-03 |
2016-09-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Use of Casein kinase I inhibitors for depleting stem cells
|
|
CA2936158C
(fr)
|
2014-02-05 |
2023-06-13 |
Yeda Research And Development Co. Ltd. |
Utilisation de mir-135 ou un precurseur connexe pour le traitement ou le diagnostic d'un trouble bipolaire
|
|
CN106573976B
(zh)
|
2014-02-06 |
2020-05-05 |
耶达研究及发展有限公司 |
抗cd84抗体、包含所述抗体的组合物及其用途
|
|
WO2015120273A1
(fr)
|
2014-02-07 |
2015-08-13 |
The General Hospital Corporation |
Diagnostic différentiel de néoplasmes hépatiques
|
|
US20170101633A1
(en)
|
2014-02-10 |
2017-04-13 |
Protalix Ltd. |
Method of maintaining disease stability in a subject having gaucher's disease
|
|
EP3105587B1
(fr)
|
2014-02-11 |
2023-09-06 |
Brainstorm Cell Therapeutics Ltd. |
Procédé de qualification de cellules
|
|
WO2015123565A1
(fr)
|
2014-02-14 |
2015-08-20 |
The General Hospital Corporation |
Méthodes de diagnostic d'une maladie liée à l'igg4
|
|
WO2015131099A1
(fr)
|
2014-02-28 |
2015-09-03 |
The General Hospital Corporation |
Diagnostic du myélome multiple et du lymphome
|
|
WO2015132784A1
(fr)
|
2014-03-03 |
2015-09-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédé et dispositif de détection de pseudomonas aeruginosa
|
|
EP2923709A1
(fr)
|
2014-03-28 |
2015-09-30 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Vaccin contre la malaria multi-composants-multi-étapes
|
|
BR112016022711A2
(pt)
|
2014-04-01 |
2017-10-31 |
Monsanto Technology Llc |
composições e métodos para controle de pragas de inseto
|
|
US11433163B2
(en)
|
2014-04-10 |
2022-09-06 |
Bonus Therapeutics Ltd. |
Bone repair compositions
|
|
WO2015159292A2
(fr)
|
2014-04-14 |
2015-10-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédé et kit permettant de déterminer l'origine tissulaire ou cellulaire de l'adn
|
|
WO2015159295A1
(fr)
|
2014-04-17 |
2015-10-22 |
Yeda Research And Development Co. Ltd. |
Procédés et kits pour analyser les fragments se liant à l'adn liés à l'adn
|
|
US11427647B2
(en)
|
2014-04-27 |
2022-08-30 |
Famewave Ltd. |
Polynucleotides encoding humanized antibodies against CEACAM1
|
|
US10550196B2
(en)
|
2014-04-27 |
2020-02-04 |
Famewave Ltd. |
Humanized antibodies against CEACAM1
|
|
ES2870658T3
(es)
|
2014-04-28 |
2021-10-27 |
Yeda Res & Dev |
Respuesta del microbioma a agentes
|
|
CA2945736A1
(fr)
|
2014-05-04 |
2015-11-12 |
Forrest Innovations Ltd. |
Compositions de lutte contre les moustiques et leurs utilisations
|
|
US10247729B2
(en)
|
2014-05-05 |
2019-04-02 |
Microbplex, Inc. |
Media elaborated with newly synthesized antibodies (MENSA) and uses thereof
|
|
DK3140653T3
(da)
|
2014-05-08 |
2022-06-20 |
Novodiax Inc |
Direkte immunhistokemianalyse
|
|
WO2015179435A1
(fr)
|
2014-05-19 |
2015-11-26 |
Bayer Healthcare Llc |
Anticorps monoclonaux humanisés optimisés dirigés contre la protéine c activée et leurs utilisations
|
|
US10294482B2
(en)
|
2014-05-22 |
2019-05-21 |
Yeda Research And Development Co. Ltd. |
Recombinant microorganisms capable of carbon fixation
|
|
EP3149155B1
(fr)
|
2014-06-02 |
2020-09-23 |
Kadimastem Ltd. |
Procédés d'induction de la myélinisation et de maturation des oligodendrocytes
|
|
US20170253881A1
(en)
|
2014-06-02 |
2017-09-07 |
Technion Research & Development Foundation Limited |
Compositions and methods of selectively inhibiting irp1 and treating inflammation
|
|
US10988764B2
(en)
|
2014-06-23 |
2021-04-27 |
Monsanto Technology Llc |
Compositions and methods for regulating gene expression via RNA interference
|
|
WO2015198320A1
(fr)
|
2014-06-24 |
2015-12-30 |
Insight Biopharmaceuticals Ltd. |
Procédés de purification d'anticorps
|
|
US10883994B2
(en)
|
2014-06-25 |
2021-01-05 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Identification of cancer stem cells markers and use of same for diagnosis and treatment
|
|
EP3161138A4
(fr)
|
2014-06-25 |
2017-12-06 |
Monsanto Technology LLC |
Procédés et compositions pour administrer des acides nucléiques à des cellules végétales et réguler l'expression génique
|
|
EP3160448B1
(fr)
|
2014-06-26 |
2025-08-06 |
Ramot at Tel-Aviv University Ltd. |
Formulations de liposome pour l'administration d'acides nucléiques
|
|
WO2016005985A2
(fr)
|
2014-07-09 |
2016-01-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Méthode pour reprogrammer des cellules
|
|
EP3169343B1
(fr)
|
2014-07-15 |
2020-03-25 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Polypeptides isolés de cd44 et utilisations associées
|
|
CA2955411A1
(fr)
|
2014-07-21 |
2016-01-28 |
Novellusdx Ltd. |
Procedes de determination d'une reponse a un medicament de mutations specifiques a un patient
|
|
WO2016013008A1
(fr)
|
2014-07-21 |
2016-01-28 |
Novellusdx Ltd. |
Procédés et systèmes pour déterminer un indice oncogénique de mutations spécifiques d'un patient
|
|
RU2021123470A
(ru)
|
2014-07-29 |
2021-09-06 |
Монсанто Текнолоджи Ллс |
Композиции и способы борьбы с насекомыми-вредителями
|
|
CN108064274A
(zh)
|
2014-07-30 |
2018-05-22 |
耶达研究及发展有限公司 |
用于培养多能干细胞的培养基
|
|
US10526641B2
(en)
|
2014-08-01 |
2020-01-07 |
Dovetail Genomics, Llc |
Tagging nucleic acids for sequence assembly
|
|
BR112017002884A2
(pt)
|
2014-08-14 |
2018-01-30 |
Memed Diagnostics Ltd |
?análise computacional de dados biológicos por meio do uso de variedade e hiperplano?
|
|
EA201790437A1
(ru)
|
2014-08-22 |
2017-08-31 |
Сорренто Терапьютикс, Инк. |
Антигенсвязывающие белки, связывающиеся с cxcr3
|
|
WO2016030899A1
(fr)
|
2014-08-28 |
2016-03-03 |
Yeda Research And Development Co. Ltd. |
Méthodes de traitement de la sclérose latérale amyotrophique
|
|
WO2016038609A1
(fr)
|
2014-09-08 |
2016-03-17 |
Yeda Research And Development Co. Ltd. |
Anticorps anti-her3 et leurs utilisations
|
|
EP2992895A1
(fr)
|
2014-09-08 |
2016-03-09 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Vaccin contre la malaria multi-composants-multi-étapes
|
|
EP3191523B1
(fr)
|
2014-09-08 |
2019-08-07 |
Yeda Research and Development Co., Ltd. |
Compositions et procédés de traitement d'un cancer résistant à un inhibiteur de la tyrosine kinase (tki)
|
|
US20170283844A1
(en)
|
2014-09-11 |
2017-10-05 |
The State of Israel, Ministry of Agriculture & Rural Development, Argricultural Research Organiza |
Methods of producing mogrosides and compositions comprising same and uses thereof
|
|
EP3191592A1
(fr)
|
2014-09-11 |
2017-07-19 |
Novartis AG |
Inhibition de prmt5 dans le traitement de maladies liées à une déficience en mtap
|
|
IL234638A0
(en)
|
2014-09-14 |
2014-12-02 |
Yeda Res & Dev |
NMDA receptor antagonists for the treatment of Gaucher disease
|
|
JP6214790B2
(ja)
|
2014-09-16 |
2017-10-18 |
イース チャーム リミテッド |
抗ｅｇｆｒ抗体および同抗体の使用法
|
|
EP3230453B1
(fr)
|
2014-09-21 |
2020-05-20 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Freination du mir-132 pour le traitement de troubles lipidiques
|
|
WO2016057424A1
(fr)
|
2014-10-06 |
2016-04-14 |
Chemocentryx, Inc. |
Compositions et méthodes pour le traitement d'une maladie inflammatoire de l'intestin à l'aide d'une polythérapie à base d'inhibiteurs à petites molécules de récepteur 9 de chimiokine c-c (ccr9) et d'anticorps bloquants anti-intégrine alpha4beta7
|
|
US20170253921A1
(en)
|
2014-10-13 |
2017-09-07 |
Life Technologies Corporation |
Methods, kits & compositions for determining gene copy numbers
|
|
US10093989B2
(en)
|
2014-10-20 |
2018-10-09 |
Gen-Probe Incorporated |
Red blood cell lysis solution
|
|
WO2016065238A1
(fr)
|
2014-10-24 |
2016-04-28 |
Danisco Us Inc. |
Procédé de production d'alcool au moyen d'une tripeptidyl peptidase
|
|
RU2741080C2
(ru)
|
2014-10-24 |
2021-01-22 |
ДюПон НЬЮТРИШН БАЙОСАЙЕНСИЗ АпС |
Трипептидилпептидазы, способные воздействовать на связи с участием пролина, и их применения
|
|
CN107406825B
(zh)
|
2014-11-13 |
2022-04-08 |
恩祖迪克控股有限公司 |
甲壳纲十足目雌性动物的功能性别反转
|
|
CN107429291A
(zh)
|
2014-11-17 |
2017-12-01 |
耶达研究及发展有限公司 |
分析微生物组的方法
|
|
WO2016079736A2
(fr)
|
2014-11-17 |
2016-05-26 |
Yeda Research And Development Co. Ltd. |
Procédés de traitement de maladies associées à une fonction mitochondriale
|
|
RU2758608C2
(ru)
|
2014-11-19 |
2021-11-01 |
Конинклейке Филипс Н.В. |
Способ диагностики с использованием hnl
|
|
WO2016079739A2
(fr)
|
2014-11-20 |
2016-05-26 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Compositions et procédés de production de polypeptides présentant un schéma de glycosylation modifié dans des cellules végétales
|
|
CN107208070B
(zh)
|
2014-11-26 |
2021-09-07 |
技术创新动力基金（以色列）有限合伙公司 |
细菌基因的靶向消除
|
|
KR20170081268A
(ko)
|
2014-11-27 |
2017-07-11 |
단지거 이노베이션즈 엘티디. |
게놈 편집용 핵산 구조체
|
|
WO2016089920A1
(fr)
|
2014-12-01 |
2016-06-09 |
The Broad Institute, Inc. |
Procédé de détermination in situ de proximité d'acide nucléique
|
|
WO2016089883A1
(fr)
|
2014-12-01 |
2016-06-09 |
Novartis Ag |
Compositions et méthodes pour le diagnostic et le traitement du cancer de la prostate
|
|
US10539566B2
(en)
|
2014-12-08 |
2020-01-21 |
Berg Llc |
Use of markers including filamin A in the diagnosis and treatment of prostate cancer
|
|
EP3230309B1
(fr)
|
2014-12-10 |
2023-03-29 |
OPKO Biologics Ltd. |
Procédés de production de polypeptides d'hormone de croissance modifiés par ctp à action prolongée
|
|
CN107209184B
(zh)
|
2014-12-11 |
2020-04-24 |
米密德诊断学有限公司 |
用于诊断多种感染的标记组合及其使用方法
|
|
US10688330B2
(en)
|
2014-12-11 |
2020-06-23 |
Yeda Research And Development Co. Ltd. |
Isolated phosphotriesterase polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
|
WO2016103269A1
(fr)
|
2014-12-23 |
2016-06-30 |
Ramot At Tel-Aviv University Ltd. |
Populations de cellules progénitrices neuronales et leurs procédés de production et d'utilisation
|
|
AR103260A1
(es)
|
2014-12-23 |
2017-04-26 |
4D Pharma Res Ltd |
Modulación inmunitaria
|
|
EP3400953A1
(fr)
|
2014-12-23 |
2018-11-14 |
4D Pharma Research Limited |
Polypeptide pirin et modulation immunitaire
|
|
EP3916085A1
(fr)
|
2014-12-30 |
2021-12-01 |
Cell Cure Neurosciences Ltd. |
Évaluation de populations de cellules épithéliales pigmentaires rétiniennes
|
|
EP3240612B1
(fr)
|
2014-12-30 |
2020-12-23 |
Cell Cure Neurosciences Ltd. |
Procédés de traitement de maladies rétiniennes
|
|
CA2972575A1
(fr)
|
2014-12-30 |
2016-07-07 |
Cell Cure Neurosciences Ltd. |
Populations de cellules de l'epr et leurs procedes de production
|
|
US11225648B2
(en)
|
2015-01-04 |
2022-01-18 |
Protalix Ltd. |
Modified DNase and uses thereof
|
|
WO2016116935A1
(fr)
|
2015-01-21 |
2016-07-28 |
Yeda Research And Development Co. Ltd. |
Utilisation de la rasa2 en tant que marqueur pronostique et thérapeutique pour un mélanome
|
|
JP6942632B2
(ja)
|
2015-01-22 |
2021-09-29 |
モンサント テクノロジー エルエルシー |
Ｌｅｐｔｉｎｏｔａｒｓａ防除用組成物及びその方法
|
|
WO2016130516A1
(fr)
|
2015-02-09 |
2016-08-18 |
Research Development Foundation |
Polypeptides ayant un domaine fc d'immunoglobuline modifié manifestant une activation du complément améliorée
|
|
EP3256165B1
(fr)
|
2015-02-13 |
2021-07-14 |
Sorrento Therapeutics, Inc. |
Agents thérapeutiques de type anticorps se liant à ctla4
|
|
WO2016134034A1
(fr)
|
2015-02-17 |
2016-08-25 |
Dovetail Genomics Llc |
Assemblage de séquences d'acide nucléique
|
|
WO2016138312A2
(fr)
|
2015-02-25 |
2016-09-01 |
Vanderbilt University |
Neutralisation à médiation anticorps du virus de marburg
|
|
WO2016135732A1
(fr)
|
2015-02-26 |
2016-09-01 |
Yeda Research And Development Co. Ltd. |
Procédé favorisant la pousse des cheveux
|
|
EP3268038B1
(fr)
|
2015-03-09 |
2021-05-05 |
Agensys, Inc. |
Conjugués anticorps-médicament (cam) se liant aux protéines flt3
|
|
EP3268475B1
(fr)
|
2015-03-11 |
2020-10-21 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Oligonucléotides leurres pour le traitement de maladies
|
|
US11873483B2
(en)
|
2015-03-11 |
2024-01-16 |
The Broad Institute, Inc. |
Proteomic analysis with nucleic acid identifiers
|
|
IL237852A0
(en)
|
2015-03-19 |
2016-03-24 |
Yeda Res & Dev |
Antibodies against amphigoline, medical preparations containing them and their use
|
|
US11807896B2
(en)
|
2015-03-26 |
2023-11-07 |
Dovetail Genomics, Llc |
Physical linkage preservation in DNA storage
|
|
WO2016160618A2
(fr)
|
2015-03-27 |
2016-10-06 |
University Of Southern California |
Thérapie à base de lymphocytes t car dirigés contre le récepteur lhr pour le traitement des tumeurs solides
|
|
US20180064748A1
(en)
|
2015-03-27 |
2018-03-08 |
Yeda Research And Development Co. Ltd. |
Methods of treating motor neuron diseases
|
|
BR112017021016A2
(pt)
|
2015-03-31 |
2018-07-03 |
Yeda Research And Development Co Ltd |
preparação de proteína, composição farmacêutica, proteína de fusão, polinucleotídeo isolado, estrutura de ácido nucleico, método para tratamento de doença ou condição associada ao excesso de glutamato, e método de purificação de um polipeptídeo
|
|
US9612534B2
(en)
|
2015-03-31 |
2017-04-04 |
Tokyo Electron Limited |
Exposure dose homogenization through rotation, translation, and variable processing conditions
|
|
US10960035B2
(en)
|
2015-04-01 |
2021-03-30 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Voleaui Center) |
Erodium crassifolium L'Her plant extracts and uses thereof
|
|
CN114716390A
(zh)
|
2015-04-07 |
2022-07-08 |
Ela制药有限公司 |
用于治疗和/或预防细胞或组织坏死的组合物和方法
|
|
US9951144B2
(en)
|
2015-04-08 |
2018-04-24 |
Sorrento Therapeutics, Inc. |
Antibody therapeutics that bind CD38
|
|
EP3081575A1
(fr)
|
2015-04-12 |
2016-10-19 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Anticorps anti-plasmodium pour parasite
|
|
IL255290B2
(en)
|
2015-04-27 |
2024-01-01 |
Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct |
Substances that bind to EGF1 and their use in the treatment of inflammatory diseases and tumors
|
|
CA2984202A1
(fr)
|
2015-04-29 |
2016-11-03 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Compositions anti-phytopathogenes
|
|
WO2016174652A1
(fr)
|
2015-04-30 |
2016-11-03 |
Technion Research & Development Foundation Limited |
Récepteurs antigéniques chimériques et méthodes d'utilisation correspondantes
|
|
WO2016178207A1
(fr)
|
2015-05-04 |
2016-11-10 |
Ramot At Tel-Aviv University Ltd. |
Procédés et kits pour fragmenter l'adn
|
|
EP3091026B1
(fr)
|
2015-05-08 |
2019-02-20 |
Centrillion Technology Holdings Corporation |
Terminateurs réversibles à liaison disulfure
|
|
EP3294280A1
(fr)
|
2015-05-11 |
2018-03-21 |
Yeda Research and Development Co., Ltd. |
Inhibiteurs de citrine pour le traitement du cancer
|
|
US11219636B2
(en)
|
2015-05-17 |
2022-01-11 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Compositions and methods for treating cancer
|
|
WO2016187354A1
(fr)
|
2015-05-18 |
2016-11-24 |
Agensys, Inc. |
Anticorps se liant à des protéines axl
|
|
EP4679095A3
(fr)
|
2015-05-18 |
2026-05-06 |
Agensys, Inc. |
Anticorps se liant à des protéines axl
|
|
WO2016185457A1
(fr)
|
2015-05-19 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Méthodes pour favoriser la lymphagiogenèse
|
|
WO2016185481A2
(fr)
|
2015-05-20 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Procédé destiné à cibler des cellules sénescentes
|
|
EA201792547A1
(ru)
|
2015-05-21 |
2018-04-30 |
Иеда Рисеч Энд Девелопмент Ко. Лтд. |
Популяции бактерий для стимуляции состояния здоровья
|
|
KR20180014754A
(ko)
|
2015-05-29 |
2018-02-09 |
옵코 바이오로직스 리미티드 |
페길화된 옥신토모둘린 변이체
|
|
US10883103B2
(en)
|
2015-06-02 |
2021-01-05 |
Monsanto Technology Llc |
Compositions and methods for delivery of a polynucleotide into a plant
|
|
EP3302030A4
(fr)
|
2015-06-03 |
2019-04-24 |
Monsanto Technology LLC |
Procédés et compositions pour l'introduction d'acides nucléiques dans des plantes
|
|
WO2016197064A1
(fr)
|
2015-06-04 |
2016-12-08 |
Epstein Alan L |
Immunothérapie des cellules car ciblées par lym-1 et lym-2
|
|
NL2014935B1
(en)
|
2015-06-08 |
2017-02-03 |
Applied Immune Tech Ltd |
T cell receptor like antibodies having fine specificity.
|
|
WO2016203221A1
(fr)
|
2015-06-15 |
2016-12-22 |
4D Pharma Research Limited |
Compositions comprenant des souches bactériennes
|
|
NZ737752A
(en)
|
2015-06-15 |
2022-02-25 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
SMT201900588T1
(it)
|
2015-06-15 |
2019-11-13 |
4D Pharma Res Limited |
Blautia stercoris e wexlerae per uso nel trattamento di malattie infiammatorie ed autoimmuni
|
|
MA41010B1
(fr)
|
2015-06-15 |
2020-01-31 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
|
MA41060B1
(fr)
|
2015-06-15 |
2019-11-29 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
|
WO2016203476A1
(fr)
|
2015-06-18 |
2016-12-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédés et compositions pour le diagnostic et le traitement d'un cancer urothélial
|
|
EP4026563B1
(fr)
|
2015-06-18 |
2025-10-29 |
Yeda Research and Development Co. Ltd |
Protocoles de conditionnement et utilisation de ceux-ci pour la régénération de tissu
|
|
PL3310347T3
(pl)
|
2015-06-19 |
2021-12-27 |
Opko Biologics Ltd. |
Długo działające czynniki krzepnięcia i sposoby wytwarzania
|
|
EP3314004A1
(fr)
|
2015-06-26 |
2018-05-02 |
DuPont Nutrition Biosciences ApS |
Aminopeptidases pour hydrolysats de protéines
|
|
AU2016291558A1
(en)
|
2015-07-10 |
2018-02-08 |
West Virginia University |
Markers of stroke and stroke severity
|
|
US10786547B2
(en)
|
2015-07-16 |
2020-09-29 |
Biokine Therapeutics Ltd. |
Compositions, articles of manufacture and methods for treating cancer
|
|
EP3322424B1
(fr)
|
2015-07-16 |
2023-10-11 |
Yeda Research and Development Co., Ltd. |
Utilisation de cellules t de mémoire centrale contre une tierce partie
|
|
WO2017013648A1
(fr)
|
2015-07-19 |
2017-01-26 |
Yeda Research And Development Co. Ltd. |
Inhibiteurs sélectifs des isoformes contenant alpha2 de la na,k-atpase et leur utilisation pour réduire la pression intraoculaire
|
|
WO2017015334A1
(fr)
|
2015-07-21 |
2017-01-26 |
Saint Louis University |
Compositions et méthodes pour diagnostiquer et traiter l'infertilité associée à l'endométriose
|
|
JP6976242B2
(ja)
|
2015-07-22 |
2021-12-08 |
フィトファーマ インターナショナル リミテッドPhytopharma International Ltd. |
ハナバチ摂取組成物、ハチミツの製造におけるその使用方法、およびそれにより製造されたハチミツ
|
|
WO2017017686A1
(fr)
|
2015-07-29 |
2017-02-02 |
Hadasit Medical Research Services And Development Ltd. |
Production à grande échelle de cellules de l'épithélium pigmentaire rétinien
|
|
ES2965461T3
(es)
|
2015-08-03 |
2024-04-15 |
Biokine Therapeutics Ltd |
Inhibidor de CXCR4 para el tratamiento del cáncer
|
|
WO2017021961A1
(fr)
|
2015-08-04 |
2017-02-09 |
Yeda Research And Development Co. Ltd. |
Procédés de criblage pour riborégulateurs et atténuateurs
|
|
CN108136051A
(zh)
|
2015-08-04 |
2018-06-08 |
Cd诊断股份有限公司 |
检测不良局部组织反应(altr)坏死的方法
|
|
EP3331995A1
(fr)
|
2015-08-05 |
2018-06-13 |
Cell Cure Neurosciences Ltd. |
Préparation de photorécepteurs pour le traitement de maladies rétiniennes
|
|
US11066642B2
(en)
|
2015-08-05 |
2021-07-20 |
Cell Cure Neurosciences Ltd |
Preparation of retinal pigment epithelium cells
|
|
EP3331549B1
(fr)
|
2015-08-06 |
2020-12-23 |
President and Fellows of Harvard College |
Molécules améliorées aptes à se lier à des microbes, et leurs utilisations
|
|
EP3334449B1
(fr)
|
2015-08-10 |
2021-09-29 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
Méthodes et compositions pharmaceutiques permettant d'améliorer la cicatrisation des plaies par cd24
|
|
EP3334831A1
(fr)
|
2015-08-13 |
2018-06-20 |
Forrest Innovations Ltd. |
Formulations et compositions d'administration d'acides nucléiques à des cellules végétales
|
|
WO2017031370A1
(fr)
|
2015-08-18 |
2017-02-23 |
The Broad Institute, Inc. |
Procédés et compositions permettant de changer la fonction et la structure de boucles et/ou de domaines de chromatine
|
|
WO2017033188A1
(fr)
|
2015-08-24 |
2017-03-02 |
Yeda Research And Development Co. Ltd. |
Huile et biocarburant d'origine algale et leurs procédés de production
|
|
EP3341725B1
(fr)
|
2015-08-25 |
2021-08-18 |
Prothena Biosciences Limited |
Procédés de détection d'alpha-synucléine phosphorylée
|
|
US10526408B2
(en)
|
2015-08-28 |
2020-01-07 |
Research Development Foundation |
Engineered antibody FC variants
|
|
US11390908B2
(en)
|
2015-09-02 |
2022-07-19 |
University Of Massachusetts |
Detection of gene loci with CRISPR arrayed repeats and/or polychromatic single guide ribonucleic acids
|
|
US10765706B2
(en)
|
2015-09-03 |
2020-09-08 |
University Of South Florida |
Method of stem cell delivery into the brain during chronic disease using blood brain barrier permeabilizers
|
|
CA3036409C
(fr)
|
2015-09-08 |
2023-07-11 |
Erik J. Sontheimer |
Activite dnase h de la proteine cas9 de neisseria meningitidis
|
|
WO2017042814A1
(fr)
|
2015-09-10 |
2017-03-16 |
Yeda Research And Development Co. Ltd. |
Utilisation de cellules dendritiques immatures positives pour la perforine dans le traitement de maladie
|
|
WO2017053567A1
(fr)
|
2015-09-22 |
2017-03-30 |
Delta Tm Technologies |
Conception de systèmes tampons personnalisés spécifiques à une protéine
|
|
WO2017059108A1
(fr)
|
2015-09-29 |
2017-04-06 |
Htg Molecular Diagnostics, Inc. |
Procédés de sous-typage de lymphome diffus à grandes cellules b (ldgcb)
|
|
WO2017062953A1
(fr)
|
2015-10-10 |
2017-04-13 |
Intrexon Corporation |
Contrôle thérapeutique amélioré de formes d'interleukine-12 déstabilisées sensibles à la protéolyse
|
|
EP3362462B1
(fr)
|
2015-10-12 |
2021-07-21 |
Advanced Cell Diagnostics, Inc. |
Détection in situ de variants nucléotidiques dans des échantillons de bruit élevé et compositions et procédés associés
|
|
CA3002740A1
(fr)
|
2015-10-19 |
2017-04-27 |
Dovetail Genomics, Llc |
Procedes d'assemblage de genomes, phasage d'haplotypes et detection d'acide nucleique independant cible
|
|
WO2017072757A1
(fr)
|
2015-10-25 |
2017-05-04 |
Yeda Research And Development Co. Ltd. |
Anticorps ciblant la quiescine sulfhydryle oxydase (qsox1) et leurs utilisations
|
|
JP6987769B2
(ja)
|
2015-10-26 |
2022-01-05 |
セル キュア ニューロサイエンシズ リミテッド |
網膜色素上皮細胞の調製法
|
|
EP3368024B1
(fr)
|
2015-10-27 |
2023-09-20 |
Akos Biosciences, Inc. |
Compositions comprenant du cannabidiol et un des seconds agents thérapeutiques pour le traitement du cancer
|
|
IL242380A0
(en)
|
2015-10-29 |
2016-02-01 |
Yeda Res & Dev |
A method of inducing cardiomyocytes proliferation and treating heart diseases
|
|
US20180303974A1
(en)
|
2015-11-03 |
2018-10-25 |
Ariel-University Research And Development Company Ltd. |
Compositions for regeneration and repair of neural tissue
|
|
RS65666B1
(sr)
|
2015-11-09 |
2024-07-31 |
Childrens Hospital Philadelphia |
Glipikan 2 kao tumor marker i terapijski cilj
|
|
EP3374524B1
(fr)
|
2015-11-11 |
2025-01-29 |
Ramot at Tel-Aviv University Ltd. |
Procédés de détection de la 5-hydroxyméthylcytosine et diagnostic du cancer
|
|
CN108513545B
(zh)
|
2015-11-20 |
2020-11-03 |
4D制药研究有限公司 |
包含细菌菌株的组合物
|
|
GB201520497D0
(en)
|
2015-11-20 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
GB201520638D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
GB201520631D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
HK1254740A1
(zh)
|
2015-11-30 |
2019-07-26 |
Kadimastem Ltd. |
分化和纯化胰腺内分泌细胞的方法
|
|
EP3383911B1
(fr)
|
2015-12-02 |
2021-01-20 |
STCube & Co. Inc. |
Anticorps et molécules se liant de manière immunospécifique à btn1a1 et leurs utilisations thérapeutiques
|
|
EP3383908A1
(fr)
|
2015-12-02 |
2018-10-10 |
Stsciences, Inc. |
Anticorps spécifiques au btla glycosylé (atténuateur de lymphocytes b et t)
|
|
EP3176183A1
(fr)
|
2015-12-02 |
2017-06-07 |
Yeda Research and Development Co. Ltd |
Compositions et procédés pour traiter un cancer non résistant à un inhibiteur de la tyrosine kinase (tki)
|
|
CA3007301A1
(fr)
|
2015-12-04 |
2017-06-08 |
Board Of Regents, The University Of Texas System |
Peptides slc45a2 pour l'immunotherapie
|
|
EP4059507B1
(fr)
|
2015-12-16 |
2024-06-05 |
Ramot at Tel-Aviv University Ltd. |
Particules comprenant un omentum décellularisé
|
|
PH12018501207B1
(en)
|
2015-12-21 |
2024-02-23 |
Novartis Ag |
Compositions and methods for decreasing tau expression
|
|
EP3393524B1
(fr)
|
2015-12-22 |
2022-04-06 |
The Regents of The University of Colorado, A Body Corporate |
Protection d'arn de la dégradation à l'aide d'arn viraux modifiés
|
|
WO2017115367A1
(fr)
|
2015-12-28 |
2017-07-06 |
The National Institute for Biotechnology in the Negev Ltd. |
Composition et méthode pour le traitement de la sclérose latérale amyotrophique
|
|
US10828318B2
(en)
|
2016-01-06 |
2020-11-10 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for treating malignant, autoimmune and inflammatory diseases
|
|
EP3403091B1
(fr)
|
2016-01-11 |
2021-12-22 |
Technion Research & Development Foundation Limited |
Méthodes de détermination du pronostic de septicémie et traitement associé
|
|
JP7019580B2
(ja)
|
2016-01-21 |
2022-02-15 |
ザ ステイト オブ イスラエル ミニストリー オブ アグリカルチャー アンド ルーラル ディベロップメント アグリカルチュラル リサーチ オーガニゼイション （エー．アール．オー．） （ボルカニ センター） |
単為結実植物およびその製造方法
|
|
IL243839B
(en)
|
2016-01-28 |
2018-01-31 |
Sp Nano Ltd |
Conductive wires
|
|
IL243838A
(en)
|
2016-01-28 |
2017-07-31 |
Sp Nano Ltd |
The composition containing sp1 protein and carbon nanoparticles and its uses
|
|
WO2017132562A1
(fr)
|
2016-01-29 |
2017-08-03 |
Heyue Zhou |
Protéines de liaison à l'antigène se liant à pd-l1
|
|
US11261433B2
(en)
|
2016-01-31 |
2022-03-01 |
Hadasit Medical Research Services And Development Ltd. |
Autosomal-identical pluripotent stem cell populations having non-identical sex chromosomal composition and uses thereof
|
|
CN108884137B
(zh)
|
2016-02-04 |
2022-04-05 |
耶达研究及发展有限公司 |
肽及其在治疗与突变型p53相关的疾病、病症或病况中的用途
|
|
WO2017139415A2
(fr)
|
2016-02-11 |
2017-08-17 |
Qiagen Waltham, Inc. |
Composés piégeurs pour un séquençage par synthèse amélioré
|
|
EP3414338B1
(fr)
|
2016-02-11 |
2022-12-21 |
Qiagen Sciences, LLC |
Additifs polyphénoliques dans le séquençage par synthèse
|
|
EP3414346B1
(fr)
|
2016-02-14 |
2019-11-13 |
Yeda Research and Development Co. Ltd. |
Diagnostic basé sur le microbiome, prédiction et traitement de l'obésité de rechute
|
|
WO2017138008A2
(fr)
|
2016-02-14 |
2017-08-17 |
Yeda Research And Development Co. Ltd. |
Procédés de modulation de l'exocytose de protéines et utilisations associées en thérapie
|
|
WO2017141253A1
(fr)
|
2016-02-16 |
2017-08-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Analogues de phénylalanine non protéiques pour inhiber la croissance végétale et de cyanobactéries
|
|
EP3416671A4
(fr)
|
2016-02-19 |
2019-10-30 |
Genisphere, LLC |
Vecteurs d'acide nucléique et leurs procédés thérapeutiques d'utilisation
|
|
US20200200735A9
(en)
|
2016-02-22 |
2020-06-25 |
Ursure, Inc. |
System and method for detecting therapeutic agents to monitor adherence to a treatment regimen
|
|
EP3420075A4
(fr)
|
2016-02-23 |
2019-10-16 |
Chaya Brodie |
Production de cellules souches cancéreuses et leur utilisation
|
|
SG11201807117WA
(en)
|
2016-02-23 |
2018-09-27 |
Dovetail Genomics Llc |
Generation of phased read-sets for genome assembly and haplotype phasing
|
|
CA3013383A1
(fr)
|
2016-02-25 |
2017-08-31 |
Dupont Nutrition Biosciences Aps |
Procede de production d'un hydrolysat proteique utilisant la tripeptidyl-peptidase aspergillus
|
|
EP3419998A4
(fr)
|
2016-02-26 |
2019-09-25 |
The Board of Regents of The University of Texas System |
Anticorps se liant aux hémicanaux de la connexine (cx) 43 et leurs utilisations
|
|
CA3015619A1
(fr)
|
2016-03-01 |
2017-09-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Anticorps specifiques du recepteur du poliovirus humain (pvr)
|
|
IL294121B2
(en)
|
2016-03-03 |
2023-09-01 |
Memed Diagnostics Ltd |
An RNA test to diagnose the type of infection
|
|
ME03487B
(fr)
|
2016-03-04 |
2020-01-20 |
4D Pharma Plc |
Compositions comprenant des souches bactériennes de blautia pour le traitement de l'hypersensibilité viscérale
|
|
GB201612191D0
(en)
|
2016-07-13 |
2016-08-24 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
|
US20190216891A1
(en)
|
2016-03-06 |
2019-07-18 |
Yeda Research And Development Co., Ltd. |
Method for modulating myelination
|
|
IL244649A0
(en)
|
2016-03-17 |
2016-06-30 |
Yeda Res & Dev |
Methods for the isolation of barrel-like proteases and the identification of peptides that are cleaved by Alidan
|
|
KR20240095481A
(ko)
|
2016-03-17 |
2024-06-25 |
세다르스-신나이 메디칼 센터 |
Rnaset2를 통한 염증성 장 질환의 진단 방법
|
|
WO2017165438A1
(fr)
|
2016-03-25 |
2017-09-28 |
Muralidhar Reddy Moola |
Synthèse combinatoire et développement de biomarqueurs
|
|
ES2883297T3
(es)
|
2016-03-29 |
2021-12-07 |
Stcube Inc |
Anticuerpos de función doble específicos para PD-L1 glucosilado y métodos de uso de los mismos
|
|
EP3436480A4
(fr)
|
2016-03-30 |
2019-11-27 |
Musc Foundation for Research Development |
Méthodes pour le traitement et le diagnostic du cancer par le ciblage d'une protéine à prédominance de répétitions de glycoprotéine a (garp) et la mise en uvre d'une immunothérapie efficace seule ou en association
|
|
WO2017175228A1
(fr)
|
2016-04-06 |
2017-10-12 |
Technion Research & Development Foundation Limited |
Prédiction de la réponse anti-tnf dans des biopsies de côlon avec les proportions de cellules immunitaires infiltrantes
|
|
EP3448998B1
(fr)
|
2016-04-27 |
2020-06-03 |
Gen-Probe Incorporated |
Réactif de lyse de cellules sanguines
|
|
WO2017194589A1
(fr)
|
2016-05-10 |
2017-11-16 |
Vib Vzw |
Inhibition du dysfonctionnement synaptique précoce à médiation par tau
|
|
KR102412442B1
(ko)
|
2016-05-13 |
2022-06-22 |
더브테일 제노믹스 엘엘씨 |
보존된 샘플로부터의 장범위 링키지 정보의 회수
|
|
CA3024490A1
(fr)
|
2016-05-16 |
2017-11-23 |
President And Fellows Of Harvard College |
Couplage de biomolecule aqueuse sur des surfaces activees par plasma de co2
|
|
EP3463402B1
(fr)
|
2016-05-22 |
2021-06-23 |
Yeda Research and Development Co. Ltd. |
Méthodes d'utilisation de cellules pulmonaires pour transplantation et induction de tolérance
|
|
IL245861A0
(en)
|
2016-05-25 |
2016-09-04 |
Yeda Res & Dev |
Use of substances to treat drug-resistant tumors
|
|
WO2017201731A1
(fr)
|
2016-05-27 |
2017-11-30 |
Beijing Vdjbio Co., Ltd. |
Anticorps, composition et kits les comprenant et leurs procédés d'utilisation
|
|
US20190100732A1
(en)
|
2016-06-02 |
2019-04-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Assay for the removal of methyl-cytosine residues from dna
|
|
US20200185063A1
(en)
|
2016-06-05 |
2020-06-11 |
Berg Llc |
Systems and methods for patient stratification and identification of potential biomarkers
|
|
US11820833B2
(en)
|
2016-06-05 |
2023-11-21 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Peptides that inhibit binding of EPCR to its ligand to treat inflammation
|
|
EP3468610A1
(fr)
|
2016-06-09 |
2019-04-17 |
OPKO Biologics Ltd. |
Formulation d'oxyntomoduline à action prolongée, et procédés de production et procédés d'administration de cette dernière
|
|
EP3472342A1
(fr)
|
2016-06-19 |
2019-04-24 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Criblage de la résistance à la chimiothérapie dans des cellules haploïdes humaines
|
|
WO2017222911A1
(fr)
|
2016-06-20 |
2017-12-28 |
The Board Of Trustees Of The Leland Stanford Junior University |
Arn circulaires et leur utilisation dans l'immunomodulation
|
|
IL263924B2
(en)
|
2016-06-27 |
2025-03-01 |
Yeda Res & Dev |
Voto cells produced from memory T cells
|
|
WO2018001932A1
(fr)
|
2016-06-30 |
2018-01-04 |
Koninklijke Philips N.V. |
Dispositif, système et procédé de détection d'analyte dans un échantillon de fluide corporel comprenant une pluralité de cellules
|
|
WO2018011796A1
(fr)
|
2016-07-10 |
2018-01-18 |
Memed Diagnostics Ltd. |
Diagnostic précoce d'infections
|
|
CA3027341A1
(fr)
|
2016-07-10 |
2018-01-18 |
Memed Diagnostics Ltd. |
Signatures de proteines permettant d'etablir la difference entre des infections bacteriennes et des infections virales
|
|
IL246722A0
(en)
|
2016-07-11 |
2016-09-29 |
Yeda Res & Dev |
Combination therapy to increase endogenous nitric oxide (no) synthesis
|
|
IL264205B2
(en)
|
2016-07-11 |
2023-12-01 |
Bonus Therapeutics Ltd |
Cellular compounds for tissue regeneration
|
|
MY206271A
(en)
|
2016-07-11 |
2024-12-06 |
Opko Biologics Ltd |
Long-acting coagulation factor vii and methods of producing same
|
|
EP3481191A2
(fr)
|
2016-07-11 |
2019-05-15 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Systeme et procédé pour la croissance des cellules
|
|
TWI802545B
(zh)
|
2016-07-13 |
2023-05-21 |
英商４Ｄ製藥有限公司 |
包含細菌菌株之組合物
|
|
US11708421B2
(en)
|
2016-07-18 |
2023-07-25 |
Ramot At Tel-Aviv University Ltd. |
Modular platform for targeted therapeutics
|
|
CN109715666B
(zh)
|
2016-07-20 |
2023-02-21 |
斯特库比股份有限公司 |
癌症治疗方法和使用结合糖基化pd-l1的抗体的组合的疗法
|
|
EP3488242B1
(fr)
|
2016-07-20 |
2025-06-11 |
Vib Vzw |
Agents thérapeutiques pour le traitement de troubles neurologiques et psychiatriques
|
|
US20190203270A1
(en)
|
2016-07-24 |
2019-07-04 |
Yeda Research And Development Co., Ltd. |
Methods and kits for analyzing dna binding moieties attached to dna
|
|
ES2965761T3
(es)
|
2016-08-08 |
2024-04-16 |
Tech Innovation Momentum Fund Israel Limited Partnership |
Sistemas bacterianos para el análisis de polipéptidos ubiquitilados
|
|
EP3504553B1
(fr)
|
2016-08-10 |
2022-04-20 |
Memed Diagnostics Ltd. |
Système et procédé d'analyse de données biologiques
|
|
WO2018029693A1
(fr)
|
2016-08-10 |
2018-02-15 |
Ramot At Tel-Aviv University Ltd. |
Analyse de l'état de méthylation et du nombre de copies
|
|
IL264825B
(en)
|
2016-08-14 |
2022-08-01 |
Univ Ramot |
Mesenchymal cell-derived exosomes to treat neurological disorders
|
|
IL247368A0
(en)
|
2016-08-18 |
2016-11-30 |
Yeda Res & Dev |
Diagnostic and therapeutic uses of exosomes
|
|
WO2018037416A1
(fr)
|
2016-08-25 |
2018-03-01 |
Yeda Research And Development Co. Ltd. |
Procédés et compositions pour le traitement de maladies auto-immunes
|
|
BR112019004180A2
(pt)
|
2016-08-28 |
2019-05-28 |
The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization A R O |
método de controle de infecções fúngicas em plantas.
|
|
WO2018047154A1
(fr)
|
2016-09-07 |
2018-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Anticorps anti-nkp46 et leur utilisation thérapeutique
|
|
WO2018051347A1
(fr)
|
2016-09-14 |
2018-03-22 |
Yeda Research And Development Co. Ltd. |
Crisp-seq, procédé intégré pour séquençage massivement parallèle d'arn unicellulaire et criblages regroupés par crispr
|
|
US11385241B2
(en)
|
2016-09-29 |
2022-07-12 |
Memed Diagnostics Ltd. |
Methods of prognosis and treatment
|
|
IL248468A0
(en)
|
2016-10-13 |
2017-01-31 |
Technion Res & Dev Foundation |
Use of caspase-3 inhibitors and caspase-3 activators in the manufacture of medicament for treating cancer and wound healing
|
|
IL248385A0
(en)
|
2016-10-18 |
2017-02-01 |
Yeda Res & Dev |
Treatment of circadian rhythm disorder
|
|
EP3534953A4
(fr)
|
2016-11-02 |
2020-10-07 |
Vanderbilt University |
Anticorps contre le virus zika humain et leurs procédés d'utilisation
|
|
EP3535409B1
(fr)
|
2016-11-04 |
2024-03-20 |
CD Diagnostics, Inc. |
Détection directe de micro-organismes dans des échantillons de patient par dosage immunologique
|
|
JP7075937B2
(ja)
|
2016-11-09 |
2022-05-26 |
キアゲン サイエンシーズ， エルエルシー |
Ｓｅｑｕｅｎｃｉｎｇ－Ｂｙ－Ｓｙｎｔｈｅｓｉｓ法におけるイメージング試薬としての光防護性混合物
|
|
US20190359956A1
(en)
|
2016-11-10 |
2019-11-28 |
Yeda Research And Development Co. Ltd. |
Phosphotriesterases for treating or preventing organophosphate exposure associated damage
|
|
RU2765737C2
(ru)
|
2016-11-23 |
2022-02-02 |
Хемоцентрикс, Инк. |
Способ лечения фокально-сегментарного гломерулосклероза
|
|
CN110234765A
(zh)
|
2016-11-28 |
2019-09-13 |
耶达研究及发展有限公司 |
分离的多核苷酸和多肽及使用它们来表达感兴趣的表达产物的方法
|
|
CN110199031A
(zh)
|
2016-11-29 |
2019-09-03 |
基因组影像公司 |
设计用于分析感兴趣的遗传区域中的特定事件的一组多核苷酸序列的方法
|
|
WO2018100574A1
(fr)
|
2016-11-30 |
2018-06-07 |
Yeda Research And Development Co. Ltd. |
Méthodes de traitement de maladies et de la toxicité hépathique
|
|
KR20190091192A
(ko)
|
2016-12-01 |
2019-08-05 |
라모트 앳 텔-아비브 유니버시티 리미티드 |
신경 손상의 병용 치료제
|
|
MX388822B
(es)
|
2016-12-05 |
2025-03-20 |
Nuritas Ltd |
Composiciones que comprenden peptido wkdeagkplvk.
|
|
EP3329930A1
(fr)
|
2016-12-05 |
2018-06-06 |
Nuritas Limited |
Compositions pharmaceutiques
|
|
EP3329905A1
(fr)
|
2016-12-05 |
2018-06-06 |
Nuritas Limited |
Compositions cosmötiques topiques contenant d'un oligpeptide contre le vieillisement de la peau
|
|
GB201621123D0
(en)
|
2016-12-12 |
2017-01-25 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
|
ES3064681T3
(en)
|
2017-01-18 |
2026-04-28 |
Yeda Res And Development Co Ltd |
Genetically modified veto cells and use of same in immunotherapy
|
|
US11519914B2
(en)
|
2017-01-25 |
2022-12-06 |
St Innovative Diagnostics Ltd |
Methods of diagnosing malignant diseases
|
|
AU2018213315A1
(en)
|
2017-01-26 |
2019-07-25 |
Oklahoma Medical Research Foundation |
Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
|
|
WO2018137705A1
(fr)
|
2017-01-26 |
2018-08-02 |
Zai Lab (Shanghai) Co., Ltd. |
Unité de liaison à l'antigène cd47 et ses utilisations
|
|
CA3051466A1
(fr)
|
2017-01-31 |
2018-08-09 |
Vanderbilt University |
Generation d'anticorps monoclonaux ige specifiques d'allergenes et d'helminthes humains pour une utilisation diagnostique et therapeutique
|
|
IL250479A0
(en)
|
2017-02-06 |
2017-03-30 |
Sorek Rotem |
Genetically engineered cells expressing a disarm system that confers resistance to phages and methods for their production
|
|
WO2018146162A1
(fr)
|
2017-02-07 |
2018-08-16 |
Academisch Medisch Centrum |
Biomarqueur moléculaire pour le pronostic de patients atteints de septicémie
|
|
CN110520139A
(zh)
|
2017-02-08 |
2019-11-29 |
哈达西特医疗研究服务和开发有限公司 |
用于治疗视网膜疾病的感光细胞
|
|
IL250916A0
(en)
|
2017-03-02 |
2017-06-29 |
Geiger Benjamin |
Methods for growing t cells in culture and their use
|
|
WO2018163051A1
(fr)
|
2017-03-06 |
2018-09-13 |
Novartis Ag |
Méthodes de traitement du cancer à expression d'ubb réduite
|
|
US20200150125A1
(en)
|
2017-03-12 |
2020-05-14 |
Yeda Research And Development Co., Ltd. |
Methods of diagnosing and prognosing cancer
|
|
WO2018167780A1
(fr)
|
2017-03-12 |
2018-09-20 |
Yeda Research And Development Co. Ltd. |
Méthodes de diagnostic et de traitement du cancer
|
|
WO2018170494A1
(fr)
|
2017-03-16 |
2018-09-20 |
Bio Time, Inc. |
Procédés de mesure d'effets thérapeutiques de traitements de maladies rétiniennes
|
|
WO2018185760A1
(fr)
|
2017-04-05 |
2018-10-11 |
Yeda Research And Development Co. Ltd. |
Système de culture ex-vivo et procédés d'utilisation de celui-ci
|
|
IL252151A0
(en)
|
2017-05-07 |
2017-07-31 |
Fainzilber Michael |
Treatment of stress disorders
|
|
WO2018207184A2
(fr)
|
2017-05-10 |
2018-11-15 |
Ariel Scientific Innovations Ltd. |
Procédés de purification d'anticorps
|
|
EP3622291A4
(fr)
|
2017-05-10 |
2021-04-21 |
Rowan University |
Biomarqueurs de diagnostic pour la détection, le sous-typage et/ou l'évaluation de la progression de la sclérose en plaques
|
|
WO2018216006A1
(fr)
|
2017-05-21 |
2018-11-29 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Combinaison de marqueurs pour diagnostiquer un cancer
|
|
DK3630136T3
(da)
|
2017-05-22 |
2021-05-25 |
4D Pharma Res Ltd |
Sammensætninger, der omfatter bakteriestammer
|
|
WO2018216011A1
(fr)
|
2017-05-23 |
2018-11-29 |
Technion Research & Development Foundation Limited |
Agents inhibant la dimérisation de gads et leurs procédés d'utilisation
|
|
EP3630942B1
(fr)
|
2017-05-24 |
2022-11-30 |
4D Pharma Research Limited |
Compositions comprenant des souches bactériennes
|
|
CN111051346A
(zh)
|
2017-05-31 |
2020-04-21 |
斯特库伯株式会社 |
使用免疫特异性结合btn1a1的抗体和分子治疗癌症的方法
|
|
KR20200015602A
(ko)
|
2017-05-31 |
2020-02-12 |
주식회사 에스티큐브앤컴퍼니 |
Btn1a1에 면역특이적으로 결합하는 항체 및 분자 및 이의 치료적 용도
|
|
WO2018220582A1
(fr)
|
2017-05-31 |
2018-12-06 |
Tropic Biosciences UK Limited |
Méthodes de sélection de cellules comprenant des événements d'édition de génome
|
|
GB201708665D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing extractability of solids from coffee beans
|
|
GB201708662D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing shelf-life of banana
|
|
KR20200026209A
(ko)
|
2017-06-06 |
2020-03-10 |
주식회사 에스티큐브앤컴퍼니 |
Btn1a1 또는 btn1a1-리간드에 결합하는 항체 및 분자를 사용하여 암을 치료하는 방법
|
|
WO2018229764A1
(fr)
|
2017-06-13 |
2018-12-20 |
Yeda Research And Development Co. Ltd. |
Traitement de la sclérose en plaques avancée ou progressive
|
|
SMT202000695T1
(it)
|
2017-06-14 |
2021-01-05 |
4D Pharma Res Limited |
Composizioni comprendenti ceppi batterici
|
|
SMT202000555T1
(it)
|
2017-06-14 |
2020-11-10 |
4D Pharma Res Limited |
Composizioni comprendenti un ceppo batterico del genere megaspaera e loro usi
|
|
CA3066189A1
(fr)
|
2017-06-14 |
2018-12-20 |
4D Pharma Research Limited |
Compositions comprenant des souches bacteriennes
|
|
US12140592B2
(en)
|
2017-06-16 |
2024-11-12 |
Oklahoma Medical Research Foundation |
Biomarkers for assessing risk of transitioning to systemic lupus erythematosus classification and disease pathogenesis
|
|
WO2019012544A1
(fr)
|
2017-07-13 |
2019-01-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Stratégie de pcr en gouttelettes à double sonde pour la détection spécifique de molécules d'adn circulantes spécifiques d'un tissu
|
|
WO2019012542A1
(fr)
|
2017-07-13 |
2019-01-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Détection d'adn spécifique d'un tissu
|
|
EP3652344A1
(fr)
|
2017-07-13 |
2020-05-20 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Cibles d'adn à titre de marqueurs de méthylation spécifiques de tissu
|
|
WO2019018747A1
(fr)
|
2017-07-20 |
2019-01-24 |
Trustees Of Boston University |
Dosage de détection du ténofovir
|
|
US11530413B2
(en)
|
2017-07-21 |
2022-12-20 |
Novartis Ag |
Compositions and methods to treat cancer
|
|
IL253642A0
(en)
|
2017-07-24 |
2017-09-28 |
Seger Rony |
Combined treatment for cancer
|
|
WO2019030759A1
(fr)
|
2017-08-08 |
2019-02-14 |
Technology Innovation Momentum Fund (Israel) Limited Partnership |
Protéine tronquée résistante au chloramphénicol et ses utilisations
|
|
IL253984A0
(en)
|
2017-08-14 |
2017-09-28 |
Yeda Res & Dev |
Immunotherapy against aranviruses that bind through transferrin receptor 1 (tfr1
|
|
IL272810B2
(en)
|
2017-08-21 |
2025-10-01 |
Savicell Diagnostic Ltd |
Methods for diagnosing and treating lung cancer
|
|
WO2019038771A1
(fr)
|
2017-08-23 |
2019-02-28 |
Technion Research & Development Foundation Limited |
Compositions et procédés d'amélioration de la tolérance à l'alcool dans la levure
|
|
US11306144B2
(en)
|
2017-08-25 |
2022-04-19 |
Five Prime Therapeutics, Inc. |
B7-H4 antibodies and methods of use thereof
|
|
CN110799546B
(zh)
|
2017-09-01 |
2023-01-24 |
四川科伦博泰生物医药股份有限公司 |
重组双特异性抗体
|
|
EP3679129A1
(fr)
|
2017-09-05 |
2020-07-15 |
GLAdiator Biosciences, Inc. |
Procédé d'administration intracellulaire
|
|
DE112018005145T5
(de)
|
2017-09-15 |
2020-07-23 |
The Regents Of The University Of California |
Hemmung von aminoacylase 3 (aa3) bei der behandlung von krebs
|
|
JP2020536580A
(ja)
|
2017-09-19 |
2020-12-17 |
ザ ステート オブ イスラエル， ミニストリー オブ アグリカルチャー アンド ルーラル ディヴェロプメント， アグリカルチュラル リサーチ オーガニゼーション （エーアールオー） （ボルカニ センター） |
ゲノム編集された鳥
|
|
SG11202002481RA
(en)
|
2017-09-19 |
2020-04-29 |
Tropic Biosciences Uk Ltd |
Modifying the specificity of non-coding rna molecules for silencing gene expression in eukaryotic cells
|
|
CN111868039A
(zh)
|
2017-09-26 |
2020-10-30 |
加利福尼亚大学董事会 |
用于治疗癌症的组合物和方法
|
|
WO2019071054A1
(fr)
|
2017-10-04 |
2019-04-11 |
The Broad Institute, Inc. |
Procédés et compositions permettant de modifier la fonction et la structure de boucles et/ou de domaines de chromatine
|
|
RU2020113612A
(ru)
|
2017-10-11 |
2021-11-12 |
Хемоцентрикс, Инк. |
Лечение фокально-сегментарного гломерулосклероза антагонистами ccr2
|
|
US11525002B2
(en)
|
2017-10-11 |
2022-12-13 |
Board Of Regents, The University Of Texas System |
Human PD-L1 antibodies and methods of use therefor
|
|
JP2021500878A
(ja)
|
2017-10-12 |
2021-01-14 |
ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム |
免疫療法のためのｔ細胞受容体
|
|
EP3700543A4
(fr)
|
2017-10-24 |
2021-08-25 |
Elani, Dalia |
Procédés de traitement d'une maladie ischémique
|
|
EP3706795A4
(fr)
|
2017-11-09 |
2021-10-13 |
Pinteon Therapeutics Inc. |
Méthodes et compositions pour la génération et l'utilisation d'anticorps tau phosphorylés spécifiques à une conformation humanisée
|
|
IL255664A0
(en)
|
2017-11-14 |
2017-12-31 |
Shachar Idit |
Hematopoietic stem cells with enhanced properties
|
|
BR112020010830A2
(pt)
|
2017-11-29 |
2020-11-10 |
Weedout Ltd. |
composições, kits e métodos para controlar erva daninha do gênero amaranthus
|
|
IL274979B2
(en)
|
2017-11-29 |
2024-07-01 |
Univ Ramot |
Methods for the prevention and treatment of neurogenic seizures
|
|
WO2019106680A1
(fr)
|
2017-12-03 |
2019-06-06 |
Yeda Research And Development Co. Ltd. |
Traitement d'une maladie cardiaque ischémique
|
|
CN109870581B
(zh)
|
2017-12-04 |
2021-05-04 |
厦门万泰凯瑞生物技术有限公司 |
一种定量检测HBsAg的试剂盒及方法
|
|
US11714090B2
(en)
|
2017-12-15 |
2023-08-01 |
Syngenta Participations Ag |
Non-antibody ligands for detecting target proteins
|
|
EP3723785A1
(fr)
|
2017-12-17 |
2020-10-21 |
Yeda Research and Development Co. Ltd |
Modulateurs du complexe signalosome cop9 (csn) et leurs utilisations
|
|
WO2019130313A1
(fr)
|
2017-12-28 |
2019-07-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédé pour reproduire des rythmes circadiens sur une puce microfluidique
|
|
WO2019130061A2
(fr)
|
2017-12-29 |
2019-07-04 |
Cell Cure Neurosciences Ltd. |
Compositions de cellules d'épithélium pigmentaire rétinien
|
|
US11851478B2
(en)
|
2018-01-05 |
2023-12-26 |
Vanderbilt University |
Antibody-mediated neutralization of chikungunya virus
|
|
CA3087291A1
(fr)
|
2018-01-29 |
2019-08-01 |
Lavie Bio Ltd. |
Preparations microbiennes vegetales, compositions et formulations les comprenant et leurs utilisations
|
|
IL257225A
(en)
|
2018-01-29 |
2018-04-09 |
Yeda Res & Dev |
Treatment of sarcoma
|
|
IL257269A
(en)
|
2018-01-31 |
2018-04-09 |
Olender Tsviya |
Signaling is directed to the endoplasmic reticulum
|
|
EP3746566A1
(fr)
|
2018-01-31 |
2020-12-09 |
Dovetail Genomics, LLC |
Préparation d'échantillon pour récupération de liaison d'adn
|
|
WO2019155465A1
(fr)
|
2018-02-08 |
2019-08-15 |
Yeda Research And Development Co. Ltd. |
Procédés d'identification et d'utilisation d'agents pour traiter des maladies associées à un dysfonctionnement de la barrière intestinale
|
|
WO2019155459A1
(fr)
|
2018-02-08 |
2019-08-15 |
Yeda Research And Development Co. Ltd. |
Inhibiteurs du protéasome 20s
|
|
WO2019155041A1
(fr)
|
2018-02-12 |
2019-08-15 |
Vib Vzw |
ANTICORPS COMPLEXES Gβγ ET LEURS UTILISATIONS
|
|
BR112020016986A2
(pt)
|
2018-02-21 |
2021-03-02 |
Five Prime Therapeutics, Inc. |
formulações de anticorpo contra b7-h4
|
|
WO2019165217A1
(fr)
|
2018-02-22 |
2019-08-29 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cd153 et/ou cd30 dans une infection
|
|
EP3755340A4
(fr)
|
2018-02-23 |
2021-11-17 |
Carmel-Haifa University Economic Corporation Ltd. |
Méthodes de traitement d'un trouble de la mémoire et d'un dysfonctionnement cognitif
|
|
EP3759493A1
(fr)
|
2018-02-28 |
2021-01-06 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Méthodes de diagnostic et de traitement du cancer de la vessie
|
|
KR20200144094A
(ko)
|
2018-03-02 |
2020-12-28 |
파이브 프라임 테라퓨틱스, 인크. |
B7-h4 항체 및 이의 사용 방법
|
|
WO2019175869A1
(fr)
|
2018-03-12 |
2019-09-19 |
Yeda Research And Development Co. Ltd |
Traitement d'une maladie cardiaque
|
|
CN119930831A
(zh)
|
2018-03-14 |
2025-05-06 |
纪念斯隆凯特琳癌症中心 |
抗聚唾液酸抗体及其用途
|
|
EP4501355A3
(fr)
|
2018-03-23 |
2025-04-30 |
Board Of Regents, The University Of Texas System |
Anticorps à double spécificité pour pd-l1 et pd-l2 et leurs procédés d'utilisation
|
|
SG11202009258RA
(en)
|
2018-03-23 |
2020-10-29 |
Univ Texas |
Dual specificity antibodies to human pd-l1 and pd-l2 and methods of use therefor
|
|
US11648260B2
(en)
|
2018-03-29 |
2023-05-16 |
Technion Research And Development Foundation Limitted |
Vesicles comprising a PTEN inhibitor and uses of same
|
|
IL258467A
(en)
|
2018-03-29 |
2018-07-04 |
Ilana Kolodkin Gal |
Methods of disrupting a biofilm and/or preventing formation of same
|
|
EP3774047A1
(fr)
|
2018-03-29 |
2021-02-17 |
Yeda Research and Development Co. Ltd |
Utilisation de gradients de champ électrique pour commander l'expression génique
|
|
EP4063519B1
(fr)
|
2018-04-09 |
2023-09-13 |
Advanced Cell Diagnostics, Inc. |
Procédés d'amélioration supplémentaire de l'amplification de signal pour la détection in situ d'acides nucléiques
|
|
AU2019258468B2
(en)
|
2018-04-24 |
2023-06-29 |
Ampsource Biopharma Shanghai Inc. |
Antibody against TIM-3 and application thereof
|
|
GB201807192D0
(en)
|
2018-05-01 |
2018-06-13 |
Tropic Biosciences Uk Ltd |
Compositions and methods for reducing caffeine content in coffee beans
|
|
WO2019213276A1
(fr)
|
2018-05-02 |
2019-11-07 |
Novartis Ag |
Régulateurs de cellules souches pluripotentes humaines et leurs utilisations
|
|
IL259392A
(en)
|
2018-05-15 |
2018-08-01 |
Yeda Res & Dev |
Vaccination with cancer neoantigens
|
|
WO2019220441A1
(fr)
|
2018-05-15 |
2019-11-21 |
Hadasit Medical Research Services And Development Ltd. |
Compositions et méthodes de traitement du cancer résistant à un agent anticancéreux
|
|
US20210292400A1
(en)
|
2018-05-17 |
2021-09-23 |
Yiping W. Han |
Methods for treating, preventing and detecting the prognosis of colorectal cancer
|
|
AU2019277908A1
(en)
|
2018-05-27 |
2021-01-07 |
Biolinerx Ltd. |
AGI-134 combined with a checkpoint inhibitor for the treatment of solid tumors
|
|
JP7350019B2
(ja)
|
2018-05-31 |
2023-09-25 |
イミュニティ ファルマ リミテッド |
筋萎縮性側索硬化症（ａｌｓ）を治療するための組成物、及び治療のためにそれを使用する方法
|
|
EP3802839A1
(fr)
|
2018-06-07 |
2021-04-14 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Constructions d'acide nucléique et procédés d'utilisation de celles-ci
|
|
EP3800998A1
(fr)
|
2018-06-07 |
2021-04-14 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Procédés de régénération et de transformation de cannabis
|
|
WO2019238962A1
(fr)
|
2018-06-14 |
2019-12-19 |
University College Cork - National University Of Ireland, Cork |
Peptide pour le traitement de maladies
|
|
TW202016144A
(zh)
|
2018-06-21 |
2020-05-01 |
日商第一三共股份有限公司 |
包括cd3抗原結合片段之組成物及其用途
|
|
WO2020003311A1
(fr)
|
2018-06-25 |
2020-01-02 |
Yeda Research And Development Co. Ltd. |
Systèmes et procédés permettant d'améliorer l'efficacité de l'édition génomique
|
|
WO2020008412A1
(fr)
|
2018-07-04 |
2020-01-09 |
Ukko Inc. |
Procédés de ré-épitopage de protéines de blé et leur utilisation pour le traitement de maladie cœliaque
|
|
US20210269860A1
(en)
|
2018-07-08 |
2021-09-02 |
Yeda Research And Development Co. Ltd. |
Person-specific assessment of probiotics responsiveness
|
|
IL280101B2
(en)
|
2018-07-11 |
2025-05-01 |
Immunity Pharma Ltd |
Peptide compounds and their therapeutic uses
|
|
KR102945860B1
(ko)
|
2018-07-11 |
2026-03-31 |
카 메디컬 리미티드 |
SIRPalpha-4-1BBL 변이체 융합 단백질 및 이의 사용 방법
|
|
AU2019315054A1
(en)
|
2018-07-31 |
2021-03-18 |
Collplant Ltd. |
Tobacco transgenic event and methods for detection and use thereof
|
|
IL261156A
(en)
|
2018-08-14 |
2020-02-27 |
Fass Deborah |
Chimeric quiescin sulfhydryl oxidase (qsox1) antibodies and uses of same
|
|
EP3841201A1
(fr)
|
2018-08-24 |
2021-06-30 |
Yeda Research and Development Co. Ltd |
Procédés de modulation de la polarisation de macrophages m2 et leur utilisation en thérapie
|
|
CA3109366A1
(fr)
|
2018-09-13 |
2020-03-19 |
The Board Of Regents Of The University Of Texas System |
Nouveaux anticorps anti-lilrb4 et leurs utilisations
|
|
CA3112135A1
(fr)
|
2018-09-20 |
2020-03-26 |
Yeda Research And Development Co. Ltd. |
Methodes de traitement de la sclerose laterale amyotrophique
|
|
US20210338767A1
(en)
|
2018-09-25 |
2021-11-04 |
Biolinerx Ltd. |
Methods of selecting treatment for cxcr4-associated cancer
|
|
WO2020069424A1
(fr)
|
2018-09-28 |
2020-04-02 |
Centrillion Technologies, Inc. |
Terminateurs réversibles à liaison disulfure
|
|
IL282267B2
(en)
|
2018-10-15 |
2026-03-01 |
Univ Massachusetts |
Programmed DNA editing by chimeric deaminase-nme2cas9 proteins
|
|
US20210349088A1
(en)
|
2018-10-18 |
2021-11-11 |
Oklahoma Medical Research Foundation |
Biomarkers For A Systemic Lupus Erythematosus (SLE) Disease Activity Immune Index That Characterizes Disease Activity
|
|
US12510539B2
(en)
|
2018-10-18 |
2025-12-30 |
Progentec Diagnostics, Inc. |
Biomarkers for a systemic lupus erythematosus (SLE) disease activity immune index that characterizes disease activity
|
|
EP3872093A4
(fr)
|
2018-10-22 |
2022-10-19 |
Shanghai Genbase Biotechnology Co., Ltd. |
Anticorps anti-cldn18.2 et ses applications
|
|
MX2021004684A
(es)
|
2018-10-23 |
2021-06-04 |
Glycardial Diagnostics S L |
Anticuerpos especificos para apoj glucosilada y usos de los mismos.
|
|
IL262658A
(en)
|
2018-10-28 |
2020-04-30 |
Memorial Sloan Kettering Cancer Center |
Prevention of age related clonal hematopoiesis and diseases associated therewith
|
|
WO2020088645A1
(fr)
|
2018-11-02 |
2020-05-07 |
Beijing Vdjbio Co., Ltd. |
Ctla4 modifié et ses méthodes d'utilisation
|
|
WO2020102660A1
(fr)
|
2018-11-16 |
2020-05-22 |
President And Fellows Of Harvard College |
Molécules et procédés d'immunodétection améliorée de petites molécules, telles que l'histamine
|
|
CN111196851B
(zh)
|
2018-11-20 |
2021-11-16 |
厦门万泰凯瑞生物技术有限公司 |
针对人抗缪勒管激素的特异性抗体及其应用
|
|
IL263184A
(en)
|
2018-11-21 |
2020-05-31 |
Yarden Yosef |
Method of treating cancer and compositions for same
|
|
US12134657B2
(en)
|
2018-11-28 |
2024-11-05 |
Oregon Health & Science University |
Therapeutic factor XII antibody
|
|
US12441776B2
(en)
|
2018-11-30 |
2025-10-14 |
Eirgen Pharma Ltd. |
Oxyntomodulin peptide analog formulations
|
|
EP3888021B1
(fr)
|
2018-11-30 |
2024-02-21 |
Caris MPI, Inc. |
Profilage moléculaire de nouvelle génération
|
|
US12478571B2
(en)
|
2018-12-17 |
2025-11-25 |
Pontis Biologics, Inc. |
Enzyme based compositions and methods for removing dental calculi
|
|
CN119350498A
(zh)
|
2018-12-28 |
2025-01-24 |
四川科伦博泰生物医药股份有限公司 |
一种抗体及其用途
|
|
EP3914698B1
(fr)
|
2019-01-23 |
2024-12-11 |
Yeda Research and Development Co. Ltd |
Milieux de culture pour cellules souches pluripotentes
|
|
CN113454238B
(zh)
|
2019-01-25 |
2025-02-11 |
哈佛大学校长及研究员协会 |
用于合成核酸的组合物和方法
|
|
SG11202107720UA
(en)
|
2019-01-31 |
2021-08-30 |
Agency Science Tech & Res |
Cnx/erp57 inhibitor for use in the treatment or prevention of cancer
|
|
IL264768A
(en)
|
2019-02-10 |
2020-08-31 |
Sagi Irit |
Anti-matrix metalloproteinase 7 (mmp-7) inhibitory antibody and uses thereof
|
|
IL264854A
(en)
|
2019-02-14 |
2020-08-31 |
Bahat Anat |
Spt5 inhibitors and methods of use thereof
|
|
SG11202108618VA
(en)
|
2019-02-15 |
2021-09-29 |
Advanced Cell Diagnostics Inc |
Methods for multiplex detection of nucleic acids by in situ hybridization
|
|
WO2020170239A1
(fr)
|
2019-02-21 |
2020-08-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédés de génération d'organoïdes pour criblage à haut rendement de médicaments
|
|
WO2020170240A1
(fr)
|
2019-02-21 |
2020-08-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédé de réduction d'une néphrotoxicité induite par des médicaments
|
|
KR20210137499A
(ko)
|
2019-03-05 |
2021-11-17 |
더 스테이트 오브 이스라엘, 미니스트리 오브 애그리컬처 & 루럴 디벨로프먼트, 애그리컬처럴 리서치 오거니제이션, (에이.알.오.), 볼카니 센터 |
게놈-편집 조류
|
|
EP3938400B1
(fr)
|
2019-03-11 |
2025-07-30 |
Memorial Sloan Kettering Cancer Center |
Anticorps cd22 et leurs procédés d'utilisation
|
|
GB201903519D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Introducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest
|
|
GB201903521D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
No title
|
|
GB201903520D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Modifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells
|
|
IL265486A
(en)
|
2019-03-19 |
2020-09-30 |
Yeda Res & Dev |
Type II stable opsins and methods of using them
|
|
WO2020194317A1
(fr)
|
2019-03-28 |
2020-10-01 |
Yeda Research And Development Co. Ltd. |
Méthode de traitement de troubles liés aux lipides
|
|
WO2020202142A2
(fr)
|
2019-03-31 |
2020-10-08 |
Yeda Research And Development Co. Ltd. |
Composés anti-viraux et anti-tumoraux
|
|
KR20210151774A
(ko)
|
2019-04-16 |
2021-12-14 |
쓰촨 케룬-바이오테크 바이오파마수티컬 컴퍼니 리미티드 |
항-FXI/FXIa 항체 및 그 용도
|
|
CN121610569A
(zh)
|
2019-04-30 |
2026-03-06 |
拉利玛生物医药公司 |
用于测定共济蛋白替代疗法的疗效的共济蛋白敏感性标志物
|
|
IL266433B
(en)
|
2019-05-02 |
2020-11-30 |
Sagi Irit |
Preparations containing the propeptide of lysyl oxidase and their uses
|
|
WO2020230133A1
(fr)
|
2019-05-13 |
2020-11-19 |
Yeda Research And Development Co. Ltd. |
Biomarqueurs de micro-adn acellulaire pour le pronostic et le diagnostic de maladies neurodégénératives
|
|
IL266728B
(en)
|
2019-05-19 |
2020-11-30 |
Yeda Res & Dev |
Identification of recurrent mutant neopeptides
|
|
WO2020234888A1
(fr)
|
2019-05-22 |
2020-11-26 |
Hadasit Medical Research Services And Development Ltd. |
Procédés de culture de cellules pluripotentes humaines
|
|
IT201900007222A1
(it)
|
2019-05-24 |
2020-11-24 |
Univ Degli Studi Di Torino |
Composizione di liposomi e metodo di dosaggio basato sull'uso degli stessi
|
|
US20220251179A1
(en)
|
2019-05-28 |
2022-08-11 |
Shanghaitech University |
Composition and methods to treat ectodermal dysplasia 2, clouston type
|
|
AU2020291694B2
(en)
|
2019-06-12 |
2025-10-02 |
Hadasit Medical Research Services And Development Ltd. |
Methods of generating oligodendrocytes
|
|
US12516313B2
(en)
|
2019-06-16 |
2026-01-06 |
Yeda Research And Development Co. Ltd. |
Method for stabilizing intracellular RNA
|
|
US12509512B2
(en)
|
2019-06-27 |
2025-12-30 |
Ramot At Tel-Aviv University Ltd. |
Semaphorin 3A antibodies and uses thereof
|
|
EP4545965A3
(fr)
|
2019-06-27 |
2025-06-11 |
Dovetail Genomics, LLC |
Procédés et compositions pour ligature de proximité
|
|
WO2021001784A1
(fr)
|
2019-07-04 |
2021-01-07 |
Ukko Inc. |
Alpha gliadine sans épitope et son utilisation pour la gestion de la maladie coeliaque et de la sensibilité au gluten
|
|
US20220267409A1
(en)
|
2019-07-11 |
2022-08-25 |
Kahr Medical Ltd. |
Heterodimers and methods of use thereof
|
|
IL268111A
(en)
|
2019-07-16 |
2021-01-31 |
Fainzilber Michael |
Methods of treating pain
|
|
US20220281960A1
(en)
|
2019-07-16 |
2022-09-08 |
Ramot At Tel-Aviv University Ltd. |
Compositions and methods for the treatment of tuberculosis
|
|
CN120484131A
(zh)
|
2019-07-19 |
2025-08-15 |
费城儿童医院 |
包含磷脂酰肌醇蛋白聚糖2结合结构域的嵌合抗原受体
|
|
US12410241B2
(en)
|
2019-07-26 |
2025-09-09 |
Vanderbilt University |
Human monoclonal antibodies to enterovirus D68
|
|
EP4004548B1
(fr)
|
2019-07-29 |
2026-01-14 |
Yeda Research and Development Co. Ltd |
Procédés de traitement et de diagnostic du cancer du poumon
|
|
CA3148950A1
(fr)
|
2019-07-30 |
2021-02-04 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (A.R.O.), Volcani Center |
Methodes de regulation de la synthese de cannabinoides chez la plante ou dans des cellules et plantes et cellules ainsi produites
|
|
WO2021028909A1
(fr)
|
2019-08-12 |
2021-02-18 |
Yeda Research And Development Co. Ltd. |
Test sanguin de réparation de l'adn pour prédire la réponse de patients atteints d'un cancer du poumon à une immunothérapie
|
|
EP4218787A3
(fr)
|
2019-08-20 |
2023-12-20 |
Nuritas Limited |
Peptides pour le traitement de l'atrophie musculaire
|
|
EP3783012A1
(fr)
|
2019-08-20 |
2021-02-24 |
Nuritas Limited |
Peptide antimicrobien
|
|
WO2021033176A1
(fr)
|
2019-08-22 |
2021-02-25 |
Ariel Scientific Innovations Ltd. |
Procédés mis à l'échelle de purification d'anticorps
|
|
EP4021463A1
(fr)
|
2019-08-27 |
2022-07-06 |
Yeda Research and Development Co. Ltd |
Traitement de la vaginose bactérienne
|
|
WO2021048852A1
(fr)
|
2019-09-11 |
2021-03-18 |
Yeda Research And Development Co. Ltd. |
Méthodes de traitement du cancer du sein
|
|
US20220296622A1
(en)
|
2019-09-16 |
2022-09-22 |
The Children's Hospital Of Philadelphia |
Compositions and methods for the treatment of swi-snf mutant tumors
|
|
EP4032907A4
(fr)
|
2019-09-20 |
2023-07-05 |
Shanghai Genbase Biotechnology Co., Ltd. |
Anticorps et récepteur antigénique chimérique ciblant bcma
|
|
IL269674B
(en)
|
2019-09-25 |
2020-08-31 |
Roy Bar Ziv |
Assembling protein complexes on a chip
|
|
US20220411511A1
(en)
|
2019-09-26 |
2022-12-29 |
Stcube & Co. |
Antibodies specific to glycosylated ctla-4 and methods of use thereof
|
|
WO2021063201A1
(fr)
|
2019-09-30 |
2021-04-08 |
四川科伦博泰生物医药股份有限公司 |
Anticorps anti-pd-1 et son utilisation
|
|
EP4041392A1
(fr)
|
2019-10-08 |
2022-08-17 |
Nectin Therapeutics Ltd. |
Anticorps dirigés contre le récepteur du poliovirus (pvr) et leurs utilisations
|
|
EP4041768A1
(fr)
|
2019-10-09 |
2022-08-17 |
StCube & Co. |
Anticorps spécifiques de lag3 glycosylé et leurs procédés d'utilisation
|
|
US12590950B2
(en)
|
2019-10-11 |
2026-03-31 |
University Of Massachusetts |
Methods for predicting ER-mediated DNA damage
|
|
JP2022553367A
(ja)
|
2019-10-22 |
2022-12-22 |
ニューリタス リミテッド |
非アルコール性脂肪肝の治療
|
|
IL270306A
(en)
|
2019-10-30 |
2021-05-31 |
Yeda Res & Dev |
Prevention and treatment of pre-myeloid and myeloid malignancies
|
|
WO2021084526A1
(fr)
|
2019-10-31 |
2021-05-06 |
Yeda Research And Development Co. Ltd. |
Bactéries autotrophes génétiquement modifiées pour la conversion de co2 en matériaux organiques
|
|
CA3160506A1
(fr)
|
2019-11-11 |
2021-05-20 |
Ibi-Ag Innovative Bio Insecticides Ltd. |
Nanocorps de lutte contre les insectes et leurs utilisations
|
|
WO2021100034A1
(fr)
|
2019-11-19 |
2021-05-27 |
Protalix Ltd. |
Élimination de constructions à partir de cellules transformées
|
|
IL270800A
(en)
|
2019-11-20 |
2021-05-31 |
Yeda Res & Dev |
A method for treating Alzheimer's disease
|
|
US10792360B1
(en)
|
2019-11-21 |
2020-10-06 |
Chemocentryx, Inc. |
Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-TNF-alpha blocking antibodies
|
|
CA3163319A1
(fr)
|
2019-12-02 |
2021-06-10 |
Caris Mpi, Inc. |
Predicteur de reponse au platine dans une approche pan-cancer
|
|
EP4073246A4
(fr)
|
2019-12-12 |
2023-12-06 |
President And Fellows Of Harvard College |
Compositions et méthodes pour le codage à barres biomoléculaire dirigé par la lumière
|
|
AU2020400221A1
(en)
|
2019-12-13 |
2022-05-19 |
Harbour Biomed (Shanghai) Co., Ltd. |
Anti-TSLP antibody and uses thereof
|
|
JP7758672B2
(ja)
|
2019-12-20 |
2025-10-22 |
ノヴァロック バイオセラピューティクス， リミテッド |
抗インターロイキン－２３ ｐ１９抗体およびそれの使用方法
|
|
IL271656A
(en)
|
2019-12-22 |
2021-06-30 |
Yeda Res & Dev |
System and methods for identifying cells that have undergone genome editing
|
|
WO2021130753A1
(fr)
|
2019-12-22 |
2021-07-01 |
Yeda Research And Development Co. Ltd. |
Diagnostic de la démence frontotemporale
|
|
EP3842452A1
(fr)
|
2019-12-26 |
2021-06-30 |
Universitat Autònoma de Barcelona |
Protéines d'échafaudage et nanoconjugués thérapeutiques à base de nidogène
|
|
US20230048361A1
(en)
|
2019-12-31 |
2023-02-16 |
Kahr Medical Ltd. |
Methods of culturing t cells and uses of same
|
|
WO2021137231A1
(fr)
|
2019-12-31 |
2021-07-08 |
Kahr Medical Ltd. |
Procédés de culture de lymphocytes t avec un polypeptide de fusion 4-1bbl et leurs utilisations
|
|
IL271778A
(en)
|
2019-12-31 |
2021-06-30 |
Ichilov Tech Ltd |
Methods for treating atopic dermatitis
|
|
CN113061165B
(zh)
|
2020-01-02 |
2026-04-21 |
厦门大学 |
EB病毒BNLF2b基因编码多肽及其检测用途
|
|
IL272074B2
(en)
|
2020-01-15 |
2024-12-01 |
Immunity Pharma Ltd |
Peptide compounds and methods of treating diseases using same
|
|
WO2021149040A1
(fr)
|
2020-01-22 |
2021-07-29 |
Ramot At Tel-Aviv University Ltd. |
Anticorps anti-ide et leurs utilisations
|
|
IL272194A
(en)
|
2020-01-22 |
2021-07-29 |
Yeda Res & Dev |
Multispecific antibodies for use in treating diseases
|
|
WO2021152584A1
(fr)
|
2020-01-28 |
2021-08-05 |
Ariel Scientific Innovations Ltd. |
Procédés d'analyse de membranes cellulaires
|
|
IL295179A
(en)
|
2020-01-29 |
2022-09-01 |
Memed Diagnostics Ltd |
Methods for diagnosis and classification of viral infections
|
|
WO2021152586A1
(fr)
|
2020-01-30 |
2021-08-05 |
Yeda Research And Development Co. Ltd. |
Procédés d'analyse du microbiome, du profil d'immunoglobuline et de l'état physiologique
|
|
EP4096647A1
(fr)
|
2020-01-30 |
2022-12-07 |
Yeda Research and Development Co. Ltd |
Traitement d'une maladie hépatique aiguë à l'aide d'inhibiteurs de tlr-mik
|
|
IL272389A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Kits containing antibodies to PD-L1 and their uses in therapy
|
|
IL272390A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Cancer treatment methods
|
|
BR102020002165A2
(pt)
|
2020-01-31 |
2021-11-30 |
Fundação Oswaldo Cruz |
Anticorpo, seu uso, composição farmacêutica o compreendendo, método de diagnóstico de infecções fúngicas, kit de diagnóstico de infecções fúngicas e método para tratamento de infecções fúngicas.
|
|
WO2021156490A2
(fr)
|
2020-02-06 |
2021-08-12 |
Vib Vzw |
Liants du coronavirus
|
|
EP3862014A1
(fr)
|
2020-02-07 |
2021-08-11 |
Nuritas Limited |
Traitement de maladies associées au panx1
|
|
KR20220151168A
(ko)
|
2020-02-09 |
2022-11-14 |
엔엘씨 파르마 엘티디 |
Sars-cov-2에 대한 신속한 검출 테스트
|
|
IL272586A
(en)
|
2020-02-10 |
2021-08-31 |
Yeda Res & Dev |
A method for cell cluster analysis
|
|
JP2023519105A
(ja)
|
2020-02-11 |
2023-05-10 |
ヴァンダービルト ユニバーシティ |
重症急性呼吸器症候群コロナウイルス２（ｓａｒｓ－ｃｏｖ－２）に対するヒトモノクローナル抗体
|
|
CA3168337A1
(fr)
|
2020-02-17 |
2021-08-26 |
Marie-Andree Forget |
Procedes d'expansion de lymphocytes infiltrant les tumeurs et leur utilisation
|
|
KR20230012464A
(ko)
|
2020-02-25 |
2023-01-26 |
브이아이비 브이지더블유 |
류신-풍부 반복 키나제 2 알로스테릭 조절제
|
|
EP4110823A1
(fr)
|
2020-02-26 |
2023-01-04 |
A2 Biotherapeutics, Inc. |
Polypeptides ciblant des complexes mage-a3 peptide-mhc et leurs méthodes d'utilisation
|
|
US20230127559A1
(en)
|
2020-03-16 |
2023-04-27 |
Yeda Research And Development Co. Ltd. |
Peptide analogs and use of same in treating diseases, disorders or conditions associated with mutant p53 protein
|
|
EP4121018A4
(fr)
|
2020-03-17 |
2024-07-03 |
Genevant Sciences Gmbh |
Lipides cationiques pour l'administration de nanoparticules lipidiques d'agents thérapeutiques à des cellules stellaires hépatiques
|
|
WO2021195385A1
(fr)
|
2020-03-26 |
2021-09-30 |
Vanderbilt University |
Anticorps monoclonaux humains dirigés contre le coronavirus du syndrome respiratoire aigu sévère 2 (sras-cov-2)
|
|
HRP20240182T1
(hr)
|
2020-03-26 |
2024-04-26 |
Vanderbilt University |
Ljudska monoklonska protutijela za teški akutni respiratorni sindrom koronavirusa 2 (sars-cov-2)
|
|
CN115348884B
(zh)
|
2020-03-29 |
2024-07-30 |
耶达研究及发展有限公司 |
用于治疗戈谢病的β-葡糖脑苷脂酶变体
|
|
WO2021199047A1
(fr)
|
2020-03-31 |
2021-10-07 |
Biomuse Ltd. |
Bactéries destinées à la prévention et au traitement de lésions pulmonaires induites par la fumée
|
|
TWI904146B
(zh)
|
2020-03-31 |
2025-11-11 |
美商卡默森屈有限公司 |
使用ｃｃｒ９抑制劑及抗ｉｌ-２３阻斷抗體治療發炎性腸道疾病的組成物及方法
|
|
EP4133107A1
(fr)
|
2020-04-06 |
2023-02-15 |
Yeda Research and Development Co. Ltd |
Méthodes de diagnostic du cancer et de prédiction de la réactivité à une thérapie
|
|
EP4132479A1
(fr)
|
2020-04-07 |
2023-02-15 |
Ramot at Tel-Aviv University Ltd. |
Compositions contenant du cannabidiol et leurs utilisations
|
|
JP2023521356A
(ja)
|
2020-04-07 |
2023-05-24 |
アドヴァンスド セル ダイアグノスティクス，インコーポレイテッド |
ｉｎ ｓｉｔｕハイブリダイゼーションによって標的核酸を検出する方法及びそのキット
|
|
US20230135456A1
(en)
|
2020-04-13 |
2023-05-04 |
Exoprother Medical Ltd. |
Cell-derived vesicles comprising wild-type p53 protein for antiviral therapy
|
|
US20210322483A1
(en)
|
2020-04-16 |
2021-10-21 |
Ichilov Tech Ltd. |
Cell-derived particles presenting heterologous cd24 and use thereof in therapy
|
|
CA3176545A1
(fr)
|
2020-04-22 |
2021-10-28 |
President And Fellows Of Harvard College |
Procedes isothermes, compositions, kits et systemes de detection d'acides nucleiques
|
|
WO2021229577A1
(fr)
|
2020-05-12 |
2021-11-18 |
Collplant Ltd. |
Collagène utilisé comme outil d'administration d'agents antiviraux à base de métaux
|
|
CN115715202B
(zh)
|
2020-05-15 |
2025-11-04 |
四川科伦博泰生物医药股份有限公司 |
抗体药物缀合物及其制备方法和用途
|
|
IL274811B
(en)
|
2020-05-20 |
2021-05-31 |
Yeda Res & Dev |
Spatial information is developed for the analysis of individual cells
|
|
EP4161653A1
(fr)
|
2020-06-03 |
2023-04-12 |
Bionecure Therapeutics, Inc. |
Anticorps de l'antigène 2 de surface cellulaire du trophoblaste (trop-2)
|
|
EP4521115A3
(fr)
|
2020-06-10 |
2025-06-11 |
Ramot at Tel-Aviv University Ltd. |
Procédés de détection de cpg méthylé
|
|
JP2023530182A
(ja)
|
2020-06-22 |
2023-07-13 |
ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド |
多重サブユニットタンパク質モジュール、それを発現する細胞、及びその使用
|
|
US20230293530A1
(en)
|
2020-06-24 |
2023-09-21 |
Yeda Research And Development Co. Ltd. |
Agents for sensitizing solid tumors to treatment
|
|
EP3939999A1
(fr)
|
2020-07-14 |
2022-01-19 |
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S.P. CNIO) |
Anticorps neutralisant la sous-unité alpha du récepteur de l'interleukine 11 (il11ra) et leurs utilisations
|
|
IL276599A
(en)
|
2020-08-09 |
2022-03-01 |
Yeda Res & Dev |
T cell receptor unique to mage-a1 and its uses
|
|
IL276627A
(en)
|
2020-08-10 |
2022-03-01 |
Yeda Res & Dev |
Compositions for diagnosis and treatment of coronavirus infections
|
|
EP4228656A4
(fr)
|
2020-08-18 |
2024-09-04 |
Yeda Research and Development Co. Ltd |
Composés anti-viraux et anti-tumoraux
|
|
WO2022038536A1
(fr)
|
2020-08-18 |
2022-02-24 |
International Rice Research Institute |
Procédés d'augmentation des taux de croisement de gramineae
|
|
WO2022040455A1
(fr)
|
2020-08-21 |
2022-02-24 |
Advanced Cell Diagnostics, Inc. |
Compositions et procédés pour déterminer une clonalité de lymphocytes t
|
|
WO2022047359A1
(fr)
|
2020-08-31 |
2022-03-03 |
Berg Llc |
Biomarqueurs protéiques du cancer du pancréas
|
|
EP4208259A2
(fr)
|
2020-09-04 |
2023-07-12 |
NovaRock Biotherapeutics, Ltd. |
Anticorps anti-nectine-4 et leurs utilisations
|
|
IL277488A
(en)
|
2020-09-21 |
2022-04-01 |
Yeda Res & Dev |
Weight regulation method
|
|
WO2022064494A2
(fr)
|
2020-09-23 |
2022-03-31 |
Yeda Research And Development Co. Ltd. |
Méthodes et compositions pour traiter des infections à coronavirus
|
|
IL277743A
(en)
|
2020-10-01 |
2022-04-01 |
Yeda Res & Dev |
A method for diagnosing breast cancer
|
|
WO2022074646A1
(fr)
|
2020-10-05 |
2022-04-14 |
Protalix Ltd. |
Cellules végétales inactivées de type dicer
|
|
EP4225903A1
(fr)
|
2020-10-07 |
2023-08-16 |
Protalix Ltd. |
Dnase à action prolongée
|
|
KR102860080B1
(ko)
|
2020-10-09 |
2025-09-15 |
더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 |
융합전-안정화된 hmpv f 단백질
|
|
EP4228637A1
(fr)
|
2020-10-15 |
2023-08-23 |
Yeda Research and Development Co. Ltd |
Méthode de traitement des cancers myéloïdes
|
|
IL278401A
(en)
|
2020-10-29 |
2022-05-01 |
Yeda Res & Dev |
Polynucleotides for editing RNA and a method for using them
|
|
KR20230107296A
(ko)
|
2020-11-09 |
2023-07-14 |
1이 테라퓨틱스 엘티디. |
촉매 서열에 기반한 박테리아 감염을 치료 또는 예방하는 방법
|
|
GB202105804D0
(en)
|
2020-11-20 |
2021-06-09 |
Univ Cape Town |
Use of microvirin in the identification of mycobacterium tuberculosis mannose-capped lipoarabinomannan
|
|
IL302707A
(en)
|
2020-11-26 |
2023-07-01 |
Ukko Inc |
Modified high molecular weight glutenin subunit and uses thereof
|
|
EP4255451A4
(fr)
|
2020-12-03 |
2025-01-01 |
The Board Of Regents Of The University Of Texas System |
Méthodes d'identification d'anticorps bloquant lilrb
|
|
KR20230144525A
(ko)
|
2020-12-04 |
2023-10-16 |
유니버시티 오브 테네시 리서치 파운데이션 |
아밀로이드 질환을 진단하기 위한 방법
|
|
IL279559A
(en)
|
2020-12-17 |
2022-07-01 |
Yeda Res & Dev |
Controlling ubiquitination of mlkl for treatment of disease
|
|
AU2021403156A1
(en)
|
2020-12-18 |
2023-07-13 |
Genevant Sciences Gmbh |
Peg lipids and lipid nanoparticles
|
|
KR20230126725A
(ko)
|
2020-12-28 |
2023-08-30 |
1이 테라퓨틱스 엘티디. |
침묵화를 위한 P21 mRNA 표적 부위
|
|
KR20230133859A
(ko)
|
2020-12-28 |
2023-09-19 |
1이 테라퓨틱스 엘티디. |
p21 mRNA 표적화 DNA자임
|
|
JP7691668B2
(ja)
|
2020-12-31 |
2025-06-12 |
諾納生物（蘇州）有限公司 |
ヒトｌｉｆｒ抗原結合タンパク質、その製造方法及び応用
|
|
AU2022206415A1
(en)
|
2021-01-10 |
2023-08-17 |
Supermeat The Essence Of Meat Ltd. |
Pluripotent stem cell aggregates and microtissues obtained therefrom for the cultured meat industry
|
|
WO2022153286A1
(fr)
|
2021-01-14 |
2022-07-21 |
Yeda Research And Development Co. Ltd. |
Procédés de production de vitamine d
|
|
IL280340B
(en)
|
2021-01-21 |
2022-04-01 |
Yeda Res & Dev |
Antibodies, peptides and combinations of same for the treatment or prevention of coronavirus infection
|
|
US20240101717A1
(en)
|
2021-01-22 |
2024-03-28 |
Bionecure Therapeutics, Inc. |
Anti-her-2/trop-2 constructs and uses thereof
|
|
GB2603166A
(en)
|
2021-01-29 |
2022-08-03 |
Thelper As |
Therapeutic and Diagnostic Agents and Uses Thereof
|
|
EP4257154A4
(fr)
|
2021-02-09 |
2026-04-22 |
Medilink Therapeutics Suzhou Co Ltd |
Conjugué à substance bioactive, son procédé de préparation et son utilisation
|
|
WO2022175951A1
(fr)
|
2021-02-18 |
2022-08-25 |
Yeda Research And Development Co. Ltd. |
Bactéries génétiquement modifiées pour générer des vaccins
|
|
IL305315A
(en)
|
2021-02-18 |
2023-10-01 |
Yeda res & development co ltd |
Methods for producing vaccines
|
|
EP4294516A1
(fr)
|
2021-02-19 |
2023-12-27 |
Vib Vzw |
Liants de récepteur de mannose-6-phosphate indépendants des cations
|
|
KR20230154317A
(ko)
|
2021-03-05 |
2023-11-07 |
상하이 젠베이스 바이오테크놀로지 씨오., 엘티디. |
항-cldn6 항체 및 이의 용도
|
|
TW202302155A
(zh)
|
2021-03-08 |
2023-01-16 |
美商伊繆諾金公司 |
用於增加靶向ａｄａｍ９之免疫結合物治療癌症之功效的方法
|
|
WO2022188652A1
(fr)
|
2021-03-09 |
2022-09-15 |
四川科伦博泰生物医药股份有限公司 |
Protéine de liaison à ror1 et son utilisation
|
|
IL281561A
(en)
|
2021-03-16 |
2022-10-01 |
Yeda Res & Dev |
Methods and devices for ex-utero mouse embryonic development
|
|
WO2022208369A1
(fr)
|
2021-03-30 |
2022-10-06 |
Biomx Ltd. |
Bactériophage de pseudomonas et ses utilisations
|
|
WO2022216841A1
(fr)
|
2021-04-06 |
2022-10-13 |
Berg Llc |
Marqueurs protéiques pour un cancer du sein positif au récepteur des œstrogènes (er) de type luminal a (la) et de type luminal b1 (lb1)
|
|
CA3214833A1
(fr)
|
2021-04-06 |
2022-10-13 |
Bpgbio, Inc. |
Marqueurs proteiques pour le pronostic de la progression du cancer du sein
|
|
WO2022216846A1
(fr)
|
2021-04-06 |
2022-10-13 |
Berg Llc |
Marqueurs protéiques pour le cancer du sein du type positif aux récepteurs des oestrogènes (er) et du type négatif aux récepteurs des oestrogènes (er)
|
|
IL282188A
(en)
|
2021-04-08 |
2022-11-01 |
Yeda Res & Dev |
Combined use of ketamine and bretigabine for the treatment of psychiatric disorders
|
|
US20240197827A1
(en)
|
2021-04-14 |
2024-06-20 |
University College Cork - National University Of Ireland, Cork |
Psg1 for use in the treatment of osteoarthritis
|
|
JP2024514195A
(ja)
|
2021-04-14 |
2024-03-28 |
ユニバーシティ・カレッジ・コークーナショナル・ユニバーシティ・オブ・アイルランド，コーク |
脳血管イベントおよび神経障害の治療
|
|
US20240212150A1
(en)
|
2021-04-16 |
2024-06-27 |
Advanced Cel Diagnostics, Inc. |
Materials and methods related to image processing
|
|
CA3215979A1
(fr)
|
2021-04-19 |
2022-10-27 |
Ghassan SAED |
Methodes de detection ou de traitement de troubles hyperproliferatifs de l'endometre et de l'ovaire
|
|
EP4337764A1
(fr)
|
2021-05-12 |
2024-03-20 |
Biomx Ltd. |
Bactériophage de staphylococcus et ses utilisations
|
|
IL283563A
(en)
|
2021-05-30 |
2022-12-01 |
Yeda Res & Dev |
Profiling of amps for the diagnosis, monitoring and treatment of microbiome-related diseases
|
|
CA3219233A1
(fr)
|
2021-06-06 |
2022-12-15 |
Ravid STRAUSSMAN |
Traitement combine du cancer
|
|
IL309333A
(en)
|
2021-06-13 |
2024-02-01 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
A method for reprogramming cells
|
|
MX2023015233A
(es)
|
2021-06-16 |
2024-01-31 |
Seedx Tech Inc |
Metodos de clasificacion de semillas de matthiola.
|
|
NL2028466B1
(en)
|
2021-06-16 |
2022-12-21 |
Sakata Holland B V |
Methods of sorting matthiola seeds
|
|
KR20240031315A
(ko)
|
2021-07-02 |
2024-03-07 |
트로픽 바이오사이언시즈 유케이 리미티드 |
바나나 과실의 갈변 지연 또는 예방
|
|
EP4370134A4
(fr)
|
2021-07-13 |
2025-08-06 |
Technion Res & Dev Foundation |
Compositions et méthodes de traitement d'un état de santé
|
|
WO2023288046A1
(fr)
|
2021-07-15 |
2023-01-19 |
President And Fellows Of Harvard College |
Compositions et méthodes associées à des cellules comprenant des particules adhérées
|
|
JP2024526837A
(ja)
|
2021-07-18 |
2024-07-19 |
ガミダ セル リミテッド |
治療用ｎｋ細胞集団
|
|
WO2023002492A1
(fr)
|
2021-07-22 |
2023-01-26 |
Yeda Research And Development Co. Ltd. |
Optimisation de codon d'acides nucléiques
|
|
EP4377352A2
(fr)
|
2021-07-30 |
2024-06-05 |
Vib Vzw |
Liants du récepteur mannose-6-phosphate indépendants des cations pour la dégradation ciblée de protéines
|
|
EP4380973A2
(fr)
|
2021-08-02 |
2024-06-12 |
Yeda Research and Development Co. Ltd. |
Anticorps pour le traitement du cancer
|
|
CA3226947A1
(fr)
|
2021-08-03 |
2023-02-09 |
Muhammad YASSIN |
Complexe tcr modifie et ses procedes d'utilisation
|
|
EP4130028A1
(fr)
|
2021-08-03 |
2023-02-08 |
Rhazes Therapeutics Ltd |
Complexe tcr modifié et leurs procédés d'utilisation
|
|
AU2022325816A1
(en)
|
2021-08-10 |
2024-03-21 |
Gamida-Cell Ltd. |
Engineered nk cells, methods of their production and uses thereof
|
|
GB202112865D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to black sigatoka disease in banana
|
|
GB202112866D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to fusarium wilt in a banana
|
|
IL286430A
(en)
|
2021-09-14 |
2023-04-01 |
Yeda Res & Dev |
Multispecific antibodies for use in the treatment of diseases
|
|
WO2023056361A1
(fr)
|
2021-09-29 |
2023-04-06 |
Board Of Regents, The University Of Texas System |
Anticorps anti-hsp70 et leurs utilisations thérapeutiques
|
|
EP4426821A1
(fr)
|
2021-11-02 |
2024-09-11 |
University of Massachusetts |
Protéines de fusion à domaine nme2cas9 incrusté
|
|
CN118284624A
(zh)
|
2021-11-19 |
2024-07-02 |
米罗生物有限公司 |
Pd-1抗体及其用途
|
|
US11833503B2
(en)
|
2021-12-07 |
2023-12-05 |
Insilixa, Inc. |
Methods and compositions for surface functionalization of optical semiconductor-integrated biochips
|
|
EP4444864A1
(fr)
|
2021-12-08 |
2024-10-16 |
Yeda Research and Development Co. Ltd |
Cellules progénitrices pulmonaires multipotentes pour la régénération pulmonaire
|
|
IL314470A
(en)
|
2022-01-25 |
2024-09-01 |
Medilink Therapeutics Suzhou Co Ltd |
Anti-Her3 antibody, conjugate and use thereof
|
|
GB202201137D0
(en)
|
2022-01-28 |
2022-03-16 |
Thelper As |
Therapeutic and diagnostic agents and uses thereof
|
|
KR20240146674A
(ko)
|
2022-01-31 |
2024-10-08 |
제네반트 사이언시즈 게엠베하 |
지질 나노입자를 위한 이온화 가능한 양이온성 지질
|
|
EP4238988A1
(fr)
|
2022-03-01 |
2023-09-06 |
Consejo Superior De Investigaciones Científicas |
Anticorps dirigés contre le sars-cov-2 et leurs utilisations
|
|
CN114853890B
(zh)
|
2022-03-16 |
2023-04-28 |
沈阳三生制药有限责任公司 |
一种prlr抗原结合蛋白及其制备方法和应用
|
|
AU2023243615A1
(en)
|
2022-04-01 |
2024-11-14 |
Board Of Regents, The University Of Texas System |
Dual specificity antibodies to human pd-l1 and pd-l2 and methods of use therefor
|
|
GB202204813D0
(en)
|
2022-04-01 |
2022-05-18 |
Bradcode Ltd |
Human monoclonal antibodies and methods of use thereof
|
|
IL315888A
(en)
|
2022-04-06 |
2024-11-01 |
Mirobio Ltd |
Transgenic CD200R antibodies and their uses
|
|
US20230357851A1
(en)
|
2022-04-06 |
2023-11-09 |
Larimar Therapeutics, Inc. |
Frataxin-sensitive markers for monitoring frataxin-replacement therapy
|
|
WO2023209708A1
(fr)
|
2022-04-25 |
2023-11-02 |
Yeda Research And Development Co. Ltd. |
Compositions pour modifier la signalisation de messager secondaire de l'adp-ribose cyclique
|
|
WO2023240201A1
(fr)
|
2022-06-08 |
2023-12-14 |
Larimar Therapeutics, Inc. |
Marqueurs sensibles à la frataxine pour surveiller la progression et le traitement du syndrome de leigh
|
|
AU2023283727A1
(en)
|
2022-06-08 |
2024-12-12 |
Onkure, Inc. |
Benzopyrimidin-4(3h)-ones as pi3k inhibitors
|
|
EP4536276A1
(fr)
|
2022-06-10 |
2025-04-16 |
Research Development Foundation |
Variants de fc igg1 sélectifs de fcriib modifiés et leurs utilisations
|
|
CA3259098A1
(fr)
|
2022-06-20 |
2025-04-18 |
Sichuan Huiyu Seacross Pharmaceutical Technology Co., Ltd. |
Anticorps et son utilisation
|
|
WO2024012524A1
(fr)
|
2022-07-14 |
2024-01-18 |
苏州宜联生物医药有限公司 |
Conjugué anticorps-médicament, son procédé de préparation et son utilisation
|
|
WO2024028794A1
(fr)
|
2022-08-02 |
2024-02-08 |
Temple Therapeutics BV |
Méthodes de traitement de troubles de l'endomètre et de l'hyperprolifération ovarienne
|
|
WO2024040020A1
(fr)
|
2022-08-15 |
2024-02-22 |
Absci Corporation |
Enrichissement de cellule spécifique à une activité d'affinité quantitative
|
|
WO2024038160A1
(fr)
|
2022-08-18 |
2024-02-22 |
Vib Vzw |
Moyens et méthodes pour moduler l'excitabilité neuronale
|
|
KR20250080854A
(ko)
|
2022-09-08 |
2025-06-05 |
온쿠레 인코포레이티드 |
Pi3k 억제제로서의 이소퀴놀론
|
|
WO2024064024A1
(fr)
|
2022-09-19 |
2024-03-28 |
Onkure, Inc. |
Dérivés de ((4-oxo-3,4-dihydroquinazolin-8-yl)méthyl)amine utilisés en tant qu'inhibiteurs de p13k pour le traitement du cancer
|
|
KR20250068694A
(ko)
|
2022-09-20 |
2025-05-16 |
온쿠레 인코포레이티드 |
Mapk 경로 돌연변이로 인한 암의 치료를 위한 hdac 억제제 oki-179
|
|
EP4594348A1
(fr)
|
2022-09-27 |
2025-08-06 |
Vib Vzw |
Antiviraux dirigés contre le virus parainfluenza humain
|
|
WO2024081345A1
(fr)
|
2022-10-14 |
2024-04-18 |
Onkure, Inc. |
Benzopyrimidin-4(3h)-ones utilisées en tant qu'inhibiteurs de pi3k
|
|
CN120379687A
(zh)
|
2022-10-14 |
2025-07-25 |
爱尔兰国立科克大学 |
胎盘表达的蛋白用于治疗肌腱损伤
|
|
WO2024102466A2
(fr)
|
2022-11-11 |
2024-05-16 |
Igan Biosciences |
Agents polypeptidiques de protéase iga
|
|
WO2024124041A1
(fr)
|
2022-12-07 |
2024-06-13 |
Advanced Cell Diagnostics, Inc. |
Détection multiplexée de cibles d'acides nucléiques
|
|
IL321992A
(en)
|
2023-01-09 |
2025-09-01 |
Univ Texas |
Human parainfluenza virus 3f proteins stabilized before transfusion
|
|
KR20250155004A
(ko)
|
2023-02-23 |
2025-10-29 |
유니버시티 오브 로체스터 |
폐쇄 말단 dna 가닥 분자를 제조하기 위한 제제 및 방법
|
|
CN121219008A
(zh)
|
2023-04-11 |
2025-12-26 |
斯特林知识产权私人有限公司 |
血液系统癌症的治疗
|
|
AU2024304180A1
(en)
|
2023-06-13 |
2026-01-08 |
Adcentrx Therapeutics, Inc. |
Methods and compositions related to antibodies and antibody drug conjugates (adcs) that bind nectin-4 proteins
|
|
WO2024261344A1
(fr)
|
2023-06-23 |
2024-12-26 |
Vib Vzw |
Nouveaux liants ciblant le pathogène résistant aux médicaments multiples acinetobacter baumannii
|
|
WO2025031446A1
(fr)
|
2023-08-09 |
2025-02-13 |
厦门大学 |
Polypeptide setdb1 citrulliné et son utilisation dans le diagnostic de la polyarthrite rhumatoïde
|
|
AU2024325407A1
(en)
|
2023-08-11 |
2026-02-19 |
Onkure Therapeutics, Inc. |
Benzopyridinones and benzopyrimidinones as pi3k inhibitors
|
|
WO2025052278A1
(fr)
|
2023-09-05 |
2025-03-13 |
Genevant Sciences Gmbh |
Lipides cationiques à base de pyrrolidine pour administration de nanoparticules lipidiques d'agents thérapeutiques à des cellules stellaires hépatiques
|
|
AU2024339036A1
(en)
|
2023-09-07 |
2026-03-12 |
University Of Tennessee Research Foundation |
Method for diagnosing amyloid diseases
|
|
WO2025125577A1
(fr)
|
2023-12-14 |
2025-06-19 |
Vib Vzw |
Anticorps dirigés contre le virus de la grippe b
|
|
WO2025133951A1
(fr)
|
2023-12-21 |
2025-06-26 |
Genevant Sciences Gmbh |
Lipides ionisables appropriés pour des nanoparticules lipidiques
|
|
WO2025150045A1
(fr)
|
2024-01-12 |
2025-07-17 |
Gabriel Nussbaum |
Cibles bactériennes, agents thérapeutiques, compositions, kits et procédés d'utilisation dans le traitement et/ou la prévention du cancer
|
|
WO2025155991A2
(fr)
|
2024-01-19 |
2025-07-24 |
Bpgbio, Inc. |
Biomarqueurs prédictifs pour la réponse à un traitement par coenzyme q10 dans le cadre d'un cancer du pancréas
|
|
WO2025202871A1
(fr)
|
2024-03-27 |
2025-10-02 |
Pfizer Inc. |
Procédés d'identification de biomarqueurs de réponse à un traitement et leur utilisation avec un inhibiteur de cdk4
|
|
WO2025207755A1
(fr)
|
2024-03-29 |
2025-10-02 |
Onkure, Inc. |
Quinolizinones utilisés en tant qu'inhibiteurs de pi3k
|
|
WO2025212360A1
(fr)
|
2024-04-01 |
2025-10-09 |
Onkure, Inc. |
Isoquinolones en tant qu'inhibiteurs de pi3k
|
|
WO2025255233A1
(fr)
|
2024-06-07 |
2025-12-11 |
Onkure, Inc. |
Composés contenant des noyaux tricycliques fusionnés utilisés en tant qu'inhibiteurs de pi3k
|
|
WO2025264533A1
(fr)
|
2024-06-17 |
2025-12-26 |
Adcentrx Therapeutics Inc. |
Procédés et compositions associés à des conjugués anticorps-médicament (adcs) qui se lient à des protéines steap-1
|
|
WO2026006151A2
(fr)
|
2024-06-24 |
2026-01-02 |
University Of Rochester |
Fonctionnalisation d'ace-arnt codant pour des picovecteurs linéaires synthétiques
|
|
WO2026008665A1
(fr)
|
2024-07-01 |
2026-01-08 |
Vib Vzw |
Liants du complexe pd-1•pd-l1 et leur utilisation
|
|
WO2026019976A1
(fr)
|
2024-07-17 |
2026-01-22 |
The Broad Institute, Inc. |
Agent de réticulation covalent universel pour conjugués anticorps-oligo
|
|
US20260078179A1
(en)
|
2024-07-18 |
2026-03-19 |
Novarock Biotherapeutics, Ltd. |
Cdh17 antibodies and uses thereof
|
|
WO2026022656A2
(fr)
|
2024-07-22 |
2026-01-29 |
Genevant Sciences Gmbh |
Formulations de particules lipidiques contenant des lipides cationiques chargés en permanence
|
|
WO2026022677A1
(fr)
|
2024-07-22 |
2026-01-29 |
Genevant Sciences Gmbh |
Lipides cationiques chargés en permanence
|
|
WO2026044000A1
(fr)
|
2024-08-20 |
2026-02-26 |
Ethyreal Bio, Inc. |
Anticorps multispécifiques et leurs méthodes d'utilisation
|
|
WO2026044153A1
(fr)
|
2024-08-21 |
2026-02-26 |
Bpgbio, Inc. |
Utilisation de biomarqueurs dans le diagnostic du cancer du pancréas
|
|
WO2026058262A1
(fr)
|
2024-09-16 |
2026-03-19 |
Esther Priel |
Composés dérivés de tri-phényle substitués, compositions les comprenant et applications de ceux-ci
|
|
WO2026083241A1
(fr)
|
2024-10-15 |
2026-04-23 |
Genevant Sciences Gmbh |
Lipides ionisables comprenant des esters d'hydroxylamine n,n-substitués
|